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Chapter 1
Introduction and Aim of the thesis






Circulatory shock (hereafter referred to as shock), or acute circulatory 
failure, is defined as systemic reduction of tissue perfusion or (micro)
circulatory arrest [1]. Shock is one of the most frequently diagnosed, 
but still poorly understood clinical conditions in critically ill patients. 
Shock is classically defined in clinical subcategories. Hemorrhagic shock 
(HS) because of massive bleeding is a form of hypovolemic shock and 
a major contributor to early mortality in surgical and trauma patients. 
Septic shock is a form of distributive shock and the host response to a 
systemic infection, and associated with the loss of peripheral resistance 
and maldistribution of blood flow [2]. 
Hemorrhagic shock and septic shock-associated multiple organ 
dysfunction syndrome (MODS) is still a major cause of morbidity and 
mortality in critical ill patients in Intensive Care Units (ICU) [1]. Multiple 
mechanisms may contribute to shock associated MODS, and include 
hemodynamic disturbances, impaired tissue oxygen delivery, systemic 
inflammation, and cross-talk between endothelial cells and leukocytes 
[3]. The systemic inflammatory cascade, which can be triggered by 
infections or a variety of non-infectious insults such as traumatic 
hemorrhage, ischemia, and burns, is considered as the leading cause 
for the development of MODS. The pathophysiology of systemic 
inflammation is characterized by initial release of pro-inflammatory 
and vasoactive mediators into the systemic circulation, which activate 
intracellular signaling pathways. These will cause amongst others, 
microvascular dysfunction and/or mitochondrial dysregulation, resulting 
in tissue hypoperfusion and biochemical and biophysical alterations, 
finally leading to MODS [3, 4]. 
To restore the circulating volume and limit tissue hypoxia, resuscitation 
by intravenous fluids and administration of vasopressors is frequently 
used as the initial therapeutic intervention in hemorrhagic shock and 
septic shock patients [5]. However, the optimal resuscitation strategy is 
controversial and the type and dose of fluid, the control of bleeding and 
blood pressure, and the prevention of traumatic coagulopathy are not 
without debate [6-8]. 
Being highly responsive to local blood flow and disturbances in 
blood composition, endothelial cells are both active participants 
and mediators in the pathogenesis of shock-induced MODS [9]. The 
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clinical hallmarks of shock - hypotension, vascular leakage, systemic 
inflammation responses, and leukocyte recruitment - are all regulated 
at the level of endothelial cells in the microvasculature. Thus endothelial 
cells are potential targets for therapeutic interventions in the treatment 
of shock-associated MODS. 
1.1.1 Hemorrhagic shock and sepsis preclinical animal models
Two clinically frequently encountered forms of shock are associated 
with hemorrhage and sepsis.
Hemorrhagic shock (HS) is defined as a clinical syndrome resulting 
from decreased blood perfusion in vital organs due to a loss of 
intravascular blood volume. Upon hemorrhage, the initial compensatory 
mechanisms can result in arterial vasoconstriction and increased heart 
rate, which are able to maintain blood pressure and redistribute the 
cardiac output in favor of vital organs [10]. However, these endogenous 
mechanisms have limited capacity, and early and effective therapies 
are needed to counteract the occurrence of cellular dysfunction and 
organ damage when counteractive mechanisms do not suffice anymore 
[11]. Besides contributing to the development of MODS as described 
above, HS is associated with the risk of secondary infections, such as 
pneumonia and sepsis.
To study the effects of HS on organ function and investigate effects 
of potential treatment strategies, several experimental animal models 
of HS have been developed, and include (1) fixed-volume hemorrhage, 
(2) fixed-pressure hemorrhage, and (3) uncontrolled hemorrhage [10]. 
In the animal model of fixed-volume hemorrhage, a predetermined 
percentage of the calculated total blood volume is removed over a 
dedicated time period. The advantage of such a model is that the 
physiological hemodynamic responses and the natural compensatory 
mechanisms following acute blood loss of a specific volume can be 
studied. The disadvantage is that the degree of hypotension is poorly 
defined, which may be associated with uncertain severity of the disease. 
In the fixed-pressure hemorrhage, animals are subjected to bleeding 
until the mean arterial pressure (MAP) reaches a predetermined level. 
Additional blood withdrawal or restitution of small volumes of blood is 
performed to maintain MAP at this level during the shock period. In this 
type of model, the degree and duration of hypotension are accurately 
controllable by monitoring the blood pressure, which contributes to the 





experimental reproducibility and standardization. On the other hand, this 
model eliminates the effects of the compensatory mechanisms, which 
does not reflect the clinical situation. In an uncontrolled hemorrhage 
model, hemorrhage is induced by a standardized vascular trauma. This 
model might be the most clinically relevant rodent model, and would 
be the best model for preclinical testing of various therapies, though 
the reproducibility of the results is limited. In this thesis, taking model-
related pathophysiology, reproducibility and reliability into account, the 
pressure-fixed hemorrhage model is used to evaluate microvascular 
endothelial behavior in major organs and MODS as well as the effects of 
pharmacological interventions.
Sepsis is characterized by the host response to (proven or suspected) 
overwhelming infection induced by bacteria or other pathogens [12]. 
Despite early diagnosis, removal of the septic focus by surgery or drainage, 
or the early application of antibiotics, sepsis remains the leading cause 
of death in critically ill patients. The pathophysiological complexity of 
sepsis makes the development of therapeutic drugs to counteract its 
consequences difficult [5, 13]. Clinically, sepsis is recognized as a disease 
continuum with progressively increased mortality rates from sepsis 
to severe sepsis when sepsis is accompanied by acute organ failure, 
and to septic shock when organ failure is accompanied by refractory 
hypotension [5]. In the development of sepsis, the host immune response 
is characterized by an initial pro-inflammatory response (systemic 
inflammatory response syndrome, SIRS) followed by immune paralysis 
(compensatory anti-inflammatory response syndrome, CARS) which is 
responsible for secondary infections. The excessive host response will 
induce microcirculatory alterations, tissue edema by capillary leakage, 
and leukocyte recruitment which will lead to tissue damage and MODS 
[3, 14].
Several animal models of sepsis have been developed to study sepsis 
pathogenesis and to test potential therapeutic agents [15]. These models 
include (1) endogenous bacterial product or bacterial toxin injection 
(amongst others the injection of lipopolysaccharide (LPS) which is a part 
of the outer membrane of Gram-negative bacteria), (2) disruption of an 
endogenous protective barrier (e.g., cecal ligation and puncture, CLP), 
and (3) intravenous or intrapulmonary infusion of exogenous bacteria. 
Recently the role of rodent models in predicting human pathology 
for systemic inflammatory response syndrome has been extensively 
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debated [16, 17]. Two drawbacks of all sepsis models with respect to 
clinical relevance are the differences in disease progress kinetics and 
the lack of clinically used supportive therapeutic interventions. The 
onset and development of sepsis to organ damage occurs in hours to 
days in most animal models, while in patients it may take a longer time. 
Moreover, modern ICU mechanical ventilation and other supportive 
measures are applied in the course of septic shock in patients, and 
these interventions cannot be easily mimicked in rodent animal models 
[18]. Despite these disadvantages, the animal sepsis models have 
contributed significantly to our understanding of the pathogenesis of 
sepsis [13]. In this thesis, the endotoxemia model induced by systemic 
LPS administration is employed because of its high reproducibility in 
pathophysiological reactions and its reliability to mimic some of the 
initial clinical features of sepsis in patients, including vasodilatation, 
release of inflammatory mediators, and increased vascular leakage [13]. 
Moreover, the intravenous LPS injection can be performed in human 
volunteers, which could be helpful for the translation of mouse data to 
human species [19].
1.1.2 Inflammatory responses in hemorrhagic shock and sepsis 
The process of inflammation starts with a response of the innate 
immune system to an injurious stimulus. Pattern recognition receptors 
(PRR) on immune cells (e.g., macrophages, monocytes, or dendritic 
cells) recognize the pathogen-associated molecular patterns (PAMPs) 
associated with infections and damage-associated molecular patterns 
(DAMPs) associated with tissue injury, leading to the release of cytokines 
by the immune cells and initiation of the inflammatory responses. HS is 
conceived as a global ischemic insult that is frequently associated with 
a systemic inflammatory response triggered by cell disruption/tissue 
damage-induced endogenous DAMPs, which renders shock patients to 
develop MODS and secondary infections [20]. Conventional resuscitation 
fluids can restore circulatory volume and tissue perfusion, but they can 
also trigger even more severe inflammatory responses [21]. 
The dysregulation of the immune system is also a notable feature of 
severe sepsis. During sepsis, the binding of infection-associated PAMPs 
to PRR, e.g., toll-like receptor (TLR)-4 on several cell types, induces the 
production of cytokines and chemokines, resulting in the activation of the 
immune system and endothelium. The severity of the sepsis-associated 





initial pro-inflammatory response affects the intensity of multiple organ 
dysfunction and shock [22]. Following the initial inflammatory response, 
a hypo-inflammatory state occurs to limit the excessive production of 
cytokines and organ damage [23]. This immunodeficiency state can 
lead to secondary infections that contribute to the failure of recovery of 
sepsis patients [22]. 
The release of cytokines and chemokines is an important factor in the 
development of SIRS. Upon infectious or non-infectious injury, TNFα, 
interleukin (IL)-1β, IL-6, and IL-8 are released excessively in a sequential 
manner, resulting in a cytokine storm [24]. TNFα and IL-1β, which are 
most rapidly produced, are considered the main inducers of most of 
the initial pathophysiological disturbances, such as the production of 
nitric oxide, the activation of cyclooxygenase enzymes, the expression 
and release of adhesion molecules, the increase of endothelial cell 
permeability, and the release of other cytokines and chemokines such 
as IL-6 and IL-8 [25, 26]. The serum levels of IL-6 have been reported 
to correlate with the degree of tissue injury, indicating that IL-6 is a 
clinically relevant and useful parameter to estimate the clinical course 
and outcome of the severe trauma and/or sepsis [27, 28]. IL-8 is a 
potent chemoattractant secreted by multiple cell types in response 
to inflammatory stimuli . Its production following injury leads to the 
recruitment and activation of leukocytes at the site of injury, therefore 
playing an important role in the pathophysiology of inflammation [29]. 
Anti-IL-8 antibody dramatically suppressed accumulation of neutrophils 
in the alveolar space and prevented LPS challenge-induced acute 
lethality [30]. 
1.1.3 Endothelial cells in shock
The vasculature plays a pivotal role in the pathogenesis of MODS in 
shock, and as mentioned above, is involved in the processes underlying 
tissue hypoperfusion, increased vascular permeability, and leukocyte 
influx into organs. Throughout the body, the vasculature consists of 
large arteries and veins, small arterioles and venules, and capillaries. 
The vascular segments differ in their architectures and functions and 
play distinct roles in health and diseases [31]. The inner surface of all 
blood vessels is covered by endothelial cells. In arteries and veins, the 
endothelium forms a continuous uninterrupted layer of endothelial 
cells, held together by tight junctions, while the endothelium in 
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capillaries and post-capillary venules - which have no muscle cell layer 
- may be continuous or discontinuous, and forms a barrier for selective 
permeability based on the needs of the underlying tissue [32]. Endothelial 
cells are highly active in sensing and responding to the stresses induced 
by alterations of the local extracellular microenvironment, as for 
instance experienced during shock, thereby modulating a variety of 
vascular functions [9]. 
Upon inflammatory insults, the transmigration of leukocytes into 
underlying tissues in organs mainly occurs in the capillaries and post-
capillary venules to induce a local immune response [33]. This process 
is facilitated by a sequential and multi-step adhesion cascade between 
leukocytes and endothelial cells [34], as indicated in Figure 1. The initial 
step of leukocyte recruitment is the tethering and/or rolling of leukocytes 
on the endothelium mediated by the interactions between amongst 
others endothelial and leukocyte selectins (P-selectin, E-selectin, 
L-selectin) and their counter ligands such as P-selectin glycoprotein 
ligand-1 (PSGL-1) [34]. Following rolling, leukocytes are activated by 
signaling molecules recognized by G-protein-coupled receptors (e.g., 
inflammatory lipids, chemokines, chemoattractants), resulting in the 
activation of leukocyte integrin receptors such as lymphocyte function 
associated antigen (LFA)-1, macrophage antigen (Mac)-1, and very late 
antigen (VLA)-4. The activation of integrin receptors will increase the 
affinity of leukocytes for their endothelial ligands that belong to the 
immunoglobulin gene superfamily (IgSF), including vascular cell adhesion 
molecule (VCAM)-1 and intercellular adhesion molecule (ICAM)-1, 
which facilitate the firm adhesion of leukocytes to the endothelium 
[35]. Eventually, adherent leukocytes will transmigrate through the 
vessel wall to inflammatory sites mediated by integrins and endothelial 
intercellular tight junction molecules such as Platelet-endothelial 
adhesion molecule-1 (PECAM-1) [35]. Other players that have been 
implicated in the process of leukocyte-endothelial transmigration have 
been reviewed by Muller [36].
1.1.4 Microcirculatory alterations in shock
Local blood flow causes mechanical stress in the blood vessel wall. This 
mechanical stress can be divided into two categories: a) circumferential 
stress due to pulse pressure variation inside the vessel, and b) shear stress 
due to blood flow [37]. Circumferential stresses due to blood pressure 





Figure 1. The multistep interaction of leukocyte and endothelial cells. Under flow 
conditions, activated endothelial cells are triggered to express selectins (P-selectin 
and E-selectin) on their surfaces, which will interact with their ligands such as 
P-selectin glycoprotein ligand-1 (PSGL-1), mediating the capture and rolling of fast-
moving leukocytes. The interactions of L-selectin on leukocytes with ligands on 
inflamed endothelial cells and other leukocytes also mediate the capture and rolling 
process [34]. Thereafter, chemokines and other pro-inflammatory molecules activate 
leukocyte integrin receptors and their endothelial ligands of the immunoglobulin 
gene superfamily (IgSF) including vascular cell adhesion molecule (VCAM)-1 and 
intercellular adhesion molecule (ICAM)-1. Integrin-IgSF interactions are involved in the 
firm adhesion and arrest of leukocytes on the endothelium. The migration of leukocytes 
into underlying tissues is mediated by integrin binding to extracellular matrix ligands 
and endothelial tight junction adhesion molecules [35]. Capture, rolling, firm adhesion, 
and transmigration all happen in parallel, involving different leukocytes in the same 
microvessels.
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are transferred to all vessel wall layers (intima, media and adventitia) 
while shear stress is applied mainly to the endothelium being directly 
in contact with the blood. Hemodynamic forces are heterogeneous due 
to the differences in blood vessel geometries and the different regions 
of the vasculature. Wall shear stresses due to blood flow at different 
locations in the circulation have been estimated [38, 39]. Blood flow in 
vivo is pulsatile in arterioles while it tends to be laminar in vessels larger 
than 0.5mm in diameter. Mean shear stress is the lowest in large veins, 
such as vena cava where it is often lower than 1 dyne/cm2, while small 
arterioles tend to face the highest shear stress which can reach 60 to 80 
dyne/cm2, and blood flow in small venules is also high (20 to 40 dyne/
cm2) [38]. It has been estimated using a computer modeling approach 
that shear stress in glomerular capillaries ranges from approximately 
1 to 95 dyne/cm2 [40].  Shear stress-induced mechanotransduction, 
which represents the cellular responses to physical alterations in the 
local environment, is an important property of endothelial cells, and 
regulates endothelial behavior, including cell proliferation/survival, 
metabolism, cytoskeletal reorganization, and cell morphology [41]. 
Mechanosensors of endothelial cells include membrane proteins, 
integrins, ion channels, and intercellular junction proteins, as well as 
local membrane structures, such as caveolae, cytoskeleton, membrane 
lipids, and glycocalyx [42]. Upon initial application of laminar shear 
stress, mechanosensors respond through adaptor molecules to 
trigger the activation of a cascade of signaling pathways, such as 
phosphatidylinositol-3-kinase (PI3K)/Akt, and mitogen-activated 
protein kinases (MAPKs) [43-45]. Thereafter, transcription factors and 
cofactors, e.g., Kruppel-like factor (KLF)-2, nuclear factor (NF) -κB, 
and activator protein (AP)-1, are activated to regulate the expression 
of several functional genes, such as endothelial nitric oxide synthase 
(eNOS), VCAM-1, monocyte chemoattractant protein (MCP)-1, and 
Angiopoietin (Ang)-2 [46, 47]. Shear stress with different patterns 
distinctly influences endothelial gene expression and induces different 
functional consequences via complex mechanisms, which will here 
not be further discussed as most of the studies in this respect have 
been focused on flow profiles observed in arteriosclerosis occurring in 
arteries. Yet, since endothelial cells can adapt themselves to a sudden 
increase or decrease of shear stress from normal levels due to changes 
in blood flow, investigation of the underlying processes may contribute 





to a better understanding of their roles in specific pathophysiological 
conditions in the microvasculature, as encountered in hemorrhagic 
shock and septic shock-associated organ hypoperfusion.
In hemorrhagic shock, acute bleeding leads to a decrease in the 
circulating blood volume, which leads to macrovascular hemodynamic 
abnormalities, e.g., decreased cardiac output and systemic 
hypotension, and alterations in the microcirculation. Both the macro- 
and microcirculation respond rapidly to compensate for the loss of 
circulating volume and to limit tissue hypoxia. The macrovascular 
response involves the autonomic nervous system-modulated increase 
in heart rate and arterial vasoconstriction, which will redistribute the 
remaining blood volume from the splanchnic, musculocutaneous, and 
renal circulation to vital organs such as the brain and the heart [48, 
49]. The microcirculation distributes blood flow throughout individual 
organs to provide adequate oxygen delivery for every cell in the organs. 
Upon HS, in addition to the macrovascular redistribution, the blood 
is also redistributed within the microvascular networks of each organ 
according to oxygen demand as well as arteriolar and capillary resistances 
[49]. However, these adaptive mechanisms are limited. Upon severe 
hemorrhage, alterations of microcirculatory blood flow will contribute 
to the development of organ dysfunction despite the microvascular 
compensatory mechanisms. Persistent decrease in cardiac output and 
oxygen delivery induces a progressive decrease in capillary blood flow 
and functional capillary density with increased perfusion heterogeneity 
[50]. 
In septic shock, marked alterations in microcirculation have been 
observed in multiple experimental and clinical trials [14, 51, 52]. While 
a dense network of capillaries exists under normal conditions, patients 
with severe sepsis have a decrease in functional capillary density 
and microvascular blood flow as well as an increase in heterogeneity 
of capillary perfusion due to the presence of intermittently or non-
perfused capillaries in close proximity to well-perfused capillaries 
[1, 14], as shown by the sublingual microcirculation under sepsis 
condition [51]. These microvascular changes are more pronounced 
in non-survivors than in survivors [52]. Microcirculatory alterations in 
sepsis may be explained by multiple mechanisms, involving endothelial 
activation, impaired endothelial cell sensitivity to vasoconstricting 
and vasodilating agents,  glycocalyx degradation, increased leukocyte 
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adhesion on the endothelium, enhanced microvascular permeability 
with capillary leakage [14, 53]. Furthermore, the diffusion distance for 
oxygen is changed due to the decreased capillary density and increased 
heterogeneous microvascular blood flow, leading to alterations in oxygen 
extraction and tissue oxygenation even in the well-perfused organ [54, 
55]. Although fluid resuscitation and vasoactive reagents may reverse 
the systemic hemodynamic alterations, the significant microvascular 
alterations may persist and contribute to the development of MODS 
[52]. Several trials have demonstrated the association between the 
severity of microvascular dysfunction and the development of organ 
dysfunction and mortality [56, 57]. Thus the crucial issue is to understand 
the contribution of the underlying molecular processes that lead to 
these microvascular alterations, and whether they can be improved 
with therapy.
The scope of the thesis encompasses shear stress and inflammatory 
activation related endothelial cell responses and the pharmacological 
intervention aimed at microvascular endothelial responses in 
hemorrhagic shock and sepsis.
1.1.5 Therapeutic interventions in the treatment of shock
In both HS and sepsis, the overwhelming inflammatory responses 
can be more threatening than the initial insults. Therefore, efficient 
anti-inflammatory strategies would potentially provide therapeutic 
benefits for both HS and septic patients, yet until now no clinical proven 
therapies are available [58]. IkappaB kinase (IKK)/NF-κB signaling is 
crucially involved in regulating the expression of many inflammatory 
mediators. Inappropriate and prolonged activation of NF-κB has 
been linked to several inflammation-associated diseases [59, 60]. It is 
tempting to speculate that IKK/NF-κB signaling can thus be considered 
an important therapeutic target for reducing tissue injury in shock 
patients  [61]. Several strategies exist to block the activation of NF-κB, 
including NF-κB-specific oligodeoxynucleotide (ODN) decoys which can 
inhibit the DNA binding activity of NF-κB [62, 63], the mutation of the 
functional part of IκB, a primary endogenous inhibitor of NF-κB, to block 
its phosphorylation-dependent degradation while keeping its NF-κB 
binding activity, or direct overexpression of intracellular levels of IκB to 
retain NF-κB inactivated in the cytoplasm. In addition, NF-κB activation 
can be selectively inhibited by several small chemical pharmacological 





inhibitors at different activation steps of this signaling pathway [61]. 
BAY11-7082, a selective IKK inhibitor, can effectively inhibit the 
activation of IKK, thereby inhibiting the phosphorylation of IκB and 
in turn attenuating the nuclear translocation of NF-κB, leading to the 
inhibition of the transcription of a variety of pro-inflammatory genes 
including cytokines, chemokines, and endothelial adhesion molecules. 
Furthermore, the transcription of genes is partly modulated by 
posttranslational modifications. Amongst others lysine (de)acetylation 
affects a large number of histone and non-histone proteins. The 
significance of histone acetylation lies in the modification of chromatin 
structure and dynamics, and thereby gene transcription regulation. The 
acetylation of non-histone proteins plays an important role in regulating 
mRNA stability, protein localization, degradation, and protein-protein 
and protein-DNA interactions [64]. Lysine acetylation which is associated 
with transcriptional activation is mediated by histone acetyltransferases 
(HATs) that transfer acetyl groups from acetyl-coenzyme A to the 
amino group of lysines. The activity of HATs is counterbalanced by the 
activity of histone deacetylases (HDACs), which mediate the removal 
of acetyl group from the lysine residues. Both hemorrhage and sepsis 
are associated with an imbalance in the activities of HATs and HDACs 
in favor of deacetylation of proteins, and HDAC inhibitors can induce 
protein acetylation and restore this balance [65]. The reported pro-
survival and anti-inflammatory effects of HDAC inhibitors indicate the 
emerging roles of HDAC inhibitors in therapeutic interventions of HS 
and septic shock [65]. The short chain fatty acid valproic acid (VPA) 
besides being frequently used in the long-term therapy of epilepsy and 
bipolar disorder, has been reported to have direct inhibitory effect on 
the catalytic activity of HDACs [66]. VPA modulates protein acetylation 
via reversing HDAC-mediated transcriptional repression, thereby 
mediating various cell functions such as cell differentiation and cell 
apoptosis, which can be used as a strategy for treatment of cancers 
[67-69]. More recently, VPA as HDAC inhibitor has been shown to have 
anti-inflammatory effects [70, 71], and proven beneficial against HS-
associated apoptosis and organ injury [72, 73].
1.1.6 Endothelial targeted delivery of drugs in shock 
The aim of drug delivery is to target drugs into selected cell populations 
to increase drug efficacy while concomitantly reducing toxicity or 
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disadvantageous pharmacokinetic behavior of the drug. Endothelial 
cells are easily accessible for intravenously administered substances 
and their heterogeneity allows for organ and/or disease specific drug 
delivery, which makes them an attractive target for selective drug 
delivery approaches, also in the context of therapeutic intervention in 
shock [74, 75].
Drug delivery systems such as lipid based liposomal formulations are 
often based on passive targeting of liposomes to sites with increased 
vascular permeability including sites of inflammation [76]. However, 
upon inflammatory stimulation, organs also display a vascular bed 
specific pattern of expression of adhesion molecule such as E-selectin 
and VCAM-1 [21, 77], providing opportunities to specifically deliver 
compounds to (micro)vascular endothelial subsets [78, 79].
Glucocorticoids inhibit many of the initial events in an inflammatory 
response and are extensively used for the treatment of both acute and 
chronic inflammatory diseases, such as ischemia, sepsis, asthma, and 
rheumatoid arthritis. Glucocorticoids exert their effects by binding to 
glucocorticoid receptors (GRs) in the cytoplasm which then dimerize 
and translocate into the nucleus where they can bind to glucocorticoid 
responsive elements on glucocorticoid-responsive genes, resulting 
in increased transcription of, e.g., anti-inflammatory genes. The 
transrepression effect of glucocorticoids on the expression of multiple 
inflammatory genes is considered as indirect genomic effects due 
the inhibition, by activated GRs, of activated transcription factors, 
such as NF-κB and activator protein (AP)-1, which in turn regulate the 
transcription of inflammatory genes [80]. The molecular mechanisms 
of glucocorticoids fit the pathophysiological mechanisms of sepsis 
and are appropriate to counteract the uncontrolled inflammation 
and to restore organ functions during sepsis [81]. However, systemic 
administration of glucocorticoids, especially at high doses or over a 
long period of time, has adverse effects. For instance, glucocorticoids 
can lead to hyperglycemia as they reduce peripheral use of glucose 
(due to reduced insulin sensitivity) and increase glucose production 
and induce immunodeficiency, resulting in higher susceptibility of the 
host to infections [82]. Moreover, it has been demonstrated that the 
administration of glucocorticoids fails to improve survival in patients 
with septic shock [83]. Thus, to minimize undesired side effects and to 
improve therapeutic effectiveness of glucocorticoids, endothelial cell 





targeted delivery of glucocorticoids to endothelial cells by selective 
drug carriers can be a promising strategy. Using endothelial cells specific 
selective drug carrier, we have previously demonstrated in a murine 
model of glomerulonephritis that endothelial specific delivery of the 
liposome-encapsulated dexamethasone locally inhibits the expression 
of pro-inflammatory genes without affecting blood glucose levels [84]. 
1.2 Aim of the thesis 
Despite substantial knowledge about the pathophysiology of shock, 
designing an effective strategy for the treatment of this condition is 
still a challenge. We and others previously showed that hemorrhage 
and sepsis-related shock induce pro-inflammatory activation of 
microvascular endothelial cells in an organ and microvascular segment 
specific manner [21, 85]. Creating a better understanding of the 
underlying molecular control of endothelial behavior during shock to 
assist in identifying potential targets for therapeutic intervention is the 
overall aim of this thesis. 
The occurrence of blood flow disturbances in the vascular system is a 
hallmark of circulatory shock. Little insight is available on the effects of 
flow cessation and its later recovery on endothelial activation as appear 
in hemorrhagic shock and subsequent resuscitation. In order to study 
flow alterations separately from shock-associated cytokine production 
and leukocyte activation as well as tissue hypoxia as occur in vivo, we 
chose in Chapter 2 an in vitro approach to dissect blood flow changes 
from the other co-existing factors. We investigated the role of shear 
stress and shear stress alterations per se on endothelial activation as 
well as their effects on endothelial responses to concomitant cytokine 
challenge. 
A role of epigenetic mechanisms, more specifically of histone (de)
acetylation, in regulating endothelial gene expression and function 
in response to shear stress has recently emerged [86]. Furthermore, 
IKK/NF-κB signaling is known to play a central role in controlling pro-
inflammatory activation of cells. To better understand these molecular 
mechanisms in microvascular endothelial activation during these 
processes as occur during circulatory shock and resuscitation, we 
investigated in Chapter 3 endothelial responses to the pre-incubation 
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of histone deacetylase inhibitor valproic acid and IKK inhibitor BAY11-
7082 during flow cessation and subsequent reflow in the absence and 
presence of cytokines in the in vitro cell culture model. 
Considering the limitations of the in vitro loss of flow/restoration 
of flow model as it cannot completely mimic the microenvironment 
of endothelial cells in tissues, we studied in Chapter 4 the effects of 
the histone deacetylase inhibitor valproic acid and the IKK inhibitor 
BAY11-7082 on microvascular endothelial behavior in a mouse model 
of pressure-controlled hemorrhagic shock and resuscitation.
Besides hemorrhage induced flow disturbances, bacterial infection-
induced sepsis and septic shock are also common causes of death 
in hospitalized patients. Glucocorticoids have been frequently 
recommended in the treatment of inflammatory diseases as they might 
blunt the overwhelming immune response. However, the systemic 
administration of glucocorticoids is associated with side effects such 
as immunodeficiency [82] and is lack of proven clinical benefit in the 
treatment of sepsis [83]. In Chapter 5, using an lipopolysaccharide 
(LPS)-induced endotoxemia mouse model, we aimed to selectively 
deliver dexamethasone, a clinically applied glucocorticoid, to activated 
endothelial cells by endothelial targeted immunoliposomes, and to 
determine its pharmacological effects on endothelial pro-inflammatory 
responses induced by LPS. 
Finally, in Chapter 6, the results of the studies presented in this thesis 
are summarized and discussed in the context of our current knowledge, 
and new insights and possible implications of our findings are put in 
perspective for future investigation. 
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Circulatory shock and resuscitation is associated with systemic hemody-
namic changes, which may contribute to the development of multiple 
organ dysfunction syndrome (MODS). In this study, we used an in vitro 
flow system to simulate the consecutive changes in blood flow as oc-
cur during hemorrhagic shock and resuscitation in vivo. We examined 
the kinetic responses of different endothelial genes in HUVEC pre-con-
ditioned to 20 dyne/cm2 unidirectional laminar shear stress (LSS) for 48 
hours to flow cessation and abrupt reflow, respectively, as well as the ef-
fect of flow cessation and reflow on tumor necrosis factor alpha (TNFα) 
induced endothelial pro-inflammatory activation. Endothelial CD31 and 
VE-cadherin were not affected by the changes in flow in the absence 
or presence of TNFα. The mRNA levels of pro-inflammatory molecules 
E-selectin, VCAM-1 (vascular cell adhesion molecule-1), and IL-8 (Inter-
leukin-8) were significantly induced by flow cessation respectively acute 
reflow, while ICAM-1 (intercellular adhesion molecule-1) was downre-
gulated upon flow cessation and induced by subsequent acute reflow. 
Flow cessation also affected the Ang/Tie2 (Angiopoietin/Tie2 receptor 
tyrosine kinase) system by downregulating Tie2 and inducing its en-
dothelial ligand Ang2, an effect that was further extended upon acute 
reflow. Furthermore, the induction of pro-inflammatory adhesion mo-
lecules by TNFα under flow cessation was significantly enhanced upon 
subsequent acute reflow. This study demonstrated that flow alterations 
per se during shock and resuscitation contribute to endothelial activati-
on and that these alterations interact with pro-inflammatory factors co-
existing in vivo such as TNFα. The abrupt reflow related enhancement of 
cytokine-induced endothelial pro-inflammatory activation supports the 
concept that sudden regain of flow during resuscitation has an aggrava-
ting effect on endothelial activation, which may play a significant role 
in vascular dysfunction and consequent organ injury. This study implies 
that the improvement of resuscitation strategies and the pharmacolo-
gical interference with pro-inflammatory signaling cascades at the right 
time of resuscitation of shock patients may be beneficial to regain and/
or maintain organ function in patients after circulatory shock.
Thesis Ranran Li.indb   32 20-08-15   14:03
209753-L-sub01-bw-Li
33
Abrupt reflow enhances pro-inflammatory activation
2
Introduction
Vascular endothelial cells are constantly exposed to blood flow 
under normal physiological conditions. Shear stress produced by the 
blood flow modulates the structure and function of endothelial cells 
(1). The occurrence of blood flow disturbances in the vascular system 
is a hallmark of circulatory shock, which is defined as reduced organ 
perfusion or (micro)circulatory arrest, and contributes to patient 
morbidity and mortality (2). Systemic inflammatory response is 
conceived as the leading cause of the development of multiple organ 
dysfunction syndrome (MODS) following shock. In hemorrhagic shock 
mice, endothelial cells show early pro-inflammatory activation and 
vascular destabilization, a phenotype which is augmented in the 
early stage of resuscitation after hemorrhagic shock (3). Activated 
endothelial cells express adhesion molecules and chemokines which 
mediate interactions between leukocytes and endothelial cells as well 
as subsequent leukocyte migration into tissues that plays a critical role 
in organ injury (4). 
Events proposed to be involved in endothelial activation and 
organ injury during hemorrhagic shock and resuscitation encompass 
leukocyte activation (5), the release of cytokine by innate immune cells 
(6), and hemodynamic alterations of microcirculatory blood flow (2). 
Elucidating endothelial responses to these different variables may shed 
light on their relative contributions to pro-inflammatory activation and 
vascular destabilization. They furthermore can support rational design 
of therapeutic strategies for maintaining proper organ function during 
microcirculatory arrest in shock and resuscitation as well as the period 
thereafter. 
In the present study, our interest was to investigate the role in 
endothelial activation of flow cessation and its later recovery as 
appear in hemorrhagic shock and subsequent resuscitation. As it is 
difficult, if not impossible, to study in vivo flow alterations separately 
from consequential cytokine production and leukocyte activation and 
tissue hypoxia, we chose an in vitro approach to dissect flow changes 
from the other co-existing factors. The aim of this study was to better 
understand the role of shear stress and shear stress changes per se in 
endothelial activation, and to evaluate their effects on concomitant 
cytokine challenge. For this purpose, we used endothelial cells that 





were pre-adapted to 48 hour laminar shear stress (LSS) to represent 
the condition of continuous blood flow in vivo until hemorrhagic shock 
and resuscitation happen. Endothelial pro-inflammatory activation and 
vascular integrity related molecules were studied during these flow 
changes (Figure 1A). They include Tie2, the expression of which was 
lost in hemorrhagic shock/resuscitation (7), and Angiopoietin-2 (Ang2), 
the vasculature destabilizing ligand of Tie2 signaling, which is known to 
be released by Weibel-Palade bodies upon stimulation and has a role 
in ischemia induced pro-inflammatory activation (8). We furthermore 
examined the responses of VE-cadherin and CD31 (or PECAM1) that 
function among others in endothelial permeability control (9, 10). 
Lastly we included cellular adhesion molecules E-selectin, VCAM-1, 
and ICAM-1 as well as chemokine IL-8 that were previously found to be 
regulated in vivo by installment of shock and following resuscitation (3). 
Transcription factor KLF2 was analyzed as a control gene to assess cell 
responsiveness to flow changes. 
Materials and methods
Cell culture 
Human umbilical vein endothelial cells (HUVEC) were obtained from 
the Endothelial Cell Facility of the UMCG. HUVEC were isolated from at 
least two umbilical cords and cultured on 1% gelatin coated plates or 
microchambers with medium (RPMI 1640, Lonza, BE) supplemented with 
endothelial growth factors, 20% heat inactivated fetal calf serum (FCS), 
2 mM L-glutamine, 5 U/ml heparin, 50 μg/ml endothelial cell growth 
factor, and antibiotics (100 IE/ml penicillin and 50 μg/ml streptomycin). 
HUVEC of passage 2 to 4 were used in this study. 
Flow experiments
HUVEC were detached with trypsin/EDTA and seeded in 1% gelatin-
coated microchambers (µ-Slide I 0.4 Luer, sterile, ibidi, Martinsried, 
Germany). 60,000 cells/cm2 were used to obtain confluent monolayers 
overnight. Cells were subjected to 20 dyne/cm2 LSS produced by 
flowing medium for 48 hours, where appropriate cells were subjected 
to flow cessation for indicated periods of time followed by reflow 
with 20 dyne/cm2 LSS for different time periods as indicated. For gene 
expression analysis, cells were lysed with RLT buffer containing 10% 
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Figure 1. Schematic representation of selected molecules investigated in endothelial 
cells and experimental setup of in vitro flow studies performed. 
(A) E-selectin, VCAM-1 and ICAM-1 are cellular adhesion molecules that mediate 
leukocyte-endothelial interactions in inflammation. IL-8 is a chemokine that is released 
upon activation to regulate leukocyte attraction. Ang2, released by Weibel-Palade 
bodies upon pro-inflammatory activation, binds to receptor Tie2, thereby destabilizing 
the vasculature. Ang2/Tie2 as well as CD31 and VE-cadherin play important roles in 
maintaining vascular integrity. KLF2 is a transcription factor that shows high sensitivity 
to shear stress exposure and is analyzed in this study to molecularly validate flow 
alterations. (B) Scheme of the experimental design: human umbilical vein endothelial 
cells (HUVEC) were seeded in ibidi microchambers and cultured overnight in static 
condition before exposure to unidirectional laminar shear stress (LSS). After 48 hours 
of 20 dyne/cm2 LSS adaptation, flow was stopped for indicated time periods to mimic 
the marked loss of shear associated with hemorrhagic shock in vivo. To mimic the 
subsequent resuscitation following hemorrhagic shock, laminar flow at 20 dyne/
cm2 was restarted for indicated time periods. At time points indicated in certain 
experiments, cells were further exposed to TNFα stimulation, which is prominently 
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β-Mercaptoethanol (see below). For flow cytometric assays, cells 
were first detached with EDTA/trypsin from the slides before further 
processing (see below). 
The experimental setup is illustrated schematically in Figure 1B. 
RNA isolation and quantitative RT-PCR 
Total RNA from cultured cells was isolated with the RNeasy Mini plus 
Kit, (Qiagen, Leusden, The Netherlands) according to the manufacturer’s 
instructions. Integrity of RNA was determined by gel electrophoresis, 
while RNA concentration (OD260) and purity (OD260/OD280) were 
measured using an ND-1000 UV-Vis spectrophotometer (NanoDrop 
Technologies, Rockland, DE, USA). One microgram of total RNA was 
subsequently used for the synthesis of cDNA with SuperScript III RNase 
reverse transcriptase (Invitrogen, Breda, The Netherlands) in 20µl final 
volume containing 250ng of random hexamers (Promega, Leiden, The 
Netherlands) and 40 units of RNase OUT inhibitor (Invitrogen). 1µl 
cDNA was used for each PCR reaction. The Assay-on-Demand primers 
purchased from Applied Biosystems (Nieuwerkerk aan den IJssel, The 
Netherlands) for quantitative PCR included housekeeping gene GAPDH 
(Glyceraldehyde-3-phosphate dehydrogenase, assay ID Hs99999905_
m1), CD31 (Platelet endothelial cell adhesion molecule, PECAM-1, assay 
ID Hs00169777_m1), VE-Cad (VE-cadherin, assay ID Hs00174344_m1), 
KLF2 (Kruppel-like factor-2, assay ID Hs00360439_g1), Tie2 (assay ID 
Hs00176096_m1), Ang2 (Angiopoietin-2, assay ID Hs00169867_m1), 
E-selectin (assay ID Hs00174057_m1), VCAM-1 (vascular cell adhesion 
molecule-1, assay ID Hs00365486_m1),  ICAM-1 (intracellular adhesion 
molecule-1, assay ID Hs00164932_m1), IL-8 (Interleukin-8, assay ID 
Hs00174103_m1). Quantitative PCR was performed in a ViiATM 7 real-
time PCR System (Applied Biosystems, Nieuwerkerk aan den IJssel, The 
Netherlands). Amplification was performed using the following cycling 
conditions: 15min 95˚C and 40 two-step cycles of 15sec at 95˚C and 
60sec at 60˚C.
Duplicate real time PCR analyses were executed for each sample, 
and the obtained threshold cycle values (CT) were averaged. According 
to the comparative CT method described in the ABI manual, gene 
expression was normalized to the expression of the housekeeping gene, 
yielding the DCT value. The average mRNA level relative to GAPDH was 
calculated by 2-ΔCT. 
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Data shows mean ± SD of one experiment with three replicates (n=3), 
which is representative of three independent experiments.
Flow cytometric analysis
After incubation at different conditions, HUVEC were detached with 
Trypsin/EDTA, and subsequently resuspended in 5% FCS solution to 
neutralize Trypsin/EDTA. After washing with PBS /5% FCS, HUVEC were 
incubated with monoclonal antibodies against E-selectin, VCAM-1 and 
ICAM-1 (hybridoma supernatants, kindly provided by Dr. M. Gimbrone, 
Boston, MA, USA), or with monoclonal antibody against CD31 (dilution 
1:25; DakoCytomation, the Netherlands) for 45min on ice followed 
by 45min incubation with FITC labeled rabbit anti-mouse antibodies 
(dilution 1:50; Jackson Immunoresearch, Suffolk, UK) on ice. Cells were 
fixed with 0.5% paraformaldehyde in PBS and the fluorescence was 
detected by flow cytometry using the FACSCalibur (Becton Dickinson, 
the Netherlands). Nonspecific binding was assessed by staining with 
irrelevant isotype-matched monoclonal antibody and fluorescence 
intensity was measured in arbitrary units corrected by isotype control.
Data shows mean ± SD of one experiment with three replicates (n=3), 
which is representative of three independent experiments.
Quantification of IL-8 protein levels by ELISA
To quantify the concentration of IL-8 protein in the medium under 
different conditions, medium supernatants were collected and protein 
expression of IL-8 was quantified using human IL-8 ELISA max standard 
sets (Biolegend, UK), according to the manufacturer’s instructions. In 
graphs, IL-8 levels were expressed as pg per ml per cm2 total cell surface 
to normalize for cell surface differences in different experimental 
conditions.
Statistical analysis 
Statistical significance of differences was studied by means of the 
Student’s T-test or a one way analysis of variance (ANOVA) followed 
by a Bonferoni correction for selected pairs of columns. All statistical 
analyses were performed using GraphPad Prism software (GraphPad 
Prism Software Inc., San Diego, California, USA). Differences were 
considered to be significant when P<0.05. 






The expression of endothelial genes is affected by prolonged laminar 
shear stress
Since LSS exposure for 1 to 2 days is essential for endothelial cells in 
vitro to develop maximal responses to the changes of flow in a more 
physiological way (11), endothelial cells in this study were allowed to be 
adapted to 48h of LSS before they were subsequently subjected to flow 
alterations (Figure 1B).
We first investigated the response of endothelial cells to prolonged 
LSS exposure at 20 dyne/cm2 for 48 hours. As shown in Figure 2, HUVEC 
cultured under LSS showed a significantly increased mRNA level of 
KLF2 compared to static control, which is in agreement with other 
studies (11, 12). At the same time, Tie2 was induced more than 3.5 
fold by prolonged LSS while Ang2 was downregulated by more than 
90% of initial expression in static conditions. Flow exposure suppressed 
the expression of adhesion molecules E-selectin and VCAM-1 as well 
as chemokine IL-8. In contrast, ICAM-1 expression was induced. The 
Figure 2. The expression of endothelial genes is affected by prolonged laminar shear 
stress. HUVEC were kept under static condition or exposed to laminar shear stress 
at 20 dyne/cm2 for 48 hours before gene expression analysis. mRNA levels of genes 
were determined by quantitative RT-PCR, using GAPDH as housekeeping gene. Values 
represent fold changes compared to static control. Data are expressed as mean ± SD, 
n=3. *, P<0.05, LSS exposure vs. static control.
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expression of CD31 and VE-cadherin in endothelial cells was unchanged 
during long-term flow exposure. Similar results were found at 24 hours 
though the changes were less extensive (data not shown).
Flow cessation after laminar shear stress pre-adaptation leads to a 
pro-inflammatory response of endothelial cells
To study the effect of loss of flow to represent the shock period 
in extensive hemorrhage, after initial 48h exposure of HUVEC to 20 
dyne/cm2 LSS flow was ceased completely for different time periods 
(Figure 3A). The gene expression results in Figure 3B showed that the 
expression of flow sensor KLF2 was rapidly abolished by flow cessation. 
In contrast, Tie2 expression was gradually downregulated after an initial 
slight increase, while the loss of flow significantly upregulated Ang2 
expression starting at a later time point, i.c., at 8h, and continuing up 
to 24h. E-selectin, VCAM-1 as well as IL-8 were induced by the loss of 
flow compared with LSS control, with an apparent peak expression of 
all three genes at 8h. After 24h loss of shear stress, VCAM-1 expression 
was still as high as its 8h expression level, while the expression of 
E-selectin and IL-8 had decreased but were still significantly higher 
than their levels under LSS conditions. The expression of ICAM-1, which 
was the only cellular adhesion molecule that was upregulated under 
LSS condition, was decreased upon loss of flow. Neither CD31 nor VE-
cadherin expression was markedly affected by flow cessation in vitro. 
At the protein level, the concentration of IL-8 in the medium of 
cells exposed to LSS was decreased compared to static control, while 
subsequent exposure to 8 hour flow cessation induced its upregulation 
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i.c., increased protein levels were measured upon LSS exposure while 
they decreased upon flow cessation (Figure 3D). At the same time, 
the expression levels of E-selectin and VCAM-1 protein did not change 
compared to baseline, which might relate to the limited extent of 
mRNA expression induction upon flow cessation. We also examined the 
expression of adhesion molecules at 24 hour, showing similar results as 
at the  8h time point (Figure 3D). Ang2 protein that is stored in Weibel-
Palade bodies may have been released into the medium upon the loss 
of flow, we however did not assess its concentration in the circulating 
medium in this study.
Although focusing on complete flow cessation, we found that 
reduction of shear stress from 20 dyne/cm2 to 5 dyne/cm2 also leads 
to endothelial activation. Under this condition, the pro-inflammatory 
molecules and Ang2 were induced, while Tie2 showed a significant 
downregulation (Figure 4), the latter being in agreement with a previous 
study (13).
Thus, endothelial cells are quickly activated by flow reduction/
cessation after long term adaptation to laminar flow, though the kinetics 
of changes in expression of the genes involved in vascular integrity as 
well as pro-inflammatory activation of endothelium are variable.
Figure 3. Flow cessation after laminar shear stress pre-adaption leads to a pro-
inflammatory response of endothelial cells. 
(A) HUVEC were kept under LSS (20 dyne/cm2) for 48 hours and next subjected to 
different time periods of flow cessation before mRNA analysis. (B) Gene expression 
levels were determined by quantitative RT-PCR, using GAPDH as housekeeping gene. 
Values represent mRNA levels relative to LSS control. Data are shown as mean ± SD, 
n=3. *, P<0.05, flow cessation vs. LSS control. (C) The concentration of IL-8 in the 
medium after 8 hour flow cessation was determined by ELISA. Data are shown as mean 
of three independent experiments. *, P<0.05, LSS vs. static control; #, P<0.05, 8 h flow 
cessation vs. LSS. (D) The protein expression levels of surface adhesion molecules were 
analyzed by flow cytometry and shown as mean fluorescence intensity (MFI) arbitrary 
units corrected by isotype control. Data are expressed as mean ± SD, n=3. *, P<0.05, 
LSS vs. static control; #, P<0.05, 8 h or 24 h flow cessation vs. LSS.





Abrupt reflow associated endothelial responses after flow cessation
Fluid resuscitation to improve microvascular blood flow is an essential 
therapy for the treatment of any form of shock (2). Our previous in vivo 
study showed that endothelial pro-inflammatory status was significantly 
induced by fluid resuscitation after hemorrhagic shock (3). To investigate 
the role of shear stress changes by itself in the process of endothelial 
Figure 4. Endothelial responses to acute reduction of laminar shear stress to 5 dyne/
cm2.
HUVEC were exposed to LSS (20 dyne/cm2) for 48 hours and then shear stress was 
reduced to 5 dyne/cm2 for 8 hours. Cells cultured in static condition were taken as 
control. Genes were determined by quantitative RT-PCR and GAPDH was taken as 
housekeeping gene. Values represent fold change of genes in comparison to the levels 
in static control. Bars show mean ± SD, n=3. *, P<0.05 vs. 48h 20 dyne/cm2.
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pro-inflammatory activation during resuscitation, we therefore 
examined the effect of acute reflow on the endothelium (Figure 5A). 
Considering that prolonged no-reflow does exist due to reperfusion 
defects after hemorrhagic shock in the clinic (14), we continued our 
study with the 8h flow cessation time point.
Upon reflow, KLF2 expression was rapidly regained (Figure 5B). 
Interestingly, Tie2, which was downregulated during flow cessation, was 
decreased even further by reflow within the 4h time period studied. 
On the other hand, the induction of adhesion molecules by 0.5h reflow 
after 8h flow cessation suggests a quick pro-inflammatory effect of 
rapid onset of reflow. 4 hour after the start of reflow, VCAM-1, IL-8 and 
Ang2 were reduced significantly, while ICAM-1 remained elevated. In 
addition, reflow did not affect the expression of CD31 and VE-cadherin.
The pro-inflammatory response of endothelial cells to TNFα stimulation 
was enhanced by 0.5h reflow
Cytokine production is a prominent systemic inflammatory response 
during hemorrhagic shock and resuscitation. After hemorrhage, TNFα 
production shows an early increase at the 1 hour time point, and 
remains high until 5 hours (15). Furthermore, systemic TNFα levels 
induced during hemorrhagic shock are further increased by subsequent 
resuscitation (6). It is not known whether the changes of flow during 
circulatory shock and resuscitation will influence the pro-inflammatory 
consequences of endothelial cells induced by cytokine exposure. To 
study this, LSS adapted endothelial cells were stimulated with TNFα 
for the final 4 hours of flow cessation period and next subjected to 
0.5h reflow exposure or maintained without reflow (Figure 6A). As 
shown in Figure 6B, the additional drop in KLF2 mRNA level by 4h TNFα 
exposure during flow cessation was rapidly increased upon 0.5h reflow 
to the similar level as it was under flow cessation conditions. Tie2 and 
Ang2, both not responsive to TNFα per se, showed a further reduction, 
respectively induction in their expression by the installation of abrupt 
reflow. At the same time, reflow increased the expression levels of pro-
inflammatory molecules E-selectin, VCAM-1 and ICAM-1 as well as IL-8 
beyond the levels induced by TNFα challenge during flow cessation. 
The protein expression data corroborated that subsequent acute reflow 
further upregulated the protein levels of VCAM-1 and ICAM-1 induced 
by TNFα exposure during flow cessation (Figure 6C). In addition, there 





Figure 5. Abrupt reflow associated endothelial responses following initial flow 
cessation. 
(A) To mimic the resuscitation procedure following hemorrhagic shock in vivo, LSS pre-
adapted HUVEC were subjected to LSS (20 dyne/cm2) for 0.5, 1 and 4 hours after an 
8 hour flow cessation period. (B) mRNA was harvested and genes were determined 
by quantitative RT-PCR, using GAPDH as housekeeping gene. Values represent fold 
changes of genes in comparison to the levels after 8h flow cessation conditions. Data 
are expressed as mean ± SD, n=3. *, P<0.05, 0.5, 1, 4h reflow vs. flow cessation which 
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is a tendency to increased IL-8 production upon reflow (Figure 6D). 
These results indicate that TNFα exposure of endothelial cells during 
flow cessation strongly activates the cells, and that the application 
of subsequent reflow aggravates this cytokine- induced endothelial 
response.
Discussion
Fluctuations in blood flow during shock and resuscitation lead to 
flow disturbances in vessels. In parallel, endothelial pro-inflammatory 
activation and vascular leakage occur (3, 16). These activations are more 
extensive at 1 hour after resuscitation compared to the endothelial 
priming observed at 90 minute of hemorrhagic shock (3). In this in 
vitro study we addressed whether, and to what extent, the changes in 
shear stress resulting from the loss as well as the subsequent regaining 
of blood flow during hemorrhagic shock and resuscitation contribute 
to endothelial activation. Using an in vitro model to mimic the flow 
changes as occur during hemorrhagic shock and resuscitation after 
long term LSS exposure, we here demonstrated that flow changes per 
se affected the expression of pro-inflammatory adhesion molecules 
by the endothelial cells. Each gene studied showed its own kinetic of 
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Figure 6. TNFα induced pro-inflammatory activation of endothelial cells during flow 
cessation is aggravated by subsequent abrupt reflow.
(A) 48 hour LSS (20 dyne/cm2) pre-conditioned HUVEC were subjected to 8 hour flow 
cessation with or without subsequent 0.5 hour reflow (20 dyne/cm2), and TNFα (10 
ng/ml) was added for the last 4 hours under both conditions. (B) Cells were lysed 
for mRNA isolation and genes were analyzed by quantitative RT-PCR, using GAPDH 
as housekeeping gene. Values represent fold change of genes in comparison to the 
levels under 8 hour flow cessation set as 1. Results are expressed as mean ± SD, n=3. 
*, P<0.05, 4h TNFα under flow cessation vs. flow cessation control; #, P<0.05 4h 
TNFα with reflow vs. 4h TNFα without reflow. (C) The expression levels of adhesion 
molecules on the endothelial surface were analyzed by flow cytometry and shown as 
mean fluorescence intensity (MFI) arbitrary units corrected by isotype control. Data 
are expressed as mean ± SD, n=3. *, P<0.05, vs. flow cessation condition alone; #, 
P<0.05, significant difference between with or without abrupt reflow exposure. (D) 
The concentration of IL-8 in the medium was determined by ELISA. Data are shown as 
mean of three independent experiments.





pro-inflammatory molecules E-selectin, VCAM-1, ICAM-1 as well as IL-
8, however, the effects of flow alteration per se were minor compared 
to their expression induced by TNFα challenge. Yet, the induction of 
pro-inflammatory adhesion molecules by TNFα stimulation during flow 
cessation was significantly higher due to the combined exposure of 
reflow, implying that both blood flow changes and pro-inflammatory 
cytokines may contribute to endothelial activation during clinical shock 
and resuscitation. In addition, we showed that at 4h after reflow Tie2 
had not regained its normal expression under LSS control, and that the 
combined exposure of reflow and TNFα extended the downregulation of 
Tie2 and upregulation of Ang2 expression.
Hemorrhagic shock/resuscitation can be conceived as a systemic 
ischemia/reperfusion injury insult, and the extent of ischemia in 
tissues during hemorrhagic shock is considered a major determinant 
of the systemic inflammatory response (17). We demonstrated in the 
present study that flow changes per se, i.c., flow cessation and reflow 
implementation, induce pro-inflammatory activation of endothelial 
cells. The flow characteristics in different microvascular beds from 
different vital organs in health and disease are not exactly known. It has 
been reported that microcirculatory responses to hemorrhagic shock 
are dependent on the vessel type. After a hemorrhage period slow and 
constant blood flow existed in some preferential capillary channels while 
other capillaries were eliminated from the circulation, and the blood flow 
in arterioles ceased several times (18). This indicates that endothelial 
cells from different microvascular beds likely experience variable 
flow changes during hemorrhagic shock. Similarly, hypotension is a 
hallmark of septic shock, and microcirculatory alterations characterized 
by increased number of intermittent- or stopped-flow capillaries may 
play an important role in sepsis-associated organ dysfunction (19). 
In addition, heterogeneity of microvascular endothelial cells likely 
underlies high cell to cell variability in their adaptation to pathology-
related microenvironmental changes, which can be organ specific and 
microvascular-bed specific (20)Pathologic/drug therapy/*metabolism/
pathology</keyword><keyword>Organ Specificity</keyword></
keywords><dates><year>2009</year><pub-dates><date>Jan</date></
pub-dates></dates><isbn>1432-0878 (Electronic. The molecular nature 
of heterogeneous responses of endothelial cells to microcirculatory 
changes per se are largely unknown and difficult to simulate in vitro. An 
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Flow  cessation (h) 
vs. LSS 
Reflow (h)  
vs. 8h flow cessation 




48 2 4 8 24 0.5 1 4 4h TNFα* 4h TNFα* 
Tie2 ↑ ↑ ↔ ↓ ↓↓ ↔ ↔ ↓ 1.00 0.77 
Ang2 ↓↓ ↔ ↔ ↑ ↑ ↑ ↔ ↓ 1.06 2.11 
E-selectin ↓↓ ↔ ↑ ↑↑ ↑ ↑ ↑ ↓ 41420 51377 
VCAM-1 ↓↓ ↔ ↑ ↑ ↑ ↑ ↑ ↓ 6866 9530 
ICAM-1 ↑ ↔ ↔ ↓ ↓↓ ↑ ↑ ↑ 154 222 
IL-8 ↓↓ ↔ ↔ ↑ ↑ ↔ ↔ ↓↓ 713 940 
Figure 7. Summary of the effects of shear stress changes in the absence/presence of 
TNFα on endothelial gene expression in vitro.
Genes associated with endothelial integrity (Tie2, Ang2) and inflammatory responses 
(E-Selectin, VCAM-1, ICAM-1 and IL-8) that were affected by the studied experimental 
conditions are shown. VE-cadherin and CD31 mRNA levels did not change under the 
conditions studied (data not shown in this table).  Effects of TNFα exposure during flow 
cessation respectively flow cessation followed by reflow are given as fold changes of 
mRNA expression (*, fold change vs. flow cessation control). ↑↑, >10 fold induction; 
↑, <10 fold induction; ↔, no change; ↓, <50% reduction; ↓↓, >50% reduction. 





important follow-up study will therefore be to investigate the effects of 
different shock forms like hemorrhagic shock and septic shock in animal 
models and to study in detail the different microvascular segments 
within organs using e.g., quantification of gene expression in laser micro 
dissected microvascular segments, and intravital microscopy to study 
blood flow specificities in different segments (21, 22). 
Several other in vitro studies have reported on the relation between 
shear stress and endothelial activation, with the majority focusing on 
effects of shear stress loss. Krizanac-Bengez et al found that under 
normoxic and normoglycemic conditions, loss of shear stress was able to 
independently induce leukocyte-mediated pro-inflammatory activation 
in brain microvascular endothelial cells, leading to failure of blood-brain 
barrier function (23). Fisher and colleagues reported that flow-adapted 
bovine pulmonary artery endothelial cells (BPAEC at 1 dyne/cm2 for 
48h)  generated reactive oxygen species (ROS) upon 1h flow cessation 
(mimicking ischemia), which resulted in the activation of NF-κB and AP-1 
(24). They furthermore showed that in flow-adapted BPAEC (5 dyne/
cm2, 24h) the sudden removal of shear stress led to ROS-dependent 
phosphorylation of ERK1/2 as well as Ca2+-dependent NO generation 
within 60 seconds (25). NF-κB, AP-1 and ERK1/2 are also involved in 
the induction of pro-inflammatory activation of endothelial cells (26, 
27), and NF-κB shows time-dependent activation during hemorrhagic 
shock and resuscitation in mice (28). Therefore, it can be speculated 
that in our study the activation of these kinases/transcription factors is 
associated with the endothelial activation observed. Since endothelial 
cells responded to flow changes with a similar gene expression profile 
as that observed in cytokine stimulation, we measured TNFα production 
in this in vitro system and found that its mRNA level was undetectable 
(data not shown). The exact molecular control of endothelial activation 
during flow cessation as well as reflow exposure are as of yet unknown 
and will be investigated in future studies using pharmacological 
inhibition of these different pathways.
KLF2 plays an important role in maintaining a quiescent endothelial 
phenotype. The current study showed that the upregulation of KLF2 
by long-term shear stress adaptation was rapidly abolished by flow 
cessation. Interestingly, the ability of 0.5h reflow to restore KLF2 
expression was inhibited by TNFα challenge (see Figure, Supplemental 
Digital Content 1, which demonstrates the expression of KLF2 upon 0.5h 
Thesis Ranran Li.indb   50 20-08-15   14:03
209753-L-sub01-bw-Li
51
Abrupt reflow enhances pro-inflammatory activation
2
TNFα exposure under flow cessation or reflow conditions), implying a 
diminished adaptive capacity of endothelial cells to cytokine stimulation 
under abrupt reflow conditions. Gracia-Sancho et al have shown that 
endothelial cells with reduced KLF2 expression upon flow cessation 
under cold storage condition (4 degree) show higher responsiveness 
to cytokine IL-1β (29). Possibly, the TNFα-related inhibition of KLF2 re-
expression upon reflow in our study contributes to the relatively higher 
responsiveness of endothelial activation under reflow conditions. 
Clinically this may be relevant to sepsis where flow changes and 
cytokines are both abundantly present. It is worthwhile to follow up on 
this observation and to investigate the in vivo kinetics of KLF2 expression 
during HS and resuscitation, and to verify whether a diminished KLF2 re-
expression by TNFα is involved in the underlying molecular mechanisms 
of endothelial activation during resuscitation.
There is accumulating evidence emphasizing the critical role of the 
Ang/Tie2 system in vascular dysfunction during critical illness. We 
previously showed in vivo that Tie2 expression was reduced at 4 h 
after HS and resuscitation, and normalized at 24 h (7). In the present 
study we showed that the removal of shear stress in vitro caused loss 
of Tie2, and that the subsequent acute re-administration of flow did 
not recover its expression. At the same time, Ang2 was induced while 
the re-expression of KLF2 was abolished by TNFα challenge, showing 
an inverse relationship between KLF2 and Ang2 that was previously 
described in a study with KLF2 overexpressing endothelial cells (30). The 
decrease of Tie2 as well as the induction of Ang2 due to flow alterations 
may thus contribute to microvascular dysfunction, including increased 
vascular leakage and extended pro-inflammatory activation as observed 
in vivo. 
Our current study has several limitations that should be kept in mind. 
First of all, it is difficult to directly translate the in vitro flow induced 
endothelial changes to the bed of the shock patient. Beyond the 
studied flow effects, other processes will likely occur simultaneously to 
induce endothelial activation during shock and resuscitation. Amongst 
others, impaired oxygen delivery induced tissue hypoxia (31), leukocyte 
activation (5) and cytokine release (6) are all known to be involved in 
endothelial activation. At the same time, exclusion of other cell types 
co-existing in vivo in the microenvironment of the endothelium may 
also make that the in vitro flow model dose not recapitulate the in vivo 





situation during shock and resuscitation. Second, unidirectional laminar 
flow has been used throughout our present study, whereas in the shock 
patient the different features of shear stress in various vessel types, e.g., 
arterial bifurcations and stenotic vessels, can influence downstream 
endothelial behavior (32). Third, we have used 20 to 5 dyne/cm2 and 20 
to 0 dyne/cm2 flow changes in our study. Although the shear stress values 
in various vessels has been estimated (33), the exact flow magnitudes 
and patterns in distinct macro- and microvascular beds under healthy 
condition as well as in critically ill patients are not known. Fourth, we 
chose specifically pre-defined time points of flow cessation and reflow 
to compare this in vitro study with our in vivo hemorrhagic shock (3) 
and LPS exposure mouse models (13). In patients, this time frame may 
be shorter or much longer, as microvascular flow derangements can be 
limited to a few seconds (preoperative hypotension after anesthesia 
induction), to several minutes (massive surgical bleeding), or be present 
for days (critically ill sepsis patients). Therefore, only carefully combining 
our in vitro data presented here with data from animal shock model and 
human organ biopsies of deceased patients (34) will help to bridge this 
bench-to-bedside gap. 
Collectively, our study revealed that flow alterations per se, as 
experienced by endothelial cells during microcirculatory shock and 
resuscitation, act as a pro-inflammatory stimulus, and that the flow 
changes in combination with other pro-inflammatory factors such 
as TNFα that co-exist in critically ill patients likely interact with each 
other. The abrupt-reflow related enhancement of cytokine-induced 
endothelial inflammatory activation suggests that inflammation related 
signaling cascades at the time of resuscitation may be potential targets 
of pharmacological interventions to attenuate endothelial activation 
and the development of consequent multiple organ failure. Moreover, 
the changes in expression of Ang2/Tie2 by flow alterations observed 
in this study indicate that improving organ perfusion, a hallmark of 
modern critical care, is likely to positively affect microvascular function. 
In addition, It has been shown that phosphorylation dependent 
activation of Tie2 can be induced by the onset of shear stress (35). 
This Tie2 phosphorylation upon flow cessation and reflow will be 
further investigated in our in vitro flow study as well as in vivo models 
(hemorrhagic shock and septic shock mice, patients) in the future. Since 
the flow alteration-associated endothelial dysfunction may be a critical 
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determinant for the development of pathological changes during shock 
and resuscitation as well as for post-resuscitation organ function, future 
studies will be executed to investigate which molecular pathways can be 
therapeutically interfered with in the microvasculature. 
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Supplementary data
Supplemental Digital Content 1. TNFα exposure diminished the expression of KLF2 
restored by 0.5h reflow.
48h LSS (20 dyne/cm2) adapted HUVEC were subjected to 8 hour flow cessation with 
or without subsequent 0.5h reflow exposure (20 dyne/cm2). TNFα (10 ng/ml) was 
added for the last 0.5h under flow cessation condition or 0.5h reflow condition. Cells 
were lysed for mRNA isolation and genes were analyzed by quantitative RT-PCR, using 
GAPDH as housekeeping gene. Values represent fold change of genes in comparison to 
the levels under 8 hour flow cessation condition alone. Data are expressed as mean ± 
SD, n=3. *, P<0.05, significant induction of KLF2 by reflow compared to the level under 
flow cessation condition; #, P<0.05, significant downregulation of KLF2 by TNFα vs. PBS 
under 0.5 hour reflow condition. 
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The involvement of histone acetylation 
and NF-kappaB signaling in flow alteration-
associated endothelial responses - an in vitro 
study






Hemodynamic changes play a role in regulating endothelial responses 
during shock and subsequent resuscitation, which may contribute to 
the pathogenesis of multiple organ dysfunction syndrome (MODS). Us-
ing an in vitro flow system, we previously demonstrated that flow alter-
ations lead to pro-inflammatory responses of prolonged LSS preadapted 
endothelial cells. Histone (de)acetylation is known to be regulated by 
flow, and NF-kappaB (NF-κB) plays a central role in controlling infl am-
mation. Therefore, in this study, we aimed to investigate the involve-
ment of these two molecular mechanisms in flow alterations associated 
endothelial pro-inflammatory activation. We demonstrated that flow al-
terations are accompanied by fluctuations of histone acetylation, while 
changes in NF-κB activation were minor. Pharmacological inhibition of 
histone deacetylase (HDAC) activity and NF-κB activation could partially 
attenuate endothelial pro-inflammatory activation associated with flow 
alterations per se as well as endothelial responses to the combined in-
sults of flow cessation and pro-inflammatory cytokine tumor necrosis 
factor alpha (TNFα) sti mulati on. The benefi cial eff ects of HDAC inhibi-
tion and NF-κB signaling blockade indicate that HDAC and NF-κB are 
potential targets to interfere with endothelial responses towards flow 
disturbances as occur in shock and resuscitation. 
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Introduction 
In physiological conditions, vascular endothelial cells lining the inner 
surface of the blood vessels are constantly exposed to blood flow-
associated shear stress. Shear stress-induced mechanotransduction, 
which represents the cellular responses to physical alterations in the 
local environment, is an important property of endothelial cells, and 
regulates endothelial behavior (1). The disturbance of local blood flow 
activates intracellular signaling of endothelial cells via mechanosensors 
(2), therefore consequently regulating cell functions, structure 
remodeling, and cell responses to other co-existing factors (3, 4). 
In hemorrhagic and septic shock and subsequent resuscitation, 
alterations in the microcirculation are characterized by reduced and/
or loss of blood perfusion and sudden reflow phenomena (5, 6). 
Alterations of blood flow associated microcirculatory dysfunction, 
such as endothelial activation, leukocyte recruitment, and vascular 
leakage, have been considered to initiate a cascade of events that 
lead to multiple organ failure (7). Endothelial cells exposed to 24-48h 
laminar shear stress (LSS) in vitro can reach a flow-adapted state (8). 
And using an in vitro flow system, we previously demonstrated that 
flow cessation and subsequent acute reflow lead to pro-inflammatory 
responses of endothelial cells that were preadapted to prolonged 
LSS (9). Understanding the molecular mechanisms induced by flow 
alterations in regulating shock-associated endothelial activation and 
investigation of potential therapeutic interventions to counteract these 
detrimental endothelial responses are of interest to find new therapies 
for shock patients. 
Posttranslational modifications play a pivotal role in controlling 
transcription of genes. Amongst others, covalent modifications of 
histones through (de)acetylation at lysine residues modulate the 
structure and the function of the chromatin, thereby influencing the 
access of DNA for transcription. Global histone acetylation is regulated 
by the counterbalance between histone acetyltransferase (HAT) 
and histone deacetylase (HDAC) activity (10). Research regarding 
hemodynamic force-mediated epigenetic regulation of gene expression, 
endothelial function, and vascular pathophysiology has emerged (11, 
12). Moreover, cellular acetylation homeostasis is disrupted in flow 
disturbance associated injuries such as hemorrhagic shock and sepsis, 





shifting the balance to a hypoacetylation status (13). The effects of flow 
alterations per se on histone acetylation in endothelial cells and the 
consequences of inhibition of this process on flow alteration-associated 
endothelial activation are not known and are subject of this study. 
Furthermore, IkappaB kinase/NF-kappaB (IKK/NF-κB) signaling is 
often involved in regulating pro-inflammatory activation. In resting 
cells, the transcription factor NF-κB is retained in the cytoplasm 
complexed with its endogenous inhibitory protein IkappaB (IκB). Upon 
pro-inflammatory insults, IκB can become phosphorylated by activated 
kinase (IKK), leading to its disassociation from NF-κB, resulting in 
nuclear translocation of NF-κB and transcription of NF-κB controlled 
pro-inflammatory genes (14). The activation of IKK/NF-κB signaling 
has been reported in several diseases that are related to blood flow 
disturbances, such as hemorrhagic shock, sepsis, and ischemia (15-
17). Whether flow alterations induced endothelial pro-inflammatory 
activation is controlled by NF-κB signaling is also subject of investigation 
in this study.
To address these issues and the consequences of HDAC inhibition and 
NF-κB blockade on flow alteration-associated endothelial activation, 
we used valproic acid (VPA) and BAY11-7082 to pharmacologically 
inhibit HDAC activity (18) respectively the activation of IKK (19). The 
global acetylation level of histone H3 and the degradation of IκB during 
prolonged LSS, flow cessation and subsequent acute reflow were 
determined by western blot analysis, and the expression of endothelial 
genes under different flow conditions in the presence or absence of pro-
inflammatory cytokine TNFα was analyzed by quantitative RT-PCR. 
Materials and Methods
Cell culture 
Human umbilical vein endothelial cells (HUVEC) were obtained 
from the Endothelial Cell Facility of the University Medical Center 
Groningen. HUVEC were isolated from at least two umbilical cords and 
cultured on 1% gelatin (Sigma, Zwijndrecht, The Netherlands) coated 
plates or microchambers with medium (RPMI 1640, Lonza, Breda, 
The Netherlands) supplemented with 50 µg/ml endothelial growth 
factors, 20% heat-inactivated fetal calf serum (FCS, Thermo Scientific 
HyClone, Cramlington, UK), 2 mM L-glutamine (Lonza), 5 U/ml heparin 
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(LEO-Pharma, Amsterdam, The Netherlands), and antibiotics (100 IU/
ml penicillin (Astellas Pharma, Meppel, The Netherlands) and 50 μg/ml 
streptomycin (Rotexmedica GmbH, Trittau, Germany). HUVEC passage 2 
to 4 were used in this study. 
Flow experiments 
HUVEC were detached with trypsin/EDTA and seeded in 1% gelatin-
coated microchambers (µ-Slide I 0.4 Luer, ibidi, Martinsried, Germany). 
60,000 cells/cm2 were used to obtain confluent monolayers overnight. 
Cells were subjected to 20 dyne/cm2 laminar shear stress (LSS) for 48 
hours in the flow system (ibidi), where indicated cells were subjected to 
different periods of flow cessation followed by reflow with 20 dyne/cm2 
LSS for different time periods as indicated. At the end of the experiments, 
cells were harvested for gene and protein analysis (see below).
RNA isolation and gene expression analysis by real-time RT-PCR
Total RNA from cells was isolated with the RNeasy Mini plus Kit, 
(Qiagen, Leusden, The Netherlands) according to the manufacturer’s 
instructions. Integrity of RNA was determined by gel electrophoresis. 
RNA concentration (OD260) and purity (OD260/OD280) were measured 
using an ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies, 
Rockland, DE, USA). cDNA synthesis, the assay-on-demand primers, and 
quantitative PCR were described previously (9).
Duplicate real time PCR analyses were executed for each sample, 
and the obtained threshold cycle values (CT) were averaged. According 
to the comparative CT method described in the ABI manual, gene 
expression was normalized to the expression of the housekeeping gene, 
yielding the DCT value. The average mRNA level relative to GAPDH was 
calculated by 2-ΔCT. 
Protein expression analysis by western blot 
Western blot was performed on HUVEC protein lysates to determine 
the protein levels of IκBα and acetylated histone H3. Protein extracts 
(30 μg protein/lane)were separated by sodium dodecyl sulphate-poly-
acrylamide gel electrophoresis (SDS-PAGE) on 12% polyacrylamide gels 
and transferred to a nitrocellulose membrane (Bio-Rad Laboratories, 
Utrecht, the Netherlands). After 1h blocking with 5% skimmed milk 
(Campina, Friesland, The Netherlands) in Tris-Buffered Saline containing 





0.1% Tween 20, membranes were incubated with primary antibodies 
overnight at 4  ͦC. The primary antibodies used in this study were anti-
IκBα (diluted 1: 1500 in 5% skimmed milk, cat. no. #06-494, Millipore, 
Temecula, CA, USA), anti-acetylated H3 (diluted 1: 5,000 in 5% skimmed 
milk, cat. no. #06-599, Millipore), and anti-actin (diluted 1: 200,000 in 5% 
BSA, cat no. #MAB1501, Millipore). The primary antibody was detected 
by horseradish peroxidase-coupled secondary antibodies (diluted 1: 
5,000 in 5% skimmed milk, Southern Biotech, Birmingham, USA) at 
room temperature for 1 hour, and visualized by horseradish peroxidase 
substrate (Millipore), and examined by Geldoc (Bio-Rad Laboratories). 
Blots were analyzed and quantified using Image Lab software (version 
5.2.1, Bio-Rad, Utrecht, The Netherlands).
Statistical analysis 
Statistical significance of differences was studied by means of the 
Student’s T-test or a one way analysis of variance (ANOVA) followed 
by a Bonferoni correction for selected pairs of columns. All statistical 
analyses were performed using GraphPad Prism software (GraphPad 
Prism Software Inc., San Diego, California, USA). Differences were 
considered to be significant when P<0.05. 
Results
Histone deacetylases and NF-κB control basal gene expression of 
endothelial cells cultured in static and laminar shear stress controlled 
conditions
We first investigated the effects of HDAC inhibition and IKK/NF-
κB blockade on endothelial cells in static culture respectively pre-
conditioned by 48h LSS. As shown by the gene expression results in 
Figure 1, LSS increased the expression of KLF2, Tie2, and ICAM-1 while it 
downregulated the expression of Ang2 and pro-inflammatory molecules 
E-selectin, VCAM-1, and IL-8, which corroborated our previous findings 
(9). 
When looking at the effects of HDAC inhibition and IKK/NF-κB 
inhibition on the expression of endothelial genes, HDAC inhibitor 
VPA significantly induced KLF2 expression while it downregulated the 
expression of VCAM-1 and ICAM-1 both under static and LSS conditions. 
IL-8 expression was decreased by VPA only under static condition. The 
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Figure 1-Effects of VPA and BAY11-7082 on endothelial gene expression under static 
and laminar shear stress conditions.
 HUVEC were exposed to laminar shear stress (LSS, 20 dyne/cm2) or cultured under 
static condition for 48h. VPA (at a final concentration of 5 mM), BAY11-7082 (10 µM), 
respectively vehicle (DMSO, veh, 0.5 µL/mL) were added 4h before cells were harvested 
for gene expression analysis. mRNA levels of endothelial genes were determined by 
real-time RT-PCR and GAPDH was taken as housekeeping gene. Values represent fold 
change compared to vehicle treated static control. Data are expressed as mean ± SD, 
n=3 per condition. *, P<0.05, LSS control vs. static control; #, P<0.05, VPA vs. vehicle 
control; &, P<0.05, BAY11-7082 vs. vehicle control.





expression of Ang2 and E-selectin was not affected by VPA under either 
static or LSS conditions. Upon blockade of IKK/NF-κB signaling by BAY11-
7082, E-selectin was reduced in static condition only, while VCAM-1 was 
decreased in both static and LSS conditions. BAY11-7082 upregulated 
Ang2 and IL-8 expression in both conditions, while the expression of 
KLF2 was not affected by BAY11-7082 in either condition. Interestingly, 
BAY11-7082 downregulated the expression of ICAM-1 in static condition, 
while it increased its expression when cells have adapted to LSS. The 
vascular integrity-related molecules CD31, VE-cadherin, and Tie2 were 
not affected by either drug. These data indicate that HDAC activity and 
NF-κB signaling pathway play a role in controlling basal transcription of 
genes in static and laminar shear stress adapted endothelial cells.
Flow cessation leads to a temporal decrease in histone acetylation and 
a later stage slight decrease of IκB expression in HUVEC
Shear stress exposure plays an important role in chromatin 
remodeling, thereby regulating the expression of genes (11), and 
endothelial gene expression was previously shown to be modulated 
Figure 2- Effects of flow alterations on histone H3 acetylation of and IκB expression 
in HUVEC. 
HUVEC were exposed to laminar shear stress (LSS, 20 dyne/cm2) or cultured under 
static condition (control, CT) for 48h. Then flow was stopped for 0.5, 1, 4h, and 8h 
before cells were harvested and the expression of histone H3 acetylation and IκB 
was determined by western blot. TNFα (10 ng/ml, 0.5h) treated HUVEC in static 
condition were used as a positive control for H3 acetylation reduction (as also shown 
in Chapter 4) and IκB degradation [1]. Actin was taken as loading control. The image is 
representative of two experiments.
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by flow cessation (9). Based on our interest in the role of HDAC and 
NF-κB signaling in regulating endothelial pro-inflammatory activation, 
we therefore here investigated the effect of flow cessation on histone 
acetylation and IkB expression in endothelial cells. 
The level of histone H3 acetylation after 48h LSS exposure was 
significantly lower compared to the level under static culture condition. 
Upon flow cessation, a transient decrease in the level of acetylated H3 
was observed within 0.5h, after which the acetylation was increased in 
a time-dependent manner until after 8h of no flow when its level was 
similar to the level under static condition (Figure 2). With respect to 
NF-κB pathway, 48h LSS pre-adapted endothelial cells showed a similar 
to slightly higher IκB level compared to static culture (Figure 2). The 
effect of flow cessation on the expression of IκB was limited, with its 
expression being slightly reduced at the later time point (8h). 
These results suggest that transient changes in histone acetylation and 
IκB degradation play a role in flow cessation-induced pro-inflammatory 
activation of LSS pre-adapted endothelial cells.
VPA and BAY11-7082 pretreatment selectively interfere with flow 
cessation-induced endothelial responses
To investigate the involvement of histone acetylation and NF-
κB signaling in flow cessation-associated endothelial inflammatory 
activation, prolonged LSS adapted HUVEC were pre-incubated with 
HDAC inhibitor VPA respectively IKK inhibitor BAY11-7082 30 min before 
the installment of flow cessation. Figure 3 showed that both VPA and 
BAY11-7082 pre-treatment attenuated flow cessation-related decrease 
of KLF2 and increase of Ang2, E-selectin, and VCAM-1. Flow cessation 
induced expression of IL-8 was downregulated by VPA but not by BAY11-
082. The downregulation of ICAM-1 due to loss of flow was reversed 
by BAY11-7082 pre-incubation but not affected by VPA. The expression 
of Tie2 which was reduced due to flow cessation was not affected by 
VPA while being upregulated by BAY11-7082. The selective attenuation 
of flow cessation-associated endothelial responses by HDAC inhibition 
and IKK/NF-κB blockade indicates an underlying role for HDAC and NF-
κB signaling in the processes of flow cessation-initiated endothelial 
activation.





Figure 3-Effects of VPA and BAY11-7082 pretreatment on endothelial gene responses 
to flow cessation.
HUVEC were pre-conditioned with laminar shear stress (LSS, 20 dyne/cm2) for 48h. 
0.5h before stopping the flow, vehicle (DMSO, veh, 0.5 µL/mL), HDAC inhibitor VPA (5 
mM) or IKK inhibitor BAY11-7082 (BAY, 10 µM) was added to the circulating medium. 
After 8h of no-flow, cells were harvested for gene expression analysis. mRNA levels 
of endothelial genes were determined by real-time RT-PCR. Values were normalized 
to GAPDH, and are represented as fold change relative to LSS control. Data are 
shown as mean ± SD of triplicate samples from one experiment representative of two 
independent experiments. *, P<0.05, 8h flow cessation plus vehicle vs. LSS; #, P<0.05, 
VPA or BAY11-7082 vs. vehicle.
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Endothelial responses to combined exposure of flow cessation and 
TNFα stimulation were reversed by VPA and BAY11-7082 pre-incubation
During shock, cytokine levels are increased in the circulation, 
representing additional stressors for endothelial cells concomitant with 
local flow changes. To investigate the effects of VPA and BAY11-7082 on 
endothelial behavior in the presence of both flow cessation and cytokine 
TNFα, LSS-adapted HUVEC were pre-incubated with VPA respectively 
BAY11-7082 prior to flow cessation and subsequent TNFα stimulation. 
The results in Figure 4 show that the presence of TNFα further decreased 
the expression of KLF2 and extensively increased the expression of pro-
inflammatory genes E-selectin, VCAM-1, and IL-8, whereas Tie2 and Ang2 
expression was not further affected by TNFα stimulation. VPA pre-treatment 
could partially rescue the decrease in the expression of KLF2 and reduce 
the levels of Ang2, VCAM-1, and IL-8, whereas it further upregulated 
E-selectin expression. On the other hand, blockade of NF-κB signaling 
by BAY11-7082 also increased KLF2 expression and downregulated the 
expression of Ang2, adhesion molecules E-selectin, VCAM-1, and ICAM-
1, as well as chemokine IL-8. Tie2 expression that was decreased upon 
flow cessation was further downregulated by BAY11-7082 pre-incubation 
in the presence of TNFα. In summary, in the presence of inflammatory 
responses induced by TNFα stimulation, pharmacological inhibition of 
HDAC activity and NF-κB activation by VPA and BAY11-7082 are capable 
of partially inhibiting the inflammatory responses of endothelial cells to 
flow cessation. 
Reflow exposure following flow cessation led to decreased histone 
acetylation in endothelial cells
Acute reflow after a period of flow cessation is detrimental to endothelial 
cells as it leads to exaggerated inflammatory responses (9). We therefore 
investigated the effects of reflow per se on histone acetylation and NF-
κB activation status in endothelial cells. Using western blot we observed 
that upon restoration of flow after 8h of no-flow, histone H3 acetylation 
initially decreased (0.5h and 1h) followed by an increase at 4h after start 
of reflow (Figure 5). When looking at the NF-κB signaling, the expression 
level of IκB after 4h reflow exposure was marginally affected by reflow 
compared to its level after 8h flow cessation. These results suggest that 
especially altered histone acetylation may play a role in reflow-associated 
endothelial pro-inflammatory responses. 





Figure 4-Effects of VPA and BAY11-7082 pretreatment on endothelial responses to 
the combined insult of flow cessation and TNFα stimulation.
HUVEC cultured under 48h of laminar shear stress (LSS, 20 dyne/cm2) were pre-
incubated with vehicle (DMSO, veh, 0.5 µL/mL), VPA (5 mM), or BAY11-7082 (BAY, 10 
µM) 0.5h before they were subjected to flow cessation (FC). TNFα (10 ng/ml) was added 
for the last 4 hours during the 8h no-flow period. mRNA expression of endothelial genes 
was determined by real-time RT-PCR and GAPDH was taken as housekeeping gene. 
Values represent fold change compared to LSS control. Data are expressed as mean 
± SD of triplicate samples from one experiment representative of two independent 
experiments. *, P<0.05, flow cessation vs. LSS control; #, P<0.05, flow cessation in the 
presence of TNFα and vehicle vs. flow cessation without TNFα; &, VPA or BAY11-7082 
vs. vehicle. 
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Effects of VPA and BAY11-7082 on endothelial responses to acute 
reflow and to TNFα stimulation combined with reflow
To investigate the effects of pharmacological intervention of HDAC 
activity and NF-κB activation on reflow-related endothelial pro-
inflammatory responses, HUVEC subjected to flow cessation were pre-
incubated with VPA and BAY11-7082 prior to the exposure of 0.5h reflow. 
As shown in Figure 6, the expression of KLF2 was increased upon acute 
reflow. The decrease of Tie2 as well as the increase of Ang2, E-selectin, 
VCAM-1, and IL-8 due to the loss of flow was further enhanced by 
0.5h reflow. When pretreated with VPA, reflow-related upregulation of 
KLF2 was inhibited. The inhibition of HDAC activity also inhibited the 
expression of VCAM-1 and IL-8 while having no effect on the expression 
of Tie2 and Ang2 nor on E-selectin and ICAM-1. NF-κB inhibition by 
BAY11-7082 reduced the expression of Ang2, E-selectin, VCAM-1, and 
IL-8 under reflow conditions while it did not affect the reflow induced 
changes in Tie2 and ICAM-1. 
As described above, since loss of flow during circulatory shock 
is accompanied by cytokine production, we also studied the effects 
Figure 5-The effect of acute reflow on histone H3 acetylation and IκB expression in 
HUVEC.
HUVEC were subjected to laminar shear stress (LSS, 20 dyne/cm2) or cultured under 
static condition (control, CT) for 48h. LSS-adapted cells were exposed to 8h flow 
cessation (FC) before the flow was restored for 0.5, 1, and 4h. Cells were next harvested 
and the expression of histone H3 acetylation and IκB was determined by western blot. 
TNFα (10 ng/ml, 0.5h) treated HUVEC in static condition were used as a positive control 
for H3 acetylation inhibition (Chapter 4) and IκB degradation [1]. Actin was taken as 
loading control. This experiment was performed once. 





Figure 6-Effects of VPA and BAY11-7082 pretreatment on endothelial responses to 
reflow.
After 48h laminar shear stress (20 dyne/cm2) pre-adaptation, HUVEC were subjected 
to 8h flow cessation (FC) followed by 0.5h reflow exposure. 30min before reflow 
installment, cells were pre-incubated with vehicle (DMSO, veh, 0.5 µL/mL), VPA (5 mM), 
or BAY11-7082 (BAY, 10 µM). mRNA expression of endothelial genes was determined 
by real-time RT-PCR and GAPDH was taken as housekeeping gene. Values represent 
fold change compared to laminar shear stress control. Data are expressed as mean 
± SD of triplicate samples from one experiment representative of two independent 
experiments. *, P<0.05, 8h flow cessation vs. LSS control; #, P<0.05, 8h flow cessation 
with 0.5h reflow vs. 8h flow cessation without 0.5h reflow; &, VPA or BAY11-7082 vs. 
vehicle.
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of drug interventions on endothelial responses to TNFα stimulation 
in conjunction with reflow exposure. In the presence of TNFα, VPA 
pre-treatment prior to reflow installment did not show any effect on 
endothelial gene expression, while BAY11-7082 increased the expression 
of KLF2 and reduced reflow-related Ang2 upregulation (Figure 7). 
Discussion
In shock, microcirculatory perfusion is altered and characterized by 
stopped or intermittent flow in capillaries (6, 20). We have previously 
demonstrated the detrimental effects of blood flow-derived shear stress 
alterations, i.c., flow cessation and subsequent acute recovery of flow, 
on endothelial cell pro-inflammatory activation in vitro (9). Shear stress-
mediated chromatin remodeling via histone (de)acetylation attributes 
to flow-dependent regulation of gene expression in endothelial cells (11, 
12). Furthermore, IKK/NF-κB signaling plays a central role in controlling 
pro-inflammatory processes (21). We aimed to investigate the role of 
histone (de)acetylation and NF-κB activation in flow alterations-related 
endothelial responses. The present study demonstrated that flow 
alterations per se disturbed the status of histone acetylation and NF-κB 
activation, showing a rapid and temporal decrease of acetylated histone 
H3 by acute flow cessation and subsequent abrupt reflow as well as a 
slight reduction in IκB expression by 8h flow cessation. We furthermore 
showed that the inhibition of HDAC activity by VPA and the blockade of 
NF-κB activation by BAY11-7082 counteracted endothelial inflammatory 
responses induced by flow alterations per se as well as by the combined 
insults of flow cessation and TNFα stimulation. Endothelial responses 
towards the combined insult of TNFα stimulation and acute reflow were 
however not extensively affected by pharmacological inhibition of either 
pathway prior to acute reflow installment. From this study we conclude 
that HDAC and NF-κB signaling are involved in endothelial responses 
towards flow alterations and thus represent molecular targets for follow 
up studies to investigate their potential in therapeutic intervention of 
circulatory shock.
Endothelial cells exposed to shear stress undergo a series of 
changes in gene expression which are controlled by a coordinated 
sequence of partly unknown molecular events (3, 11). Histone (de)
acetylation, amongst other posttranslational modifications, modulates 





Figure 7-Effects of VPA and BAY11-7082 pretreatment on endothelial responses to 
reflow in the presence of TNFα.
After 48h laminar shear stress (20 dyne/cm2) pre-adaptation, HUVEC were subjected 
to 8h flow cessation (FC) followed by 0.5h reflow exposure. TNFα (10 ng/ml) was 
added for the last 4 hours of the incubation. Vehicle (DMSO, veh, 0.5 µL/mL), VPA 
(5mM), or BAY11-7082 (BAY, 10 µM) were added 0.5h before reflow. mRNA expression 
of endothelial genes was determined by real-time RT-PCR and GAPDH was taken as 
housekeeping gene. Values represent fold change relative to flow cessation control. 
Data are expressed as mean ± SD, n=3. *, P<0.05, flow cessation in the presence of 
TNFα vs. flow cessation without TNFα; #, P<0.05, flow cessation plus TNFα vs. flow 
cessation plus TNFα with reflow; &, P<0.05, BAY11-7082 vs. vehicle. Data represent 
one experiment.
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the structure of chromatin, thereby regulating the transcription of 
target genes. Hyperacetylation for example leads to loose chromatin 
and transcriptional activation while hypoacetylation result in compact 
chromatin and transcriptional repression (22). Short-term LSS exposure 
(1 to 4h) of HUVEC has been reported to increase the acetylation of 
histone H3 at lysine K14 (H3K14) (12). The present study showed that 
prolonged LSS (48h) decreased the level of acetylated histone H3 in 
endothelial cells, which was paralleled by a significant reduction of 
pro-inflammatory genes E-selectin, VCAM-1, and IL-8 as we previously 
reported (9). Possibly, a difference in histone acetylation status is related 
to a difference in activation status between endothelial cells subjected 
to short-term LSS and sustained LSS. The sudden onset of shear stress 
to static-adapted endothelial cells has been shown to activate multiple 
signal transduction molecules including the ras/extracellular signal-
regulated kinase (ERK1/2) and p38 MAPK (23), to initiate LSS effects and 
thereby induce the expression of several early responsive genes such as 
MCP1 (24). These processes may directly or indirectly involve histone 
acetylation. Short-term LSS associated increase of histone acetylation 
was furthermore shown to be attenuated by the inhibition of MAPK p38 
but not by the inhibition of ERK1/2 (12), suggesting certain interactions 
between histone acetylation and the activation of other signaling 
pathways induced by short-term LSS. On the other hand, endothelial 
cells will eventually adapt to sustained LSS, leading to a more quiescent 
status by inhibiting several pathways such as MAPKs (25). Whether this 
is associated with the hypoacetylation as we observed here remains to 
be investigated.  
The preconditioning of an endothelial monolayer with prolonged 
LSS makes the in vitro environment more physiological than is the case 
with cells grown under static conditions (8). It furthermore enables us 
to interrogate how endothelial cells respond to alterations in the level 
of shear stress that influence their behavior (4). In the current study, 
we observed reduced acetylation of histone H3, both upon acute flow 
cessation (0.5h) in prolonged LSS adapted endothelial cells, and upon 
abrupt reflow (0.5h and 1h) in 8h flow cessation adapted endothelial 
cells. HDAC inhibition by VPA counteracted flow alteration-induced 
endothelial responses, particularly the expression of pro-inflammatory 
genes. Decreased histone acetylation has been reported to be associated 
with multiple injuries in several animal studies. For instance, histone 





H3/4 has been shown to be deacetylated due to ischemia-induced 
HDAC activity (26). Decreased histone acetylation in organs has also 
been observed in sepsis and hemorrhagic shock, and was associated 
with cell and tissue damage as well as post-shock survival (13, 27, 28). 
It is of note that abrupt reflow following 8h flow cessation reduced 
histone acetylation in endothelial cells. Together with the previous 
reported increase in histone acetylation by short term LSS exposure 
of static cultured endothelial cells (12), we may infer that endothelial 
cells primed by LSS preadaptation and subsequent 8h flow cessation 
exposure exhibit a different molecular status compared to those under 
static condition. This may underlie the different responses of amongst 
others histone acetylation to the onset of flow and to pharmacological 
inhibition thereof. Since the effects of VPA are broad and not exclusively 
mediated by HDAC inhibition (29), further studied are needed to 
elucidate the link between VPA induced histone hyperacetylation and 
the effects of VPA on endothelial responses under flow alterations. 
KLF2 is a transcription factor that is highly sensitive to flow and 
acts as a mechano-activated mediator for the integration of multiple 
endothelial functions, including inflammation, vascular barrier function, 
and vascular tone (30-32). Shear stress stimulates phosphorylation 
dependent nuclear export of HDAC5 to dissociate HDAC5 from myocyte 
enhancer factor (MEF)-2 and enhance MEF2 transcription activity, 
thereby inducing the expression of KLF2 (33). These data suggest that 
HDAC5 acts as a negative regulator of KLF2 expression. In our current 
study we showed that flow cessation-related loss of KLF2 could be 
counteracted by HDAC inhibitor VPA, which further confirmed a likely 
partial role of HDACs in flow mediated KLF2 expression. Furthermore, 
our data demonstrated that the blockade of NF-κB activation by BAY11-
7082 effectively reversed flow cessation-associated decrease of KLF2 
expression and induction of pro-inflammatory genes, which corroborates 
the fact that NF-κB plays a role in regulating KLF2 expression (34). 
Together, these data imply that strategies to restore KLF2 expression 
to counteract endothelial pro-inflammatory responses under flow 
cessation condition can focus on interfering with HDAC activity and NF-
κB signaling. Interestingly, although the degradation of IκB was minor 
upon flow alterations, strong effects of BAY11-7082 were still observed, 
which may be explained by the non-canonical NF-κB pathway in which 
the activation status of NF-κB is independent of IκB expression (35).  
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Figure 8-Schematic summary of the involvement of HDAC activity and NF-κB signaling 
in flow alteration associated endothelial responses.
The responses at mRNA level of shear stress sensitive transcription factor (KLF2), 
vascular integrity molecules (Tie2, and Ang2), and pro-inflammatory molecules 
(E-selectin, VCAM-1, ICAM-1, and IL-8) to HDAC inhibition by VPA and NF-κB blockade 
by BAY11-7082 under different flow conditions are shown. The mRNA levels of CD31 
and VE-cadherin did not change under the conditions studied (data not shown in this 
table). ↑, induction by intervention; ↓, reduction by intervention; ↔, not affected by 
intervention. LSS, laminar shear stress; Fig. refers to figures present in this study with 
experimental data.
In the present study, the flow cessation-related decrease of KLF2 was 
rapidly increased upon acute reflow, which was diminished by VPA and 
BAY11-7082 pre-incubation prior to reflow installment. Interestingly, 
the pre-incubation of both drugs inhibited the expression of pro-
inflammatory genes induced by abrupt reflow, which suggests KLF2-
independent anti-inflammatory effects of both drugs. VPA, via increasing 
acetylation of mitogen-activated protein kinase phosphatase (MKP)-1, 
increased the activation of MKP-1 to dephosphorylate MAPK p38 and 
c-Jun N-terminal kinase (JNK), thereby leading to the downregulation 
of cyclooxygenase (COX)-2 in LPS stimulated brain microvascular 
endothelial cells (36). Moreover, phosphorylation dependent activation 
of NF-κB subunit p65 and its binding to COX-2 promoter region upon 
LPS stimulation were both inhibited by VPA pre-incubation (36). These 
alternative mechanisms of VPA suggest that it is of interest in future 
studies to disclose more details with regard to the involvement of these 
mechanisms in endothelial responses under different flow conditions. 
In summary, our current study demonstrated that both histone 
deacetylation and NF-κB activation are involved in flow alterations 
associated endothelial activation in vitro, and the inhibition of HDAC 
activity respectively blockade of NF-κB signaling are capable of 
counteracting endothelial pro-inflammatory responses to these flow 
alterations as well as to the combined exposure of flow cessation and 
cytokine stimulation. the main findings of our study are summarized in 
Figure 8. It is of note that we only studied the effects of drugs under flow 
alterations for a selected number of time periods, i.c., 8h flow cessation 
and 0.5h reflow. However, endothelial responses are highly dynamic and 
might be differently affected when taking different time periods of flow 
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Objective: To investigate the consequences of histone deacetylase inhi-
bition by HDAC inhibitor valproic acid (VPA) respectively of IkappaB ki-
nase/NF-kappaB (IKK/NF-κB) signaling blockade by IKK inhibitor BAY11-
7082 on (microvascular) endothelial cell behavior in vitro as well as in 
mice subjected to hemorrhagic shock (HS)/resuscitation in vivo. 
Design: Prospective, randomized laboratory investigation using an es-
tablished mouse model of hemorrhagic shock.
Setting: Research laboratory at university teaching hospital.
Subjects: Endothelial cells and C57BL/6 male mice.
Interventions: Endothelial cells were incubated with tumor necrosis 
factor-α in the absence or presence of valproic acid or BAY11-7082 in 
vitro. Mice were subjected to hemorrhagic shock by blood withdrawn 
until the mean arterial pressure of 30 mm Hg and maintained at this 
pressure for 90 minutes. At 90 minutes, subgroups of mice were resus-
citated with 4% human albumin in the absence or presence of vehicle, 
valproic acid (300 μg/g body weight) or BAY11-7082 (400 μg per mou-
se). Mice were killed 1 hour and 4 hours after resuscitation.
Measurements and Main Results: VPA and BAY11-7082 selectively di-
minished TNFα-induced endothelial pro-infl ammatory acti vati on in vi-
tro. In vivo, both systemic and local inflammatory responses were signif-
icantly induced by HS/resuscitation. The decreased histone acetylation 
in kidney after HS/resuscitation was restored by VPA treatment. In glo-
merular endothelial cells, the nuclear translocation of NF-κB,which was 
induced by HS/resuscitation,was eliminated by BAY11-7082 treatment 
while enhanced in the presence of VPA. Both VPA and BAY11-7082 sig-
nificantly attenuated the HS/resuscitation-induced protein expression 
of endothelial cell adhesion molecules E-selectin and vascular cell ad-
hesion molecule-1 in the microvasculature of kidney and liver, although 
mRNA expression levels of these molecules analyzed in whole organ 
lysates of kidney, lungs, and liver were not extensively affected. The 
reduced protein expression of adhesion molecules was paralleled by 
diminished the adhesion/transmigration of polymorphonuclear leuko-
cytes in kidney and liver after HS/resuscitation.
Conclusion: Suppressionof HDAC activity and blockade of IKK/NF-κB 
signaling during resuscitation ameliorate microvascular endothelial pro-
inflammatory responses in organsin mice after HS.
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Introduction
Hemorrhagic shock (HS), a life-threatening organ hypoperfusion 
caused by rapid and substantial blood loss, is a medical emergency 
frequently encountered by anesthesiologists and intensivists (1). Severe 
HS is associated with multiple organ dysfunction syndromes (MODS) 
and death in trauma, surgical,and medical patients. Fluid resuscitation 
to restore tissue perfusion is the first therapeutic intervention in HS 
(2),althoughitremains controversial because of the increased blood loss 
and mortality due to aggressive restoration of the intravascular volume 
and increasedblood pressure (3, 4). Nowadays,treatment of HS combines 
early control of bleeding, correction of coagulopathy, maintenance of 
critical tissue perfusion, and management of the systemic inflammatory 
response syndrome (SIRS) (1). No drugs interferingwith the inflammatory 
responses have so far proven clinical benefit. Therefore, the search 
foreffective drugsthatare able to counteract systemic inflammatory 
response-related MODS in HS/resuscitation continues.
Multiple mechanisms are involved in the pathogenesis of MODS after 
HS, including the production of pro-inflammatory cytokines and the 
disturbance of the (micro)circulation (5, 6). Microvascular endothelial 
cells actively engage in the development of MODS, orchestrating 
theirinteraction with leukocytes via induced expression of, among 
others, the adhesion molecules E-selectin, VCAM-1, and ICAM-1 on 
theirmembrane (7). This endothelial cell-leukocyte interaction is crucial 
for the recruitment and transmigration of leukocytes into underlying 
tissues, leading to organ injury via the release of proteases and oxygen-
derived radicals (8). Furthermore, microvascular endothelial cells 
regulate vascular leakage and the development of tissue edema which 
also contribute to the development of MODS after HS. We previously 
showed that HS results in an early and organ specific pro-inflammatory 
activation of microvascular endothelial cells independent of tissue 
hypoxia (5, 9).
A better understanding of the molecular effects of drug intervention 
on specific cell types within the complex organismis important for 
the development of therapeutic strategies (10). In the present study, 
we therefore focused on the microvascular endothelial inflammatory 
responses in HS/resuscitationto drug interventions aimed at two 
mechanisms, i.e., histone (de)acetylation and IKK/NF-κB signaling. 





Histone (de)acetylation is a posttranslational protein modification 
that regulates the structure and function of chromatin, and thereby 
modulates the expression of genes (11). Histone acetylation is controlled 
by the enzymes histone acetyl transferase (HAT) and histone deacetylase 
(HDAC). HS/resuscitation disrupts cellular acetylation homeostasis 
through increasing HDAC activity, leading to histone hypoacetylation 
and the alteration of gene expression (12). Modulation of protein 
acetylation in hemorrhagic and septic shock is reviewed elsewhere 
(13). Valproic acid, an HDAC inhibitor,increases survival in HS models 
(14-16). Furthermore, the addition of HDAC inhibitors to resuscitation 
fluid reversed shock induced changes in histone acetylation status (12). 
However, the precise effects of HDAC inhibition on pro-inflammatory 
responses of microvascular endothelial cells in different organs during 
HS and resuscitation are not known.
Besides by posttranslational modification, endothelial inflammatory 
activation is regulated by IKK/NF-κB intracellular signaling (17, 18). 
NF-κB is a transcription factor that controls the expression of several 
pro-inflammatory mediators and plays a pivotal role in the onset of 
inflammation. NF-κB is normally complexed with its inhibitory protein 
IκB in the cytoplasm. Upon activation, IκB is rapidly phosphorylated 
by IKK leading to the dissociation from NF-κB, which is followed by the 
degradation of IκB and subsequent nuclear translocation of NF-κB and 
transcription of target genes (19). NF-κB signaling is strongly activated 
during HS and resuscitation (20, 21), which makes it a potential 
therapeutic target for suppressing inflammation and tissue damage. 
Based on the knowledge available at present as summarized in 
Figure 1A, we hypothesized that the pro-inflammatory activation 
of microvascular endothelial cells in organs will be counteracted by 
pharmacological intervention of histone (de)acetylation and IKK/NF-κB 
signaling in the resuscitation phase following HS. We first examined the 
effects of HDAC inhibitor valproic acid and IKK inhibitor BAY11-7082 on 
TNFα-induced endothelial activation in vitro. Thereafter, using a mouse 
model of pressure-controlled HS, we investigated the consequences of 
HDAC activity inhibition by HDAC inhibitor valproic acid respectively 
blockade of IKK/NF-κB signalingby IKK inhibitor BAY11-7082 on 
microvascular endothelial cell behaviorin kidney, lungs, and liver during 
HS/resuscitation (22, 23). 
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Eight- to twelve-week-old C57BL/6 male mice (20-30g) were obtained 
from Harlan (Horst, the Netherlands). Mice were maintained on mouse 
chow and tap water ad libitum in a temperature-controlled chamber at 
24°C with a 12-hour light/dark cycle. All procedures performed were 
approved by the local committee for care and use of laboratory animals 
and were performed according to strict governmental and international 
guidelines on animal experimentation.
Mouse Hemorrhagic shock (HS) /Resuscitation Injury Model  
The HS/resuscitation injury model has been previously described 
(5). In brief,after induction of anesthesia, animals were placed on a 
temperature-controlled surgical pad (37-38°C). HS was achieved by 
blood withdrawal from the left femoral artery using a roller pump 
(Ismatec, Geldermalsen, the Netherlands) until a reduction of the MAP 
to 30mmHg was reached. Blood was collected in a heparinized 1mL 
syringe. Additional blood withdrawal or restitution of small volumes of 
blood was performed to maintain MAP at 30mmHg during the shock 
period. After 90 min of shock, a subset of mice was resuscitated with 4% 
human albumin in saline (Sanquin, Amsterdam, the Netherlands) using 
two times the volume of withdrawn blood. Mice were allowed to wake 
up for 1 hour or 4 hours after volume resuscitation was achieved. During 
sacrifice, animals were anesthetized with isoflurane, subsequently 
blood was drawn via cardiac puncture and thereafter, the kidneys, lungs, 
and liver were harvested, snap-frozen in liquid nitrogen, and stored at 
-80°C until analysis. Each group in this study consisted of 8 animals. The 
experimental setup is illustrated schematically in Figure 1B.
Pharmacological interventions during resuscitation  
4% human albumin in saline (AL) was used as resuscitation fluid. 
Control mice were left untreated and received isoflurane anesthesia only 
during termination. HDAC inhibitor VPA (300µg/g body weight, which 
was selected based on previous publications (14, 24-27) and which is 
higher than the doses used in humans for treatment of epilepsy, yet 
in the same range as the daily dose used for treatment of cancer (28, 
29)) and IKK inhibitor BAY11-7082 (400µg per mouse) (30)were used 
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Figure 1-Schematic representation of molecular responses in endothelial cells 
involved in the pathogenesis of hemorrhagic shock and the setup of the hemorrhagic 
shock/resuscitation mouse model.
(A) Local blood flow is disturbed upon the induction of hemorrhagic shock. As a 
consequence, the disturbance of flow sensed by endothelial cells leads to the loss of 
KLF2 through mechanotransduction. Concomitantly, endothelial cells are exposed to 
pro-inflammatory cytokines (e.g., TNFα) present in the circulation. This can cause 
activation of NF-κB signaling, leading to the transcription of the adhesion molecules 
E-selectin, VCAM-1, ICAM-1, and the pro-inflammatory cytokines IL-1β, MCP1, IL-6 
and IL-8. In addition, upon pro-inflammatory activation, Ang2 is released from Weibel 
Palade Bodies. After its release, Ang2 binds to its receptor Tie2 on the endothelial cell 
membrane, thereby reducing Tie2 phosphorylation, which leads to vascular instability. 
The hemorrhagic shock insult can furthermore disrupt the homeostasis of histone 
acetylation via an increase in histone deacetylase activity. 
In this study, we examined the in vitro and in vivo effects of HDAC inhibitor valproic 
acid and IKK inhibitor BAY11-7082 (red boxes) to assess their effects on organ specific 
microvascular endothelial inflammation during hemorrhagic shock/resuscitation.
Abbreviations: TNFα, tumor necrosis factor alpha; IL-1β, Interleukin-1 beta; MCP1, 
monocyte chemotactic protein 1; IL-6 Interleukin 6; IL-8, Interleukin 8; CD31, cluster 
of differentiation 31 (also known as Platelet endothelial cell adhesion molecule-1); 
VE-cad, vascular endothelial-cadherin. KLF2, Kruppel-like factor-2; VCAM-1, vascular 
cell adhesion molecule-1; ICAM-1, intercellular adhesion molecule-1; NF-κB, nuclear 
factor-kappa B; Ang2, Angiopoietin-2; Tie2, receptor tyrosine kinase; HDAC, histone 
deacetylase; HAT, histone acetyl transferase. 
(B) After the induction of anesthesia, blood withdrawal was started to induce 
hemorrhagic shock. After 90min of shock, mice were either sacrificed (†) or resuscitated 
with 4% human albumin (AL) as resuscitation fluid, where appropriate containing 
vehicle (Dimethyl sulfoxide, DMSO), valproic acid (VPA), or BAY11-7082, after which 
mice were allowed to wake up for 1h or 4h before termination. Control mice were 
terminated (†) at the start of the experiment.





as experimental drugs. VPA was dissolved in sterile saline (50mg/ml) 
and BAY11-7082 was reconstituted in dimethyl sulfoxide (DMSO, 40mg/
ml). Shortly before resuscitation, both drugs were further diluted 
in resuscitation fluid to achieve the final doses. DMSO in 4% AL at a 
final concentration equivalent to the concentration in the BAY11-7082-
contained solution was prepared as DMSO vehicle control. This same 
final concentration of DMSO was created in VPA-contained resuscitation 
fluid.
After 90min of HS, a subset of mice was randomly allocated into 
the following groups: 90min HS (HS without fluid resuscitation), AL (HS 
resuscitated with 4% human albumin), vehicle (HS resuscitated with 4% 
AL containing vehicle DMSO), VPA (HS resuscitated with 4% AL containing 
VPA), BAY (HS resuscitated with 4% AL containing BAY11-7082). Mice 
were sacrificed 1 hour and 4 hours after resuscitation. 
Cell culture  
Human umbilical vein endothelial cells (HUVEC) were obtained from 
Lonza (Breda, The Netherlands). Cells were cultured in EBM-2 medium 
supplemented with EGM-2 MV SingleQuot Kit Supplements & Growth 
Factors (Cat. No. CC-3202, Lonza, the Netherlands). Culture plates 
(Costar, Corning, New York) were incubated with EGM-2MV medium for 
30min, thereafter cells were seeded and grown until confluent before 
the experiments. In all experiments, cells between passages 5 to 7 were 
used. All cell cultures were maintained by the Endothelial Cell Facility of 
the UMCG.
Gene expression analysis by real time RT-PCR
Total RNA was isolated from HUVEC respectively tissue cryosections 
of mouse kidney, lungs, and liver using the RNeasy Mini plus Kit (Qiagen, 
Westburg, Leusden, The Netherlands) according to the manufacturer’s 
instructions. Integrity of RNA was determined by gel electrophoresis, 
while RNA concentration (OD260) and purity (OD260/OD280) were 
measured by NanoDrop® ND-1000 UV-Vis spectrophotometer (NanoDrop 
Technologies, Rockland, DE, USA). cDNA synthesis and real-time PCR 
were performed as described previously(9, 31). The Assay-on-Demand 
primers purchased from Applied Biosystems (Nieuwerkerk aan den 
IJssel, The Netherlands) for quantitative PCR included the housekeeping 
gene GAPDH (Glyceraldehyde-3-phosphate dehydrogenase, assay ID 
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Mm99999915_g1), CD31 (Platelet endothelial cell adhesion molecule, 
PECAM-1, assay ID Mm00476702_m1), VE-Cad (VE-Cadherin, assay ID 
Mm00486938_m1), KLF2 (Kruppel-like factor-2, assay ID Mm00500486_
g1), Tie2 (receptor tyrosine kinase, assay ID Mm00443242_m1), Ang2 
(Angiopoietin-2, assay ID Mm00545822_m1), E-selectin (assay ID 
Mm00441278_m1), VCAM-1 (vascular cell adhesion molecule-1, assay 
ID Mm00449197_m1),  ICAM-1 (intracellular adhesion molecule-1, assay 
ID Mm00516023_m1), MCP-1 (monocyte chemotactic protein-1, assay 
ID Mm00441242_m1), IL-6 (Interleukin-6, assay ID Mm00446190_m1), 
IL-8 (Interleukin-8, assay ID Mm00433859_m1), TNF-α (tumor necrosis 
factor α, assay ID Mm00443258_m1), IL-1β (Interleukin-1β, assay ID 
Mm00434228_m1), NGAL (Neutrophil gelatinase-associated lipocalin, 
assay ID Mm01324470_m1), and MPO (myeloperoxidase, assay ID 
Mm00447886_m1). Quantitative PCR was performed in a ViiATM 7 real-
time PCR System (Applied Biosystems, Nieuwerkerk aan den IJssel, The 
Netherlands). Gene expression levels were normalized to the expression 
of the housekeeping gene GAPDH. The mRNA levels relative to GAPDH 
were calculated by 2-ΔCT values and averaged per group. The fold change 
of gene expression levels relative to the control groups was calculated 
by 2-Δ Δ CT.
Cytokine quantification by Enzyme-linked immunosorbent assay 
(ELISA)   
The concentrations of TNFα, IL-6, and NGAL in plasma were 
measured by ELISA (TNFα and IL-6: Biolegend, CA, USA; NGAL: R&D 
Systems, Minneapolis,Minnesota, USA). 
Immunofluorescence staining of NF-κB subunit p65 localization in 
HUVEC 
HUVEC were cultured on sterile glass coverslips (Menzel-Gläser, 
Braunschweig, Germany) in 6-well plates. Cells were pretreated 
with valproic acid (5mM, sodium salt, VPA; Sigma-Aldrich, St. Louis, 
MO, USA) or BAY11-7082 (10µM, (E)-3-[(4-methylphenylsulfonyl]-
2-propenenitrile; Enzo life Sciences, Lausen, Switzerland) for 30min 
before being challenged with TNFα (10ng/ml,Boehringer Ingelheim, 
Germany) for indicated time periods. Cells were next fixed with 1% 
formaldehyde in PBS for 20min. Subsequently, cells were permeabilized 
by 5min incubation with 0.25% Triton X-100 in PBS, then blocked with 





PBS/3% bovine serum albumin (BSA, Sigma-Aldrich) for 30min at 
room temperature and incubated with rabbit anti-p65 antibody (cat. 
no. D14E12, Cell Signaling Technology,Inc., Leiden, The Netherlands) 
diluted 1:200 in PBS/0.5% BSA/0.05% Tween 20 (Sigma-Aldrich). Next, 
coverslips were washed with PBS and incubated for 1h with Alexa 
Fluor®
555
-conjugated donkey anti-rabbit secondary antibody (cat.no. 
A-31572, Molecular Probe, Leiden, The Netherlands) diluted 1:100 in 
PBS/0.5% BSA/0.05% Tween 20. Thereafter, coverslips were washed 
with PBS and mounted using Aqua Poly/Mount medium (Polysciences, 
Warrington, PA, USA) containing DAPI (4’,6-Diamidino-2-Phenylindole, 
Dihydrochloride; Molecular Probe), air dried for 24h, and stored in 
the dark at 4°C. Fluorescence images were taken with a Leica DM/
RXA fluorescence microscope using Quantimet HR600 image analysis 
software (Leica, Wetzlar, Germany). 
Protein Expression Analysis by Western Blot
Western blot analysis was performed with mouse kidney tissues to 
determine the protein expression levels of IκBα and acetylated histone 
H3. Protein extracts (75µg protein/lane) were separated by sodium 
dodecyl sulphate-poly-acrylamide gel electrophoresis (SDS-PAGE) on 
10% (IκBα) and 12% (acetylated H3) polyacrylamide gels and transferred 
to a nitrocellulose membrane (Bio-Rad Laboratories, Utrecht, the 
Netherlands). After 1h blocking with 5% skimmed milk (Campina, 
Friesland, The Netherlands), membranes were incubated with primary 
antibodies overnight at 4℃. The primary antibodies used in this study 
were: IκBα (cat. no. #06-494, Millipore, Temecula, CA, USA) diluted 1:500 
in 5% skimmed milk, acetylated H3 (cat. no. #06-599, Millipore) diluted 
1: 2,000 in 5% skimmed milk, and actin (cat no. #MAB1501, Millipore) 
diluted 1:200,000 in 5% BSA. The primary antibodies were detected by 
horseradish peroxidase-coupled secondary antibodies (diluted 1:5,000 
in 5% skimmed milk, Southern Biotech, Birmingham, Alabama, USA) at 
room temperature for 1 hour, and visualized by horseradish peroxidase 
substrate (Millipore), and examined by Geldoc (Bio-Rad). Blots were 
analyzed using Image Lab software (Bio-Rad).
Western blot analysis of acetylated H3 was also performed with 
HUVEC protein lysates with 30µg protein/lane loading. The primary 
antibody for acetylated H3 was diluted 1:5,000. Detection was performed 
as described above.
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Immunofluorescence double staining for NF-κB subunit p65 and CD31 
in mouse kidney
Immunofluorescence staining was performed on 5µm thick 
cryosections of mouse kidney. Tissue cryosections were fixed in 
acetone for 10min. Endogenous biotin was blocked by a Biotin Blocking 
System (DAKO, Glostrup, Denmark). p65 was detected with rabbit 
anti-p65 antibody (1:200, cat. no. D14E12, Cell Signaling), and then 
incubated with goat anti-rabbit biotin secondary antibody (IgG (H+L)-
BIOT, Southern Biotech) in the presence of 2% normal mouse serum 
(Sanquin), followed by the incubation with Alexa Fluor®
555
-conjugated 
streptavidin (1:100, Molecular Probes). To detect CD31, sections were 
incubated with rat anti-mouse CD31 primary antibody (1:200, cat. 
no. #550274, BD Pharmingen, San Diego, CA, USA), followed by Alexa 
Fluor®
488
-conjugated goat anti rat secondary antibody (1:100, Molecular 
Probes) plus 2% normal mouse serum. All incubation steps were carried 
out in the presence of 5% fetal calf serum (FCS, Sigma-Aldrich). After 
proper washing, sections were then incubated with 0.1% Sudan Black B 
(Sigma-Aldrich) in 70% ethanol for 30min. Sections were mounted and 
examined as described above. 
Immunohistochemical detection of endothelial cell adhesion 
molecules and leukocyte infiltration in mouse kidney and liver
The expression and localization of adhesion molecules E-selectin, 
VCAM-1, and ICAM-1, as well as CD45+ polymorphonuclear leukocytes 
in kidney and liver were determined by immunohistochemistry. Frozen 
organs were cryostat-cut at 5μm, mounted onto glasses, and fixed in 
acetone for 10min. Endogenous peroxidase was blocked by 10min 
incubation with Peroxidase Block (EnVision + System-HRP (AEC), 
DAKO, Carpentaria, CA, USA). For specific protein detection, sections 
were incubated for 60min at room temperature with primary rat anti 
mouse antibodies (10 μg/ml) recognizing E-selectin (MES-1 10 μg/
ml, kindly provided by Derek Brown, Ph.D., UCB Celltech, Brussels, 
Belgium), VCAM-1 (1: 50, clone M/K-1.9, ATCC, Manassas VA, USA), 
ICAM-1 (1: 100, Southern Biotech), and CD45 (1: 100, cat. no. #550539, 
BD Pharmingen) diluted in PBS/5% FCS. This was followed by 30min 
incubation with unconjugated rabbit anti-rat IgG antibody (mouse 
adsorbed, Vector Laboratories, Burlingame, CA, USA) diluted 1: 300 
in PBS/5% FCS supplemented with 2% normal mouse serum at room 





temperature. Sections were further incubated for 30min at room 
temperature with anti-rabbit labeled polymer HRP antibody from the 
EnVision kit. Between incubations with different antibodies, sections 
were washed extensively with PBS. Peroxidase activity was detected 
with 3-amino-9-ethylcarbazole (AEC) from the EnVision kit and sections 
were counterstained with Mayer’s hematoxylin (Merck, Darmstadt, 
Germany). 
Statistical analysis   
Statistical significance of differences was studied by means of the 
Student’s T-test or a one way analysis of variance (ANOVA) followed 
by Bonferoni correction for selected pairs. All statistical analyses were 
performed using GraphPad Prism 5 software (GraphPad Prism Software 
Inc., San Diego, CA, USA). Differences were considered to be significant 
when P<0.05.
Results
Hemorrhagic shock/resuscitation induce systemic and local 
inflammatory responses and organ damage in kidneys, lungs, and liver 
First, the inflammatory activation and organ damage arising during 
HS and subsequent resuscitation were studied. The plasma levels of 
pro-inflammatory cytokines TNFα and IL-6 were both significantly 
increasedafter 90min of HS (77 fold respectively 45 fold). 1h after 
resuscitation,the TNFα level was decreased while IL-6 remained high 
(Fig.2, A, B). 4h after resuscitation, both TNFα and IL-6 were back to 
control levels. This systemic pro-inflammatory activation was paralleled 
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by an increase in mRNA levels of the pro-inflammatory cytokines 
MCP1, TNFα, IL-1β, IL-6, and IL-8, as well as of the endothelial adhesion 
molecules E-selectin, VCAM-1, and ICAM-1 in kidney, lungs, and liver 
both after 90min of HS and at 1h post-resuscitation (Fig.2, D, E, and F). 
The expression of MPO in lungs was significantly induced after 90min 
HS,and was next diminished after resuscitation. 
Furthermore, in response to HS/resuscitation, Tie2 expression 
in kidney, lungs, and liver was strongly reduced in a time-dependent 
manner, while the expression of Ang2, the ligand of Tie2, was 
induced by resuscitation in kidney and liver but decreased in lungs. 
CD31 expression was downregulated in kidney after 90min of HS and 
decreased both in kidney and lungs 4h after resuscitation. Resuscitation 
significantly increased VE-cadherin expression in kidney. In addition, 
KLF2 was significantly downregulated in both kidneys and lungs, which 
was gradually restored after resuscitation. NGAL, a biomarker of kidney 
injury, was slightly increased by HS, and this increase was markedly 
enhanced after resuscitation (25 fold at 1h and 59 fold at 4h). The level 
of circulating NGAL in blood corroborated its gene expression profile 
(Fig.2, C). These observations indicate that both systemic inflammation 
and local endothelial inflammatory responses as well as kidney organ 
damage occurred during HS/resuscitation.
In vitro effects of valproic acid and BAY11-7082 on TNFα-induced pro-
inflammatory activation of endothelial cells
To study the effects of inhibiting HDAC activity or blocking IKK/NF-
κB signaling on endothelial pro-inflammatory activation in vitro, we 
Figure 2-Hemorrhagic shock (HS) and resuscitation (R) lead to systemic and local 
inflammatory responses and organ damage in kidney, lungs and liver.
Systemic concentrations of TNFα (A), IL-6 (B), and NGAL (C) protein in plasma of control 
mice, and mice subjected to 90min HS respectively 90min HS followed by resuscitation 
(1h and 4h after R). mRNA expression of endothelial pro-inflammatory molecules 
(cell adhesion molecules and cytokines), vascular integrity related molecules (Tie2, 
CD31, VE-cadherin, Ang2), and organ damage related markers NGAL in kidney (D), 
Myeloperoxidase (MPO) in lungs (E), and liver (F) were determined by real time RT-
PCR using GAPDH as housekeeping gene. All data are presented as mean ± SD of each 
group (n = 8 animals per group). *, P<0.05 compared to healthy control; #, P<0.05, 1h 
after R vs. 90min HS; &, 4h after R vs. 90min HS.
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p65 as revealed by CD31/p65 double staining (Fig.4, C). In addition, VPA 
administration caused an increase of p65 nuclear translocation in the 
glomeruli of the kidney compared to vehicle control, which corroborates 
the in vitro observation in HUVEC (Fig. 3, G).
These results indicate that treating the mice with VPA and BAY11-
7082 during the resuscitation phase pharmacologically affected the 
increase of histone acetylation respectively attenuated NF-κB nuclear 
translocation in glomerular endothelial cells.
Systemic and local effects of valproic acid and BAY11-7082 treatment 
in mice subjected to hemorrhagic shock/resuscitation
The next step was to determine which molecular consequences were 
associated with these inhibitory effects of the drugs. The administration 
of VPA during resuscitation to HS mice increased the circulating 
level of TNFα but did not affect IL-6,while BAY11-7082 significantly 
downregulated the plasma level of both TNFα and IL-6 compared to 
vehicle control (Fig.5, A and B). The systemic level of NGAL was not 
affected by either VPA or BAY11-7082 (Fig.5, C). At whole organ mRNA 
level, VPA and BAY11-7082 treatment did not show extensive effects on 
endothelial activation in either kidney, lungs or liver although areduction 
was seen in the expression of some pro-inflammatory molecules, i.c., of 
Figure 3-Pharmacological effects of valproic acid and BAY11-7082 on tumor necrosis 
factor alpha-induced pro-inflammatory activation of endothelial cells in vitro.
After 30min pretreatment with VPA (5mM) or BAY11-7082 (10µM), human umbilical 
vein endothelial cells (HUVEC) were subjected to TNFα (10ng/ml) stimulation for 4h. 
Expression of endothelial adhesion molecules E-selectin (A), VCAM-1 (B), and ICAM-1 
(C) as well as pro-inflammatory cytokines MCP1 (D) and IL-6 (E) was determined by 
real time RT-PCR using GAPDH as housekeeping gene. Values represent mRNA level 
relative to GAPDH. Data are shown as mean ± SD of three independent experiments. *, 
P<0.05, vehicle + TNFα vs. vehicle; &, P<0.05, VPA + TNFα vs. vehicle + TNFα; #, P<0.05, 
BAY+TNFα vs. vehicle + TNFα. (F) Representative image of western blot for acetylation 
of histone H3. Whole cell lysate of HUVEC challenged by TNFα (10ng/ml) for 0.5h, 
1h, and 4h in the absence or presence of VPA pretreatment was assessed by western 
blot for the acetylation of histone H3. Actin was taken as loading control. (G) HUVEC 
were treated with vehicle, VPA (5mM), or BAY11-7082 (10µM) for 30min, and then 
stimulated with TNFα (10ng/ml) for 20min before fixation for immunofluorescence 
staining for NF-κB p65 (red) and the nucleus (DAPI blue). Arrows show cells that were 
magnified. Original magnification was 400x. 
Thesis Ranran Li.indb   98 20-08-15   14:03
209753-L-sub01-bw-Li
99
Drug interventions in hemorrhagic shock
4
first treated HUVEC with HDAC inhibitor VPA respectively IKK inhibitor 
BAY11-7082 for 30min before challenging the cells withTNFα. VPA 
selectively inhibited the expression of endothelial adhesion molecule 
VCAM-1 and pro-inflammatory cytokines MCP1 and IL-6 induced by 
TNFα (Fig. 3, A-E). BAY11-7082 significantly reduced the upregulation of 
endothelial adhesion molecules E-selectin, VCAM-1, and ICAM-1 as well 
as of the pro-inflammatory cytokine MCP1 (Fig. 3, A-E). In contrast, NF-
κB inhibition led to a significant upregulation of the pro-inflammatory 
cytokine IL-6  (Fig.3, E). 
Acetylation of histone H3 in endothelial cells subjected to TNFα 
was decreased compared to unstimulated control in a time-dependent 
manner, and this decreasewas effectively inhibited by VPA pretreatment 
(Fig.3, F). TNFα stimulation-related nuclear translocation of NF-κB 
subunit p65 was effectively eliminated by BAY11-7082 pretreatment. 
It is of note that VPA pre-incubation led to increased p65 nuclear 
accumulation (Fig.3, G). These data demonstrated that both VPA and 
BAY11-7082 ameliorated endothelial inflammatory responses in vitro, 
albeit to a different extent.
Effects of valproic acid and BAY11-7082 treatment on histone acetylation 
status and activation of IKK/NF-κB signaling after hemorrhagic shock/
resuscitation
Acute kidney injury is often the first complication of HS/resuscitation 
and it is an important factor associated with mortality in critically ill 
patients (32). Therefore, here we focused on the molecular changes 
occurring in the kidney during HS/resuscitation. 
To determine the effects of HDAC inhibitor VPA on histone acetylation 
patterns duringHS/resuscitation, the acetylation level of histone H3 in 
kidney was assessed by western blot. Mice subjected to 90min HS and 
resuscitation showed a decrease in acetylation of histone H3 compared 
to control mice,while the addition of VPA in resuscitation fluid markedly 
restored histone acetylation (Fig. 4, A). 
Similarly, the effects of BAY11-7082 on NF-κB signaling was examined. 
HS and resuscitation lowered the expression of IkBα in kidney compared 
to healthy control. IKK inhibitor BAY11-7082 inhibited the degradation 
of IkBα both at 1h and 4h after resuscitation (Fig.4, B). In glomerular 
endothelial cells, the blockade of the NF-κB signaling cascade by BAY11-
7082 was confirmed by the markedly reduced nuclear translocation of 





Figure 4-Effects of valproic acid and BAY11-7082 treatment on histone acetylation 
status and activation of IkappaB kinase/NF-kappaB signaling during hemorrhagic 
shock/resuscitation.
Representative images of western blot for the expression of acetylated histone H3 
respectively IκBα. Western blot analysis of (A) the acetylation of histone H3 and (B) 
IκBα in the kidney of control (CT) mice, and mice subjected to 90min hemorrhagic 
shock (90min HS) followed by resuscitation in the absence or presence of vehicle, VPA, 
or BAY11-7082. Actin was used as loading control. (C) Immunofluorescence staining for 
cell nucleus (DAPI blue), endothelial marker CD31 (green), and NF-κB subunit p65 (red) 
in glomerulus of control kidney and kidney of mice subjected to hemorrhagic shock 
and resuscitation in the presence of vehicle, VPA, respectively BAY11-7082. Original 
magnification 400x.
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Figure 5-Systemic and local effects of valproic acid and BAY11-7082 treatment in 
mice subjected to hemorrhagic shock/resuscitation.
Concentrations of pro-inflammatory cytokines TNFα (A) and IL-6 (B) as well as kidney 
damage biomarker NGAL (C) in plasma after hemorrhagic shock/ resuscitation and the 
effects of pharmacological intervention thereon were quantified by ELISA. 
Expression of endothelial adhesion molecules and pro-inflammatory cytokines (D), 
vascular integrity related molecules (Tie2, CD31, VE-cadherin, Ang2), flow responsive 
molecule (KLF2) (E), and organ damage related markers (NGAL and MPO) (F) in kidney 
(Ki), lungs (Lu), and liver (Li), was determined by real time RT-PCR using GAPDH as 
housekeeping gene. Data are expressed as mean ± SD of 8 mice per group. *, P<0.05, 
VPA vs. vehicle; #, P<0.05, BAY11-7082 vs. vehicle.
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E-selectin, ICAM-1, TNFα, and IL-8 in kidney,andof ICAM-1, MCP1 and 
IL-8 in liver by BAY11-7082, as well as the reduction of MCP1 and IL-6 in 
lungs and liver by VPA treatment (Fig.5, D, Eand F).
To reveal possible microvascular differences in endothelial pro-
inflammatory activation and in response to drug interventions duringHS/
resuscitation, we examined the protein levels of endothelial cell adhesion 
molecules in kidney and liver using immunohistochemistry. In kidney, 
E-selectin was not present in healthy controls, while VCAM-1 showed 
basal expression in arteriole, peritubular capillaries, and post-capillary 
venules. Constitutive ICAM-1 expression was observed in all vascular 
beds in healthy kidney (Fig.6, A, F, K). Upon 90min HS, E-selectin was 
inducedin glomerular capillariesand VCAM-1 in arterioles, peritubular 
capillaries, and post-capillary venules.The induction of ICAM-1 was 
observed in all renal vascular beds (Fig.6, B, G, L). The upregulation of 
these adhesion molecules was aggravated 1h after resuscitation, with 
VCAM-1 having also been induced in the glomerulus compared to its 
absence after 90min HS (Fig.6, C, H, M). The presence of VPA and BAY11-
7082 during resuscitation diminished the high upregulation ofE-selectin 
and VCAM-1 protein, while effects on ICAM-1 could not be discerned 
(Fig.6, D and E, I and J, N and O). 
In the liver of control mice, E-selectin was not expressed while the 
basal expression of VCAM-1 and ICAM-1 mainly occurred in central 
veins and sinusoidal endothelial cells (Fig.7, A, F, K). The expression 
of all three adhesion molecules was significantly upregulated after HS, 
which was even further increased at 1h after resuscitation compared to 
HS insult only (Fig.7, B and C, G and H, L and M). VPA and BAY11-7082 
treatment prevented the upregulation of E-selectin and VCAM-1 in 
the vasculature of the liver, while no effects on ICAM-1 were observed 
(Fig.7, D and E, I and J, N and O).
These data indicate that HDAC inhibition and NF-κB blockade exert 
anti-inflammatory effects by suppressing the expression of endothelial 
adhesion molecule proteins in the microvasculature of kidney and liver.
The effect of VPA and BAY11-7082 treatment on polymorphonuclear 
leukocyte adhesion/influx in kidney and liver 
The expression of adhesion molecules facilitates the recruitment 
and transmigration of polymorphonuclear leukocytes from blood into 
underlying tissues, which results in tissue damage under conditions of 
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HS (33). Upon HS and subsequent resuscitation, the number of adhering 
and invading CD45+ leukocytes in kidney and liver wasincreased. VPA 
and BAY11-7082 treatment during resuscitation reduced this number 
of adhering and invading leukocytesin both organs compared to 
vehicle control (Fig.8, A-J). This finding led us to conclude that the 
molecular inhibitions of histone deacetylation and NF-κB activation 
during resuscitation after HS is an effective strategy to interfere with 
detrimental influx of leukocytes into the organs. 
Discussion
Hemorrhagic shock (HS) is associated with a high morbidity and 
mortality (1). Upon HS, several endogenous compensatory mechanisms 
are stimulated to mitigate organ dysfunction. Insufficiency of these 
mechanisms combined with the reperfusion-associated damage can 
lead to microvascular endothelial inflammatory activation and leukocyte 
recruitment into tissues, which may manifest as tissue damage. 
Various molecular mechanisms have been proposed to be involved 
in HS-associated MODS, and amongst others the roles of histone (de)
acetylation and NF-κB activation were highlighted (15, 34). The current 
work aimed to examine the pharmacological effects of interfering 
with HDAC activity respectively IKK/NF-κB signaling activation on HS/
resuscitation-associated microvascular endothelial inflammatory 
activation and leukocyte recruitment into tissues. In a mouse model of 
HS/resuscitation, we demonstrated that the administration of either the 
HDAC inhibitor VPA or the IKK inhibitor BAY11-7082 in the resuscitation 
fluid inhibited the pro-inflammatory activation of the microvasculature 
in kidney, lungs, and liver. The HS/resuscitation-related induction of 
protein expression of endothelial cell adhesion molecules E-selectin 
and VCAM-1, as well as the consequent influx of polymorphonuclear 
leukocytes in kidney and liver were significantly reduced by treatment 
with either drug. In addition, BAY11-7082 reduced the systemic level 
of cytokines TNFα and IL-6. Taken together, our data show that either 
inhibition of HDAC activity or of NF-κB signaling during the resuscitation 
phase of HS/resuscitation has anti-inflammatory effects on endothelial 
cells in organs.
HS/resuscitation modulates the acetylation of histone and non-
histone proteins, which affects cell signaling pathways and gene 





transcription (13). The current study showed that the level of histone 
acetylation in kidney was reduced upon HS/resuscitation, which 
was restored by the administration of the HDAC inhibitor VPA during 
resuscitation. This observation is consistent with studies which showed 
that VPA administration effectively modulated the balance between 
the activity of HATs and HDACs in cardiac tissue in a rat model of HS, 
and induced global hyperacetylation of several histone proteins in the 
liver (12, 16). Besides the effects on histone proteins, HDAC inhibitors 
mayaffect other mechanisms via acetylating non-histone proteins. For 
example, HDAC inhibition has been shown to exert protective effects 
on organ injury via the upregulation of pro-survival molecule Bcl-2 
through acetylation-associated nuclear translocation of β-catenin (14).
Furthermore, multiple studies have demonstrated the beneficial effects 
of HDAC inhibition onthe outcome of sepsis-associated multiple organ 
injury, such as enhanced recovery of acute kidney injury, inhibition of 
septic cell apoptosis, and protection against pulmonary inflammation 
(27, 35, 36). A downside of HDAC inhibition is the potential harmful 
consequences to the host due to the here observed enhancement of 
nuclear accumulation of NF-κB in endothelial cells by VPA. It is tempting 
to speculate that a combination of HDAC inhibition and IKK/NF-κB 
signaling blockade would be a potent anti-inflammatory therapeutic 
approach for HS patients as the latter could counteract VPA-induced 
NF-κB nuclear accumulation in endothelial cells while not affecting 
VPA’s other anti-inflammatory effects. To investigate the possibilities 
of this combination in an animal model, extensive dose optimization 
of drug combinations and the effects on survival, organ function, and 
microvascular endothelial behavior and the molecular causes thereof 
should be undertaken, which was beyond the scope of our studies. It 
is of note that in these studies the translation of the VPA dosing has to 
be taken into account, as in humans treated for advanced cancer, the 
maximum tolerated dose of VPA was 30mg/kg (37), while in our current 
mouse study the dose of VPA was 300mg/kg based on previous animal 
studies(27, 28).
Surprisingly, in our model the administration of VPA during 
resuscitation resulted in upregulation of TNFα while it did not 
significantly affect the level of IL-6 (Figure 5, A and B). Similar 
observations have been reported before, showing that VPA treatment 
did not have effects on inflammatory features in mice with cecal 
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ligation and puncture (CLP)-induced sepsis, and even upregulated 
the expression of TNFα in lungs (36).The exact reason for this is not 
clear to us. There are a few explanations possible. First, in our study, 
the mice were resuscitated with two times the volume of blood 
loss, which may excessively dilute the systemic levels of VPA. VPA at 
different concentrations might have different effects, which can result 
in the variation in effects of VPA on different cytokines. Second, the 
expression of TNFα and IL-6 have different kinetics in HS, indicating 
that the production of IL-6 may be partially independent of those 
mechanisms in hemorrhage that are involved in the release of TNFα 
(38). Furthermore, VPA, used as an HDAC inhibitor, has broad effects 
via different molecular mechanisms. Thus, it may affect the production 
of TNFα and IL-6 through different mechanisms, contributing to the 
observed differences between the two cytokines. In addition, cytokines 
are secreted by several different cell types, and the effects of HDAC 
inhibition on inflammatory genes may vary between different cell types 
and challenges, or even between different mediators in the same cells 
(39, 40).
Activation of IKK/NF-κB signaling is a hallmark of inflammation and 
organ injury, and various strategies have been aimed towards blocking 
this pathway at different molecular and cellular levels. In the present 
study, in the kidney of mice subjected to HS/resuscitation, we observed 
degradation of IκB and the consequent nuclear translocation of NF-κB 
subunit p65 in glomerular endothelial cells (Fig 3, G), both of which 
were abolished by administration of IKK inhibitor BAY11-7082 during 
resuscitation. Our results corroborate the study by Coldewey et al.who 
demonstrated in experimental sepsisthat delayed inhibition of IKK 
by the selective inhibitor IKK 16 effectively suppressed inflammation 
(41). In addition, Yang et al. revealed that inhibition of NF-κB DNA-
binding activity using double-stranded oligodeoxynucleotides reduced 
tissue damage and cytokine expression in the liver following a rat 
polytrauma model of combined closed femur fracture, laparotomy and 
lipopolysaccharide injection (34). However, the IKK/NF-κB pathway has 
a critical role in innate and adaptive immune responses, and systemic 
blockade of IKK/NF-κB signaling is associated with severe side effects 
such as immunosuppression and cell apoptosis (42). Strategies have been 
developed to circumvent these severe side effects by selectivelyinhibiting 
NF-κB in endothelial cells only.This approach is protective to the host in 





models of sepsis and arthritis, and likely reduces the risk of side effects 
compared to thegeneral blockade of NF-κB in all cells in the body (43, 
44). Our group has recently shown that using endothelial-targeted 
immunoliposomes as the carrier, selective pharmacological inhibition 
of NF-κB in inflamed microvascular endothelial cells can be achieved to 
interfere with disease-associated endothelial activation (45).
In the present study, the nuclear accumulation of NF-κB after both 
TNFα activation in vitro and HS/resuscitation in vivo was enhancedby 
treatment with VPA. HDAC inhibitors modulate NF-κB-mediated gene 
transcription via the acetylation of both histone proteins and NF-κB itself 
(46). Although not completely understood, acetylation of NF-κB works 
in concert with the acetylation of histones to regulate DNA binding 
affinity, transcriptional activation, and the duration of action (47). The 
reported anti- respectively pro-inflammatory effects of HDAC inhibition 
are not fully understood, as the drugs are studied in various cell types 
and HDAC inhibitors employed lack HDAC subtype selectivity (48-50).
Moreover, HDAC3 acts as a positive regulator of IL-1-induced gene 
expression in HEK293 (Human Embryonic Kidney 293) cells by removing 
inhibitory acetyl groups from NF-κB subunit p65, which suggests an 
inhibitory effect of selective HDAC3 inhibition on NF-κB signaling (51). In 
our study, NF-κB subunit p65 accumulation in the nucleus was increased 
by VPA treatment (Fig 3, G). However, whether this led to increased 
DNA binding activity of p65 in the nucleus of endothelial cells, or was 
dependent on the effect of certain HDAC subtypes was not part of the 
research question addressed here and hence not studied. 
Our present study has several strengths and weaknesses. A strong 
point is the combination of studying in vitro and in vivo pharmacological 
effects of VPA and BAY11-7082 on endothelial pro-inflammatory 
behavior. The in vitro study enabled us to determine the effects of drugs 
on endothelial cells, which was confirmed by the in vivo study in which 
we examined the molecular consequences of drug intervention in the 
mouse model of HS/resuscitation in the complex context of the whole 
organism. A first limitation is that the differences between in vitro 
and in vivo drug effects, as well as the discrepancies between protein 
and mRNA expression of endothelial adhesion molecules in organs in 
response to drug interventions, are still not completely understood. 
At the mRNA level, both VPA and BAY11-7082 significantly reduced 
TNFα-induced upregulation of endothelial adhesion molecules and 
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pro-inflammatory cytokines in vitro. When studied in the organs in the 
mouse HS model, neither drug showed strong effects on the mRNA levels 
of endothelial activation in kidney, lungs or liver (Fig 5, D-F). At the same 
time, however, the protein levels of endothelial adhesion molecules in 
the specific microvascular beds in the kidney and liver were extensively 
reduced (Fig 6).These discrepancies arepossibly due to the fact that the 
behavior of endothelial cells within the organism are controlled by their 
microenvironment, including mechanical forces and interactions with 
leukocytes and other cell types, which cannot be easily mimicked in vitro. 
Furthermore, the link between the changes in mRNA level and protein 
level in vivo is not as clear as it is in vitro,due to the complexity of the 
organism. In addition, endothelial behavior is dependent on different 
microvascular beds in different organs as reflected by,e.g., the different 
basal mRNA expression of genes in different organs (Supplementary 
table 1), as well as the glomerulus-restricted upregulation of E-selectin 
protein in the kidney after HS (Fig 6, B and C). The microvascular 
bed specific behavior of endothelial cells is concealed when mRNA 
expression profiles arestudied in whole organs and can be unmasked 
using laser microdissection of microvascular beds from organs prior to 
mRNA analysis (10, 45). Another issue is that it is difficult to directly 
translate our data from mice to HS patients. Translation is hindered 
because patients are faced with multiple comorbid diseases which are 
not mimicked in the healthy young male mice in our study. Moreover, 
the surgical rescue procedures and intensive care measures were not 
simulated in our animal model. In addition, while shock patients are 
resuscitated with fluid regimens including crystalloids, human colloids, 
and blood products, 4% human albumin in 0.9% NaCl was used as 
the fluid regimen for resuscitation in our study. We chose this colloid 
regimen in order to compare the results with our previous studies in 
which a 6% hydroxyethyl starch (HES) 130/0.4 was used as a colloidal 
resuscitation fluid (5, 9). Care should be taken when extrapolating data 
from one study to the other, as endothelial microvascular behavior 
might be different when using different resuscitation fluids. For example, 
the response of cremaster microvasculature in rats resuscitated with 
crystalloid and colloid infusion fluids after HS differs (52), and the choice 
of resuscitation fluids influences neutrophil activation and soluble 
plasma levels of endothelial adhesion molecules in trauma patients (53).
Our observations however give rise to some options for translation, 





and the analyses of soluble cell adhesion molecules and organ biopsies 
of patients who died during HS can be instrumental to validate the 
observations described here in patients (54, 55).
In summary, the current work demonstrated that in vivo inhibition 
of HDAC activity as well as IKK/NF-κB signaling activation during 
resuscitation resulted in an attenuation of endothelial inflammatory 
response induced by HS/resuscitation. The protective effects of 
these interventions as therapeutic strategies for the treatment of HS-
associated systemic inflammation needs further study, encompassing 
validation in larger animal models and examination of specimens from 
HS patients. 
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Table 1. Basal expression of genes investigated in this study in kidney, lungs, and 
liver of healthy mouse
mRNA expression levels of genes in healthy control mice was analyzed in kidney, lungs 
and liver using real time RT-PCR. GAPDH was taken as housekeeping gene. Data are 
expressed as the mean of relative mRNA level vs. GAPDH (minimum-maximum) from 
8 mice per group.
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Microvascular endothelial cells play a pivotal role in the pathogenesis 
of sepsis-induced inflammatory responses and multiple organ failure, 
therefore they represent an important target for selective pharmacolo-
gical intervention in the treatment of sepsis. Dexamethasone is a gluco-
corticoid that is widely used in clinical practice due to its pleiotropic 
and strong anti-inflammatory effects. Therefore, the current study was 
aimed to investigate the effects of endothelial targeted delivery of dexa-
methasone in a mouse model of endotoxemia induced by two consecu-
tive i.p. injections of lipopolysaccharide (LPS “double hit”). To achieve 
endothelial cell specific delivery of dexamethasone, we modified SAINT-
O-Somes, which are  conventional liposomes combined with the cati-
onic amphiphile SAINT-C18 (1-methyl-4-(cis-9-dioleyl) methyl-pyridini-
um chloride, with antibodies against vascular cell adhesion protein-1 
(VCAM-1). In LPS “double hit” challenged mice, dexamethasone loaded 
anti-VCAM-1 SAINT-O-Somes specifically localized at VCAM-1 expres-
sing endothelial cells in the microvasculature of inflamed organs. This 
was associated with attenuation of the expression of pro-inflammatory 
genes in kidney and liver although to a limited extent. In contrast, the 
systemic administration of free dexamethasone hardly had any effects 
on the microvascular inflammatory response. This study reveals that 
endothelial targeted dexamethasone containing anti-VCAM-1 SAINT-O-
Somes improve the pharmacological effects of dexamethasone in the 
treatment of sepsis compared to systemic administration of free dexa-
methasone although the effects were limited. Further pharmacokinetic 
and pharmacodynamic studies will reveal whether dexamethasone con-
taining anti-VCAM-1 SAINT-O-Somes are suitable nanotherapeutics for 
endothelial directed delivery of drugs in the treatment of inflammatory 
diseases like sepsis.
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Introduction
Sepsis is characterized by uncontrolled systemic inflammation 
triggered by infections, and is the most common cause of death among 
hospitalized patients [1]. Sepsis has a wide range of clinical symptoms 
and can lead to the dysregulation of the immune system and ultimately 
multiple organ dysfunction syndromes (MODS) [2, 3]. Despite substantial 
efforts in understanding the pathophysiology of sepsis and investigating 
potential therapeutic strategies, effective treatment of sepsis remains a 
clinical challenge [4]. 
Glucocorticoids were used in the treatment of sepsis patients because 
they were thought to diminish systemic and tissue inflammation and 
restore organ function [5, 6]. Glucocorticoids exert their effects by 
binding to intracellular glucocorticoid receptors (GRs) in the cytoplasm 
which then translocate into the nucleus. There the GR complex regulates 
inflammatory responses through transactivation of anti-inflammatory 
genes and inhibition of nuclear factor kappa B (NF-κB) and activator 
protein (AP)-1 driven inflammatory mediators such as cytokines and 
adhesion molecules [7]. The molecular mechanisms of glucocorticoids 
are considered appropriate to counteract the uncontrolled inflammation 
in sepsis [6]. However, systemic administration of glucocorticoids can 
lead to immunodeficiency due to their effects on immune cells [8]. 
Moreover, recent evidence showed that hydrocortisone does not 
improve survival or reverse the shock state in patients with septic shock 
[9]. Therefore, effective strategies are urgently needed to improve the 
therapeutic effects of glucocorticoids on sepsis induced MODS while 
avoiding their side effects.
In sepsis induced MODS, activated endothelial cells play a central 
role by orchestrating the recruitment of leukocytes from blood into 
underlying tissue through expression and/or release of adhesion 
molecules, cytokines, and chemokines as well as by regulating vascular 
barrier functions [10]. Moreover, their accessibility for intravenously 
administered substances and their heterogeneity allows for organ 
microvascular and/or disease specific drug delivery. Upon inflammatory 
stimulation, a vascular bed specific pattern of cell adhesion molecules 
such as E-selectin and vascular cell adhesion molecule (VCAM)-1 is 
induced [11], providing opportunities for specific delivery of therapeutic 
reagents to diseased (micro)vascular endothelial subsets [12]. 





Selective delivery of therapeutic reagents can be achieved using 
liposomes that are designed to encapsulate pharmacologically active 
entities. When liposomes are modified with monoclonal antibodies, they 
become high-capacity drug carriers with binding specificity for selective 
epitopes [13]. We have previously demonstrated that endothelial 
specific delivery of liposome-encapsulated dexamethasone, a clinically 
applied glucocorticoid, attenuates the expression of pro-inflammatory 
genes in a murine model of glomerulonephritis without affecting 
blood glucose levels as the side effect of systemic administration 
of dexamethasone [14]. To create superior intracellular release of 
their content in endothelial cells compared to conventional liposome 
technology, we have designed a new generation of liposomes, SAINT-
O-Somes, by combining the cationic lipid SAINT-C18 (1-methyl-4-(cis-9-
dioleyl) methyl-pyridinium chloride) with conventional liposomes [15]. 
These SAINT-O-Somes targeted to E-selectin and VCAM-1 can effectively 
deliver small inference RNA into inflamed endothelial cells both in vitro 
and in vivo [16, 17]. 
In the current study, we aimed to evaluate the targeting specificity 
of dexamethasone loaded anti-VCAM-1 (Ab
VCAM-1
) SAINT-O-Somes to 
inflamed endothelium in sepsis as well as their effects on microvascular 
endothelial behavior in vivo. Endotoxemia induced by a single injection 
of lipopolysaccharide (LPS) has been frequently used as a model for 
sepsis as it mimics many of the initial immune responses of clinical 
sepsis [18]. To simulate the host response to a more continuous LPS 
presence and to extend the duration of the response as often occurs 
in sepsis patients, we set up an LPS “double hit” model in which 
animals were challenged with two consecutive i.p. injections of LPS. 





activated endothelial cells in vitro and their accumulation at the site 
of inflamed microvasculature in vivo, and studied the pharmacological 
effects of endothelial targeted dexamethasone on endothelial cells in 
response to the “double hit” of LPS. 
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Cholesterol (Chol) was obtained from Sigma (St. Louis MO, USA). 
1-methyl-4-(cis-9-dioleyl) methyl-pyridinium-chloride (SAINT-C18) was 
obtained from Synvolux Therapeutics Inc. (Groningen, The Netherlands). 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 2-distearoyl-
sn-glycero-3-phosphoethanolamine-N- [methoxy(polyethylene 
glycol)-2000] (DSPE-PEG2000) and 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethyleneglycol)-2000]-
maleimide (Mal-PEG2000 -DSPE) were obtained from Avanti Polar Lipids 
(Alabaster AL, USA). 
Antibodies 
E1/6-aa2 (mouse IgG1 anti-human VCAM-1 antibody) monoclonal 
antibody-producing hybridoma were kindly provided by Dr. M. 
Gimbrone from Harvard Medical School (Boston, MA, USA). The M/K-
2.7 (rat IgG1a anti-mouse VCAM-1 antibody) producing hybridoma 
was obtained from American Type Culture Collection (ATCC, Manassas, 
VA, USA). Rat IgG antibody (irrelevant IgG) was purchased from Sigma-
Aldrich (Zwijndrechet, The Netherlands).
Other reagents
N-succinimidyl-S-acetylthioacetate (SATA) was obtained from Sigma 
(St. Louis, MO, USA). Nucleic acid stain Hoechst 33342 (trihydrochloride) 
and lipophilic tracer 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-
indocarbocyanine perchlorate (DiI) were obtained from Molecular 
Probes (Leiden, The Netherlands).
Preparation and characterization of SAINT-O-Somes and liposomes 
Lipids from stock solutions in chloroform : methanol (9 : 1), i.c., Chol, 
POPC, SAINT-C18, DSPE-PEG2000 and Mal-PEG2000-DSPE, were mixed 
in a mol% ratio of 40 : 37 : 18 : 4 : 1, for the preparation of SAINT-O-
Somes. For the preparation of liposomes, POPC, Chol, DSPE-PEG2000 
and Mal-PEG2000-DSPE were mixed in a mol% ratio of 55 : 40 : 4 : 
1. To label the SAINT-O-Somes and liposomes fluorescently, DiI was 





added to the lipid mixture in a 0.25 mol% ratio of total lipid (TL). The 
lipids were dried under a stream of nitrogen. To form dexamethasone 
containing SAINT-O-Somes and liposomes, the lipids were hydrated 
in 145 mM dexamethasone disodium phosphate solution (Pharmacy 
UMCG, Groningen, The Netherlands). To form control SAINT-O-Somes 
without dexamethasone, the lipids were hydrated in HN buffer (135 
mM NaCl, 10 mM HEPES, pH 6.7). The concentration of lipids during 
the hydration was 40 µmol TL/ml. After hydration, 10 cycles of rapid 
freezing (liquid nitrogen) and thawing (warm water, 40 °C) were 
performed. The formed SAINT-O-Somes and liposomes were sized by 
repeated and successive extrusion at 40 °C through polycarbonate 
filters (Costar, Cambridge MA, USA) with pore sizes of 200 nm, 100 
nm, and 50 nm (5 times each). Free dexamethasone was removed 
by gel chromatography on a Sephadex G-50 column (Sigma-Aldrich, 
Zwijndrecht, the Netherlands) using HN buffer (pH 6.7) as eluent. SATA-
modified anti-human VCAM-1, anti-mouse VCAM-1, respectively rat 
IgG antibodies were coupled to these SAINT-O-Somes and liposomes by 
the sulfhydryl maleimide method as described before for albumin [19]. 
After extrusion, gel chromatography, and protein coupling, the diameter 
of the SAINT-O-Somes and liposomes was measured using dynamic light 
scattering (DLS) in the volume weighing mode (NICOMP particle sizing 
systems, Santa Barbara, CA, USA). The SAINT-O-Somes and liposomes 
were characterized by determining the amount of coupled protein using 
rat IgG as a standard and the total lipid concentration was determined 
by phosphorus assay as described before [10].
Cell culture
Human umbilical vein endothelial cells (HUVEC) were obtained 
from the Endothelial Cell Facility of the UMCG. HUVEC were isolated 
from at least two umbilical cords to circumvent donor bias, and were 
cultured on 1% gelatin (Sigma, Zwijndrecht, The Netherlands) coated 
flasks with medium (RPMI 1640, Lonza, BE) supplemented with 20% 
heat inactivated FCS (Fetal Calf Serum; Thermo Scientific HyClone, 
Cramlington, UK), 2 mM Glutamine (Lonza, Breda, The Netherlands), 
5 U/ml heparin (LEO-Pharma, Amsterdam, The Netherlands), 50 μg/ml 
endothelial cell growth factor, 100 μg/ml streptomycin (Rotexmedica 
GmbH, Trittau, Germany) and 100 IU/ml penicillin (Astellas Pharma, 
Meppel, The Netherlands).
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Analysis of SAINT-O-Some association with HVUEC by fluorescence 
microscopy and flow cytometry
For fluorescence microscopy, HUVEC were cultured on 8-well LabTek 
chamber slides (Nunc, Rochester, NY, USA). Cells were activated with 
two times lipopolysaccharide (LPS, 1 µg/ml, Escherichia coli, serotype 
0.26 : B6l, Sigma, St. Louis, MO, USA)  in medium containing 5% FCS 
(37 °C, 5% CO2), with 3h in between. 2h after the first stimulation, 
Dil labeled anti-VCAM-1 respectively non-targeted SAINT-O-Somes 
containing dexamethasone (80 nmol TL/ml) were added to the cells for 
another 4h. Cell nuclei were stained using Hoechst 33342 (10 µg/ml) for 
the last 10 min of the incubation. In the end, cells were washed twice 
with ice-cold serum-free culture medium, placed on ice, and subjected 
to imaging within 45 min. Fluorescence images of cells were taken with 
a Leica DM/RXA fluorescence microscope (Wetzlar, Germany) using 
Quantimet HR600 image analysis software (Leica). Images were taken 
at excitation/emission wavelengths of 550/570 nm for DiI, and 350/461 
nm for Hoechst 33342.
For flow cytometry experiments, HUVEC were seeded in 24-well 
plates. Cells were stimulated with LPS (1 µg/ml) and incubated with 
SAINT-O-Somes in a similar way as described for the fluorescence 
microscopy experiments. For competition experiments, a 50-fold excess 
of anti-VCAM-1 monoclonal antibodies over the amount of antibodies 
coupled to the SAINT-O-Somes were added to the cells together with 
the liposomes. 5h or 21h after addition of SAINT-O-Somes, cells were 
washed with PBS and detached from the surface using trypsin/EDTA 
(Sigma, Ayrshire, UK) after which they were immediately transferred to 
tubes containing PBS with 5% FCS and kept on ice. Next, samples were 
centrifuged for 5 min at 500 g at 4 °C, followed by two wash steps with 
3 mL of PBS/5% FCS and resuspended in 0.2 ml PBS for flow cytometry 
analysis (Calibur, BD Biosciences, Franklin Lakes, NJ, USA). When flow 
cytometry was performed the following day, cells were fixed with 0.5% 
paraformaldehyde in PBS and stored at 4 °C. 






Male C57bl/6OlaHsd mice (18-23 g) were purchased from Harlan 
(Zeist, the Netherlands) and randomly divided into experimental groups. 
The animals were housed individually and maintained on a mouse chow 
diet in a temperature and light-dark cycle controlled environment (24 °C, 
12 : 12h). All intravenous (i.v.) injections were performed in the orbital 
plexus under general anesthesia (inhalation of isoflurane/O
2
). 
To induce systemic inflammation, the mice were injected 
intraperitoneally with LPS in 0.9% NaCl at a dose of 1 mg/kg. Three 
hours later, the mice received the second dose of LPS (1 mg/kg). For the 
intervention groups, 2h after the first injection of LPS, the mice were 
administered a single dose of free dexamethasone or dexamethasone 
containing SAINT-O-Somes respectively liposomes conjugated with 
either anti-VCAM-1 or irrelevant IgG antibody. To compare the different 
effects between one time and two times LPS challenge, one group of 
mice was injected with a single dose of LPS (2 mg/kg, i.p.) followed by 
an injection of 0.9% NaCl 3h later. Physical appearance and behavior 
of the mice were observed until termination 24h after the first LPS 
injection. At 24h, the mice were anesthetized with isoflurane/O
2
, 
subsequently blood was withdrawn via cardiac puncture. Organs were 
harvested and immediately snap frozen in liquid nitrogen or embedded 
in paraffin. Frozen organs were stored at -80 °C until analysis. All animal 
experiments were performed according to national guidelines and upon 
approval of the local Animal Care and Use Committee of the University 
of Groningen. 
Gene expression analysis by real-time RT-PCR
Total RNA was isolated from tissue cryosections of mouse kidney, 
lungs and liver using the RNeasy Mini plus Kit, (Qiagen, Westburg, 
Leusden, The Netherlands) according to the manufacturer’s instructions. 
Integrity of RNA was determined by gel electrophoresis, while RNA 
concentration (OD260) and purity (OD260/OD280) were measured 
using a NanoDrop® ND-1000 UV-Vis spectrophotometer (NanoDrop 
Technologies, Rockland, DE, USA). cDNA synthesis and real-time PCR 
were performed as described previously [20]. The Assay-on-Demand 
primers purchased from Applied Biosystems (Nieuwerkerk aan den 
IJssel, The Netherlands) for quantitative PCR included the housekeeping 
gene GAPDH (Glyceraldehyde-3-phosphate dehydrogenase, assay ID 
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Mm99999915_g1), CD31 (Platelet endothelial cell adhesion molecule, 
PECAM-1, assay ID Mm00476702_m1), VE-Cad (VE-Cadherin, assay ID 
Mm00486938_m1), KLF2 (Kruppel-like factor-2, assay ID Mm00500486_
g1), Tie2 (receptor tyrosine kinase, assay ID Mm00443242_m1), Ang2 
(Angiopoietin-2, assay ID Mm00545822_m1), E-selectin (assay ID 
Mm00441278_m1), VCAM-1 (vascular cell adhesion molecule-1, assay 
ID Mm00449197_m1),  ICAM-1 (intracellular adhesion molecule-1, assay 
ID Mm00516023_m1), MCP1 (monocyte chemotactic protein 1, assay 
ID Mm00441242_m1), IL-6 (Interleukin-6, assay ID Mm00446190_m1), 
IL-8 (Interleukin-8, assay ID Mm00433859_m1), TNF-α (tumor necrosis 
factor α, assay ID Mm00443258_m1), NGAL (Neutrophil gelatinase-
associated lipocalin, assay ID Mm01324470_m1), and Kim1 (Kidney 
injury molecule 1, assay ID Mm00506686_m1). Quantitative PCR was 
performed in a ViiATM 7 real-time PCR System (Applied Biosystems, 
Nieuwerkerk aan den IJssel, The Netherlands). Gene expression levels 
were normalized to the expression of the housekeeping gene GAPDH 
(glyceraldehyde-3-phosphate dehydrogenase). The mRNA levels relative 
to GAPDH were calculated by 2-ΔCT values and averaged per group. The 
fold changes of gene expression relative to the control was calculated 
by 2-Δ ΔCT.
Protein quantification by Enzyme-linked immunosorbent assay (ELISA) 
The concentration of neutrophil gelatinase associated lipocalin 
(NGAL) in plasma was measured by ELISA (Quantikine®, R&D Systems, 
Minneapolis, USA) according to the manufacturer’s instruction. 
Immunohistochemical and immunofluorescent detection of adhesion 
molecule protein and localization of anti-VCAM-1 dexamethasone 
SAINT-O-Somes and liposomes in mouse tissues
Tissue cryo sections (5 µm) were fixed in acetone for 10 min. 
Endogenous peroxidase was blocked by 10 min incubation with 
Peroxidase Block (EnVision + System-HRP (AEC), DAKO, Carpentaria, CA, 
USA). For immunohistochemical detection of specific proteins, sections 
were incubated for 60 min at room temperature with primary rat anti 
mouse antibodies (10 μg/ml) recognizing E-selectin (MES-1, 10 µg/ml, 
kindly provided by Dr. Derek Brown, UCB Celltech, Brussels, Belgium) 
and VCAM-1 (1: 50, clone M/K-2.7, ATCC, Manassas VA, USA) diluted 
in PBS/5% fetal calf serum (FCS, Sigma-Aldrich). This was followed by 





30min incubation with unconjugated rabbit anti-rat IgG antibody (mouse 
adsorbed, Vector Laboratories, Burlingame, CA, USA) diluted 1: 300 in 
PBS/5% FCS supplemented with 2% normal mouse serum (Sanquin, 
Amsterdam, the Netherlands) at room temperature. Sections were 
then incubated for 30 min at room temperature with anti-rabbit labeled 
polymer HRP antibody from the EnVision kit (DAKO). Between incubations 
with different antibodies, sections were washed extensively with PBS. 
Peroxidase activity was detected with 3-amino-9-ethylcarbazole (AEC) 
from the EnVision kit and sections were counterstained with Mayer’s 
hematoxylin (Merck, Darmstadt, Germany).
Direct immunohistochemical detection of dexamethasone 
containing anti-VCAM-1 and IgG SAINT-O-Somes and liposomes after i.v. 
administration was performed on the cryo sections with rabbit anti-rat 
antibody (Vector) in PBS/2% normal mouse serum and using EnVision 
kit to detect peroxidase activity as described above. 
Immunofluorescence double staining for immunoliposomes and CD31 
was performed as previously described [14]. Briefly, endogenous biotin 
was blocked by a Biotin Blocking System (DAKO, Glostrup, Denmark). 
Anti-VCAM-1 and IgG dexamethasone SAINT-O-Somes and liposomes 
were detected with Alexa Fluor®
555
-conjugated donkey anti-rat antibody 
(cat.no. A-31572, Molecular Probes, Leiden, The Netherlands) diluted 
1:100 in PBS/5% FCS in the presence of 2% normal mouse serum. To 
detect CD31, sections were incubated with biotin conjugated rat anti-
mouse CD31 primary antibody (1: 200, cat. no. #550274, BD Pharmingen, 
San Diego, CA, USA), followed by AlexaFluor®
488
-conjugated streptavidin 
(1: 100, Molecular Probes) plus 2% normal mouse serum. All incubation 
steps were carried out in the presence of 5% FCS (Sigma-Aldrich). After 
proper washing, sections were then incubated with 0.1% Sudan Black 
B (Sigma-Aldrich) in 70% ethanol for 30 min. Slides were washed with 
PBS and mounted using Aqua Poly/Mount medium (Polysciences, 
Warrington, PA, USA) containing DAPI (4’,6-Diamidino-2-Phenylindole, 
Dihydrochloride; Molecular Probe), air dried for 24h, and stored in 
the dark at 4 °C. Fluorescence images were taken with a Leica DM/
RXA fluorescence microscope using Quantimet HR600 image analysis 
software (Leica, Wetzlar, Germany).
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 dexamethasone SAINT-O-Somes specifically associate with 
LPS-activated primary endothelial cells in vitro 
Anti-VCAM-1 SAINT-O-Somes were prepared to achieve specific 
delivery of dexamethasone to activated endothelial cells. LPS 
“double hit” activated HUVEC were incubated with DiI (red) labeled 
dexamethasone SAINT-O-Somes to determine the binding of SAINT-O-
Somes to endothelial cells. Fluorescence microscopy showed increased 
association of Ab
VCAM-1
 SAINT-O-Somes with LPS-activated HUVEC 
compared to non-activated cells (Figure 1A). In addition, SAINT-O-Somes 
without anti-VCAM-1 antibodies on their surface were not taken up by 
either resting or activated cells. To prove that the uptake of targeted 
SAINT-O-Somes by activated endothelial cells was mediated by VCAM-
1, cells were co-incubated with an excess of free antibody against 
the target protein VCAM-1. The significant decrease in binding of DiI 
(red)-labeled Ab
VCAM-1
 SAINT-O-Somes to LPS-activated HUVEC in the 
presence of excess anti-VCAM-1 antibodies confirmed the specificity 
of association of Ab
VCAM-1
 SAINT-O-Somes with VCAM-1 expressed by 
activated HUVEC (Figure 1B). 
Two consecutive challenges of LPS result in microvascular responses in 
organs comparable to those after a single LPS challenge 
We compared the microvascular responses of mice subjected to 
endotoxemia induced by an LPS “double hit” and a single LPS challenge. 
24h after the initial challenge, the gene expression of pro-inflammatory 
adhesion molecules and cytokines in kidney, lungs, and liver upon 
the LPS “double hit” challenge was comparable with their expression 
induced by a single LPS injection (Figure 2, A, B, C). 24h after the first 
LPS challenge, Tie2 mRNA expression was decreased in lungs compared 
to saline control while not affected in kidneys and liver. In addition, 
downregulation of VE-cadherin was also restricted to lungs at this time 
point. The expression of Ang2 was lower in single and double hit LPS 
mice than in untreated mice in both lungs and liver at 24h. The increase 
of kidney damage markers NGAL and Kim1 was significantly higher 
upon LPS “double hit” challenge compared to the levels induced by 
single LPS administration. Since there was no extensive difference in the 
microvascular pro-inflammatory responses at 24h between the single 





Thesis Ranran Li.indb   130 20-08-15   14:03
209753-L-sub01-bw-Li
131
Endothelial targeted delivery of dexamethasone in sepsis
5
challenge and “double hit” of LPS, we focused our further analysis on 
the LPS “double hit” model.
The LPS “double hit” challenge results in abundant VCAM-1 expression 
and leukocyte recruitment in kidney, lungs, and liver
Twenty four hours after LPS “double hit” challenge, VCAM-1 
was abundantly expressed in most of the  microvascular segments 
of the organs investigated, i.c., arterioles, peritubular capillaries 
and post-capillary venules in kidney, arterioles in lungs, and large 
venules and sinusoidal endothelium in liver (Figure 3). Furthermore, 
immunohistochemical staining of CD45 suggests that the adhesion/
infiltration of CD45+ leukocytes in the microvasculature was increased 
following LPS challenge. 
Ab
VCAM-1
 dexamethasone SAINT-O-Somes and liposomes localization 
follows the expression patterns of VCAM-1 protein in the 
microvasculature of organs of LPS challenged mice
We hypothesized that in the LPS “double hit” animals, the first LPS 
challenge allows Ab
VCAM-1
 SAINT-O-Somes/liposomes to home to their 
target vasculature when administered to the mice 2 hours after the first 
Figure 1-Ab
VCAM-1 
dexamethasone SAINT-O-Somes specifically associate with LPS-
activated primary endothelial cells in vitro.
Human umbilical vein endothelial cells (HUVEC) were stimulated twice with LPS. 
The second stimulation was given 3h after the first challenge. Then quiescent 
respectively LPS activated HUVEC were incubated with anti-VCAM-1 and non-
targeted dexamethasone containing SAINT-O-Somes (dex SOS). (A) Fluorescence 
microscopy images show the uptake of targeted SAINT-O-Somes by activated HUVEC 
after 4h incubation. The liposome membrane was labeled with Dil (red) and the 
nuclei of the cells were stained using Hoechst (blue). Original magnification 400x. 
(B) Specificity of Ab
VCAM-1
 SAINT-O-Some association to VCAM-1 was determined by 
co-incubation of cells with 50 times excess of anti-VCAM-1 monoclonal antibodies 
together with Ab
VCAM-1
 SAINT-O-Somes. After 3h respectively 21h co-incubation, 
the association of SAINT-O-Somes with activated HUVEC was quantified by flow 
cytometric analysis. Data are presented as mean florescence intensity (MFI) values 
± SD of triplicate samples from one experiment. *, P < 0.05, Ab
VCAM-1
 SAINT-O-
Somes vs. non-targeted SAINT-O-Somes; #, P<0.05, association of Ab
VCAM-1 
SAINT-O-
Some with LPS stimulated HUVEC vs. unstimulated HUVEC; &, P<0.05, significant 
difference between with or without excess anti-VCAM-1 antibodies.





Figure 2-Two consecutive challenges of LPS result in microvascular responses in 
organs comparable to those induced by a single LPS challenge.  
Mice were challenged with LPS by one single i.p. injection (2mg/kg) or two consecutive 
injections (1mg/kg per injection)，with the second injection 3h after the first challenge. 
Twenty four hours after the initial challenge, mRNA expression of endothelial pro-
inflammatory molecules, vascular integrity related molecules, blood flow-sensitive 
transcription factor KLF2 in kidney (A), lungs (B), and liver (C), and kidney damage 
related markers NGAL and Kim1 (A) were determined by real time RT-PCR using GAPDH 
as housekeeping gene. All data are presented as fold change relative to saline control. 
Values are shown as mean ± SD (n = 6 per group). *. P<0.05, 1xLPS respectively 2xLPS 
vs. control; #, P<0.05, 2xLPS vs. 1xLPS. 
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recruitment in organs.
Immunohistochemical staining of adhesion molecule VCAM-1 and CD45 positive 
leukocytes. Staining was performed on organ sections of control mice and mice 
challenged with two times of LPS with 3 hours in between. Mice were sacrificed 
24h after the first challenge. VCAM-1 and CD45+ leukocytes stain red. Original 
magnification: 200x.





LPS injection. Immunohistochemical staining to determine the intra-
organ localization of SAINT-O-Somes/liposomes indeed showed homing 
of Ab
VCAM-1
 SAINT-O-Somes and liposomes which followed the expression 
patterns of VCAM-1 in kidney, lungs, and liver (Figure 4A). Both Ab
VCAM-1
 
SAINT-O-Somes and liposomes were visible in arterioles, venules and 
peritubular capillaries in the kidney, arterioles in the lungs, and large 
venules in the liver. Non-targeted IgG SAINT-O-Somes and liposomes 
were found to accumulate only in the glomerular compartment of the 
kidney while being undetectable in lungs and liver. The association 
of Ab
VCAM-1
 SAINT-O-Somes with endothelial cells was confirmed by 
double immunofluorescence staining showing the co-localization of 
Ab
VCAM-1
 SAINT-O-Somes and liposomes with CD31 mainly in the venules 
and arterioles of LPS challenged mouse kidney (Figure 4, B and C). 
The localization of Ab
VCAM-1
 SAINT-O-Somes and liposomes indicates 
association of the dexamethasone containing drug delivery devices with 




 dexamethasone SAINT-O-Somes and liposomes localization follows 
the expression patterns of VCAM-1 protein in the microvasculature of organs of LPS 
challenged mice.
(A) Immunohistochemical detection of VCAM-1 protein and localization of 
dexamethasone loaded SAINT-O-Somes respectively liposomes in kidney, lungs, and 
liver. LPS was administered intraperitoneally with 3 hours in between, and Ab
VCAM-1 
respectively IgG SAINT-O-Somes respectively liposomes were administered 2h after 
the first LPS injection. Mice were sacrificed 24h after the first LPS injection. VCAM-1 
expression was detected in LPS “double hit” challenged mice without intervention, and 
the localization of dexamethasone containing Ab
VCAM-1
 respectively IgG SAINT-O-Somes/
liposomes was detected in intervention groups. Black arrows indicate the location of 
SAINT-O-Somes and liposomes in kidney, lungs, and liver. Original magnification: 200x. 
The images are representative of 3 mice per group. 
Fluorescence microscopy images of double immunofluorescent staining for endothelial 
marker CD31 (green) and anti-VCAM-1 dexamethasone SAINT-O-Somes (B) and 
liposomes (C) (red) in kidney of LPS “double hit” mice 24h after the first LPS challenge. 
White arrowheads point at arterioles and venules and indicate the merged staining 
of CD31 and SAINT-O-Somes/liposomes. Original magnification: 400x. The images are 
representative of 2 mice per group.
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Effects of endothelial targeted Ab
VCAM-1
 dexamethasone SAINT-O-
Somes and liposomes in organs of LPS “double hit” mice
To determine the pharmacological effects of non-targeted respectively 
endothelial targeted dexamethasone, we analyzed the expression of 
inflammation and vascular integrity related genes in kidney, lungs, and 
liver of LPS challenged mice. The administration of free dexamethasone 
hardly had any effect in these organs except for the upregulation of KLF2 
in the kidney and the downregulation of VCAM-1 in liver (Figure 5, 6, 7). 
Both Ab
VCAM-1 
and non-targeted IgG dexamethasone liposomes similarly 
increased KLF2 expression in kidney, and decreased the expression of 
ICAM-1, IL-8, and TNFα in liver while they had no effect in lungs of LPS 
challenged mice. Non-targeted IgG dexamethasone SAINT-O-Somes only 
showed reduction of MCP1 and induction of KLF2 in the kidney while no 
effect was observed in lungs and liver (Figure 5, 6, 7). When Ab
VCAM-1 
dexamethasone SAINT-O-Somes were administered, in kidney of LPS 
challenged mice, the expression of ICAM-1 and IL-6 was downregulated 
and KLF2 was upregulated (Figure 5) while no effect was shown in 
lungs (Figure 6). In liver, they significantly decreased the expression of 
E-selectin, VCAM-1, ICAM-1, IL-8, and TNFα (Figure 7). 
With respect to organ injury, the plasma levels of kidney damage 
marker NGAL were markedly upregulated by both one time and two 
times LPS challenge, as shown in Figure 8, and were not affected by any 
of the therapeutic interventions studied.
Discussion
The microvascular endothelium plays a pivotal role in regulating 
the inflammatory processes associated with several diseases including 
sepsis, ischemia, and hemorrhage. Therefore, endothelial cell directed 
therapeutic interventions are considered promising approaches for 
anti-inflammatory treatment. In the present study, we first introduced 
a model of LPS “double hit” challenge induced endotoxemia, in which 
the inflammatory responses were comparable to a single challenge 
of LPS, demonstrating increased VCAM-1 expression and leukocyte 
recruitment in the microvasculature of organs. We then investigated 
the effectiveness of Ab
VCAM-1
 dexamethasone SAINT-O-Somes and 
conventional liposomes in inhibiting sepsis-associated microvascular 
endothelial cell responses. Both Ab
VCAM-1
 dexamethasone SAINT-O-Somes 
and conventional liposomes selectively homed to VCAM-1 expressing 
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Figure 5-Effects of endothelial targeted AbVCAM-1 dexamethasone SAINT-O-Somes 
and liposomes in kidney of LPS “double hit” mice
mRNA expression of endothelial pro-inflammatory molecules, vascular integrity related 
molecules, blood flow-sensitive transcription factor KLF2, and organ damage related 
markers NGAL and Kim1 in kidney was determined by real time RT-PCR using GAPDH 
as housekeeping gene. All data are presented as mRNA level relative to GAPDH. Values 
are shown as mean ± SD (n = 6 per group). *, P<0.05, free dexamethasone vs. 2xLPS; 
#, P<0.05, anti-VCAM-1 respectively IgG dexamethasone SAINT-O-Somes vs. 2xLPS; &, 
P<0.05, anti-VCAM-1 respectively IgG dexamethasone liposomes vs. 2xLPS.




5 Figure 6-Effects of endothelial targeted AbVCAM-1 dexamethasone SAINT-O-Somes and liposomes in lungs of LPS “double hit” mice
mRNA expression of endothelial pro-inflammatory molecules, vascular integrity related 
molecules, and blood flow-sensitive transcription factor KLF2 in lungs was determined 
by real time RT-PCR using GAPDH as housekeeping gene. All data are presented as 
mRNA level relative to GAPDH. Values are shown as mean ± SD (n = 6 per group). 
*, P<0.05, free dexamethasone vs. 2xLPS; #, P<0.05, anti-VCAM-1 respectively  IgG 
dexamethasone SAINT-O-Somes vs. 2xLPS; &, P<0.05, anti-VCAM-1 respectively IgG 
dexamethasone liposomes vs. 2xLPS.
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mRNA expression of endothelial pro-inflammatory molecules (cell adhesion molecules 
and cytokines), vascular integrity related molecules (Tie2, CD31, VE-cadherin, 
Ang2), blood flow-sensitive transcription factor KLF2 in liver was determined by real 
time RT-PCR using GAPDH as housekeeping gene. All data are presented as mRNA 
level relative to GAPDH. Values are shown as mean ± SD of each group (n = 6). *, 
P<0.05, free dexamethasone vs. 2xLPS; #, P<0.05, anti-VCAM-1 respectively IgG 
dexamethasone SAINT-O-Somes vs. 2xLPS; &, P<0.05, anti-VCAM-1 respectively IgG 
dexamethasone liposomes vs. 2xLPS.





endothelial cells in dedicated microvascular segments in organs of 
LPS challenged mice. The administration of Ab
VCAM-1
 dexamethasone 
SAINT-O-Somes effectively inhibited the expression of a number of pro-
inflammatory genes in kidney and liver of LPS challenged mice, whereas 
the administration of free dexamethasone hardly had any effect on the 
genes of interest. Possibly, dexamethasone containing Ab
VCAM-1
 SAINT-O-
Somes can be further developed to attenuate endothelial inflammatory 
responses, though extensive dose studies are warranted as the effects 
brought about in this study were limited.
Endothelial cell directed liposomes modified with ligands for 
specific receptors can improve therapeutic outcomes by increasing 
the drug concentration at the target tissue in the target cells and 
simultaneously preventing healthy tissue from drug exposure thereby 
reducing toxicity [13]. Endothelial cells are not equipped to process 
Figure 8-Effects of endothelial targeted Ab
VCAM-1
 dexamethasone SAINT-O-Somes and 
liposomes on the plasma level of NGAL 
Plasma concentration of NGAL protein in control mice, and mice challenged with one or 
two times LPS, and two times LPS-challenged mice treated with free dexamethasone, 
dexamethasone-loaded Ab
VCAM-1
 and IgG SAINT-O-Somes respectively liposomes was 
determined by ELISA. Data was shown as mean ± SD of each group (n = 6). *, P<0.05, 
1xLPS respectively 2xLPS vs. saline control.
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conventional liposomes, leading to inferior intracellular release of the 
delivered liposomal content. We previously showed that SAINT-O-
Somes, generated by incorporating the cationic pyridinium-derived lipid 
- SAINT - into the lipid bilayer of long circulating liposomes, have more 
efficient intracellular content release properties in endothelial cells 
[15]. In the present study, we observed that administration of Ab
VCAM-1
 
dexamethasone SAINT-O-Somes inhibited the induced expression of 
several pro-inflammatory genes in kidney and liver of mice challenged by 
LPS “double hit”, while the effects of Ab
VCAM-1
 dexamethasone liposomes 
was less pronounced. As both formulations were shown to accumulate 
in the same microvasculatures, this may imply that SAINT-O-Somes 
indeed exerted better release properties compared to conventional 
Ab
VCAM-1
 liposomes. It is of note that Ab
VCAM-1
 and IgG liposomes also 
decreased the expression of ICAM-1, IL-8, and TNFα in liver, which may 
be attributed to the uptake by Kupffer cells and macrophages in the liver 
through phagocytosis followed by local drug effects [21, 22].
VCAM-1 is an inducible endothelial cell adhesion molecule that 
is hardly expressed in resting endothelium and upregulated upon 
inflammatory stimulation during hemorrhagic shock and sepsis [11, 
23]. In the present study, after an LPS “double hit” challenge, VCAM-1 
was induced in all vascular segments, except in glomeruli in kidney, the 
latter corroborating a previous report from our group where glomeruli 
were shown to exert higher micro-RNA-126 expression which inhibits 
VCAM-1 protein translation [24]. Ab
VCAM-1
 SAINT-O-Somes and liposomes 
consequently homed to arterioles and venules, while non-targeted IgG 
SAINT-O-Somes and liposomes preferentially accumulated in glomeruli, 
which is likely a result of increased leakage of the glomerular capillaries 
due to LPS challenge [25]. Upon access via leakage, IgG liposomes 
may next be taken up by mesangial cells within glomeruli due to their 
phagocytotic properties where they also may exert pharmacological 
effects [26]. 
Because of their pleiotropic anti-inflammatory and immune-
modulatory effects, glucocorticoids have been used to treat a variety of 
inflammatory and immune diseases, including sepsis [6]. However, the 
therapeutic role of glucocorticoids in sepsis is controversial [4]. Annane 
et al have reported improved survival and reversal of shock in patients 
who received a 7-day treatment with low doses of hydrocortisone and 
fludrocortisone [27]. In contrast, Sprung et al have demonstrated that 





hydrocortisone had no significant effect on the rate of death in patients 
with septic shock at 28 days [9]. In the current work, the systemic 
administration of free dexamethasone hardly exerted any effect on LPS 
“double hit” induced microvascular endothelial inflammation. Several 
animal studies of sepsis have suggested that endothelial cell restricted 
inhibition of endothelial inflammatory signaling such as NF-κB is beneficial 
to the host while its inhibition in immune cells is detrimental to the 
host [28]. The difference in effect may in part explain the lack of clinical 
benefit of glucocorticoids in sepsis. We furthermore demonstrated that 
dexamethasone loaded Ab
VCAM-1
 SAINT-O-Somes were capable of partially 
attenuating the increased expression of inflammatory genes in kidney 
and liver. This may attributed to the ability of Ab
VCAM-1
 SAINT-O-Somes 
to increase local accumulation of their content in activated endothelial 
cells while to avoid drug access to immune cells, thereby enhancing 
the beneficial anti-inflammatory effects of dexamethasone. The limited 
instead of rapid and robust effects of Ab
VCAM-1
 dexamethasone SAINT-
O-Some may be due to the slow release property of the drug carrier 
in endothelial cells and additional investigations are necessary to shed 
light on these pharmacokinetic/pharmacodynamic issue as well.
The endothelium comprises a small part of the whole organ, thus 
pharmacological effects of endothelial cell targeted drugs may be 
masked when whole organ homogenates are analyzed [14, 17]. Laser 
microdissection in combination with quantitative RT-PCR enables 
analysis of effects in endothelial cells from specific vascular segment 
such as arterioles, venules, and glomeruli. Using laser microdissection 
prior to mRNA quantification, we previously demonstrated that targeted 
delivery of NF-κB subunit RelA specific siRNA by Ab
VCAM-1
 SAINT-O-Somes 
resulted in the downregulation of target genes in renal venules but not in 
glomeruli [17]. These data corroborated the immunofluorescence data 
that showed the homing of Ab
VCAM-1
 dexamethasone SAINT-O-Somes to 
these vascular segments. Laser microdissection of particular vascular 
beds is therefore needed to investigate whether pharmacological effects 
of endothelial cell targeted dexamethasone are concealed in the whole 
organ analysis as performed here.
Numerous therapeutic strategies that showed promising effects in 
animal models of sepsis have failed to demonstrate clinical efficacy 
in human clinical trials [29]. To study the pathophysiology in sepsis 
patients and test potential therapeutics for this condition, novel animal 
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models that are able to simulate the progress and severity of human 
sepsis as well as enable new therapeutic strategies to be investigated 
are urgently needed [2]. We expected the LPS “double hit” induced 
endotoxemia model to more closely resemble the pathophysiological 
scenario of sepsis patients, and thus, be better suited to characterize 
anti-inflammatory interventions. Furthermore, with this approach, the 
homing of targeted liposomes was allowed upon the first LPS injection, 
and the second hit of LPS was given within the hyper-inflammatory 
period of endothelial cells to achieve exaggerated inflammatory 
responses. We however found that the LPS “double hit” resulted in 
comparable microvascular inflammatory responses at 24h after the 
initial challenge as induced by a single challenge of LPS. A detailed 
study investigating the effects of single and double hit LPS at earlier, 
and later, time points than the 24h studied here should be pursued. In 
addition, since due to the transient inflammatory response following 
LPS administration, circulating cytokines such as TNFα and IL-6 (data 
not shown) as well as the expression of pro-inflammatory genes were 
not significantly increased anymore at 24h after the initial challenge. 
This makes it difficult to characterize the anti-inflammatory effects of 
endothelial targeted delivery of dexamethasone. Therefore, animal 
models of sepsis associated with sustained inflammation are required 
in future research. 
In summary, we here reported the specific accumulation of 
dexamethasone loaded anti-VCAM-1 SAINT-O-Somes in endotoxemia 
activated microvasculature, which represent a potential therapeutic 
approach to interfere with sepsis associated endothelial activation. 
Anti-VCAM-1 SAINT-O-Somes were demonstrated to improve the anti-
inflammatory effect of dexamethasone in the microvasculature of LPS 
“double hit” challenged mice compared to systemic administration of 
free dexamethasone. Future studies need to be performed to elucidate 
their real therapeutic benefit in the treatment of sepsis.
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Shock initiated by hemorrhage and sepsis is frequently encountered 
in the intensive care unit. One of the main complications of shock, 
multiple organ dysfunction syndrome (MODS), remains a major 
determinant of morbidity and mortality in patients in the intensive care 
units. Due to the complex mechanisms underlying the pathogenesis of 
shock, the treatment of this condition is still a big challenge and new 
pharmacological strategies are urgently needed. 
The vascular endothelium has a high sensing capacity and can 
swiftly respond to alterations in the local extracellular environment as 
occur under both physiological and pathophysiological conditions [1]. 
Microvascular endothelial cells play a crucial role in the pathogenesis 
of MODS in critical ill patients through sensing microcirculatory 
alterations and diminished blood pressure as well as regulating vascular 
permeability and leukocyte recruitment/transmigration into underlying 
tissue, leading to tissue injury and organ damage (as described in Chapter 
1). Endothelial cells constantly face mechanical forces associated with 
the local blood flow, and they can sense alterations in these mechanical 
forces and transform them into biochemical signals, modulating their 
morphology and function [2]. Microvascular endothelium is highly 
activated to a pro-inflammatory state during shock - induced by either 
hemorrhage or sepsis - through the expression of cytokines, chemokines, 
and adhesion molecules [1, 3]. In this thesis, we investigated potential 
therapeutic strategies for the treatment of shock associated changes 
in microvascular endothelial behavior in hemorrhage and sepsis. Our 
aims were to understand the role of microvascular flow alterations 
in regulating endothelial behavior and test the effects of different 
therapeutic interventions on the inflammatory activation status of 
microvascular endothelial cells created by flow alterations and cytokines 
both in vitro and in vivo. 
Shock is associated with a decrease and loss of intravascular blood 
flow. In Chapter 2, we investigated the role of flow cessation and the 
later recovery of flow as occur in shock and resuscitation in regulating 
endothelial behavior by dissecting the changes of flow from the other in 
vivo co-existing factors using an in vitro flow system [4]. We demonstrated 
that flow alterations per se contribute to endothelial pro-inflammatory 
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activation and that these alterations can interact with pro-inflammatory 
factors that co-exist in vivo during shock such as TNFα. The abrupt reflow 
related enhancement of cytokine-induced endothelial pro-inflammatory 
activation supports the concept that sudden regain of perfusion during 
resuscitation has an aggravating effect on endothelial pro-inflammatory 
activation, which may play a significant role in vascular dysfunction 
and consequent organ injury after recovery from hemorrhagic shock. 
This study implies that by improved resuscitation strategies and/or by 
pharmacological interference with pro-inflammatory signaling cascades 
during resuscitation following circulatory shock, the inflammatory 
responses of the microvasculature and associated organ dysfunction 
may be dampened. 
The expression of genes is partly regulated by posttranscriptional 
modifications, including histone (de)acetylation. In acute injuries, 
the homeostasis of histone (de)acetylation is disturbed in favor of 
increased activity of HDACs. Furthermore, IkappaB kinase (IKK)/NF-κB 
signaling plays a crucial role in regulating endothelial inflammatory 
activation. Based on the effects of flow alterations on endothelial cells 
in Chapter 2, we next studied flow alterations-associated molecular 
changes, i.c., histone acetylation and NF-κB activation, as well as the 
effects of pharmacological interventions at the level of these changes, 
on endothelial responses in the absence and presence of cytokine 
stimulation. In Chapter 3, we demonstrated that histone acetylation 
in steady flow-preadapted endothelial cells was significantly disturbed 
during the period of flow cessation as well as during subsequent acute 
reflow, showing decreased level of histone acetylation, which suggested 
a potential beneficial effect of histone deacetylase inhibitor valproic acid 
(VPA) on these processes. VPA treatment before the installment of 8h 
flow cessation significantly attenuated loss of flow-induced endothelial 
pro-inflammatory responses, both in the absence and presence of pro-
inflammatory cytokine TNFα. We furthermore showed that although 
the expression of IκB was not affected during loss of shear stress, 
pre-incubation with IKK inhibitor BAY11-7082 effectively inhibited the 
upregulation of pro-inflammatory molecules induced by flow cessation 
both in the absence and presence of TNFα. These results indicate that 
pharmacological intervention at the level of HDAC respectively NF-
κB activity may represent a potential therapeutic approach for the 





treatment of shock induced endothelial pro-inflammatory activation. 
In Chapter 4, we next investigated the effects of VPA and BAY11-
7082 administration to mice on microvascular endothelial responses 
and leukocyte adhesion in tissues during HS/resuscitation. In a model 
of pressure-controlled HS, the blood pressure was maintained at a 
mean arterial pressure (MAP) of 30 mmHg for 90 minutes, after which 
subgroups of mice were resuscitated with 4% human albumin as such, or 
supplemented with HDAC inhibitor VPA respectively IKK inhibitor BAY11-
7082. Mice were sacrificed at 1 hour or 4 hours after resuscitation was 
completed. An acute induction of both systemic and local inflammation 
occurred both before and after resuscitation following HS. The 
administration of either HDAC inhibitor VPA or IKK inhibitor BAY11-7082 
in the resuscitation fluid attenuated the pro-inflammatory activation of 
the microvasculature in kidney, lungs, and liver. The reduced protein 
expression of adhesion molecules was paralleled by diminished influx of 
polymorphonuclear leukocytes in kidney and liver after HS/resuscitation. 
The anti-inflammatory effects of VPA and BAY11-7082 administration in 
the resuscitation phase indicated that HDACs and IKK/NF-κB signaling 
are important targets for therapeutic intervention in the treatment of 
HS/resuscitation patients that warrant follow up studies.
As described in Chapter 1, the clinical hallmarks of shock, hypotension, 
vascular leakage, and leukocyte recruitment-mediated inflammation, 
are regulated at the level of endothelial cells. Endothelial cells are both 
active participants and mediators in the pro-inflammatory process. 
Thus endothelial-targeted delivery of drugs presents an interesting anti-
inflammatory intervention that may also be able to assist in creating a 
better understanding of the role of endothelial cells in shock related 
inflammatory processes. Dexamethasone is a glucocorticosteroid which 
has pleiotropic anti-inflammatory and immunosuppressive effects. Local 
delivery of dexamethasone can be instrumental to counteract its adverse 
effects while maintaining its desired effects on the target cells of interest. 
In Chapter 5, we thus formulated dexamethasone into SAINT-O-Somes 
modified with antibodies against adhesion molecule VCAM-1, one of 
the molecular determinants expressed on the lumen surface of inflamed 
endothelial cells. To evaluate the targeting specificity and efficacy 
of dexamethasone loaded anti-VCAM-1 (Ab
VCAM-1
) SAINT-O-Somes, 
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an LPS “double hit” induced mouse model of sepsis was applied, in 
which animals were challenged with two consecutive injections of 
LPS, and Ab
VCAM-1
 dexamethasone SAINT-O-Somes were administered 
in between. We showed that Ab
VCAM-1
 dexamethasone SAINT-O-Somes 
were specifically delivered into LPS activated endothelial cells in the 
microvasculature in kidney, lungs, and liver. Moreover, compared to 
the administration of free dexamethasone and dexamethasone loaded 
conventional liposomes, Ab
VCAM-1
 dexamethasone SAINT-O-Somes were 
capable of decreasing the expression of several pro-inflammatory 
genes in kidney and liver of mice challenged with two times of LPS. This 
work reveals that endothelial cell targeted delivery of dexamethasone 
by anti-VCAM-1 SAINT-O-Somes represents a potential therapeutic 
approach to interfere with sepsis associated endothelial activation. The 
real therapeutic impacts of this strategy in more clinical relevant model 
of sepsis need to be further investigated. 
II. Conclusions 
NF-κB signaling could be a potential target for therapeutic intervention 
of microcirculation alteration-associated endothelial inflammation. 
The subsequent in vivo study on pharmacological intervention 
during resuscitation after hemorrhagic shock demonstrated the anti-
inflammatory effects on microvascular endothelial cells of HDAC 
activity inhibition and IKK/NF-κB signaling blockade, providing a lead 
for future therapeutic targeting of these two mechanisms in clinical 
trials. Furthermore, the administration of dexamethasone containing 
anti-VCAM-1 SAINT-O-Somes in a mouse model of LPS “double hit” 
induced endotoxemia achieved specific drug delivery to LPS activated 
endothelium and resulted in anti-inflammatory effects in kidney and 
liver. Future studies need to be performed with more clinical relevant 
animal models and with immunoliposomes loaded with more effective 
drugs to elucidate their real therapeutic beneficial in the treatment of 
sepsis.
The active involvement of microvascular endothelial cells in the 
pathogenesis of shock and their responses to drug interventions 
suggest that these cells deserve more attention in the development of 
therapeutic strategies for the treatment of shock induced organ failure.






Shock is associated with a high morbidity and mortality, and prompt 
recognition and medical management are essential to correct the 
cause of shock and stabilize the associated physiological disturbances 
[5]. Effective therapeutic strategies for the treatment of shock patients 
remain a challenging conundrum in clinical care. Microvascular 
endothelium, being highly sensitive to its extracellular dynamic 
environment, plays an important role in the pathophysiology of (micro)
circulatory shock and its deranged function is associated with multiple 
organ dysfunction syndrome (MODS) following a systemic inflammatory 
response. Therefore, microvascular endothelial cells represent an 
attractive target for the development of novel therapies to reverse the 
inflammatory response in shock. A number of interesting issues are 
considered relevant for future research and will be discussed below.
Engineering a more physiological environment to study endothelial 
behavior in vitro
Current cell culture conditions for drug development fail to simulate 
the body’s cellular microenvironment and instead lead to loss of function 
in primary cell culture. To be specific, while endothelial cells in vivo are 
subjected and presumably adapted to natural levels of shear stress 
generated by blood flowing over their luminal surfaces, most studies 
have been performed with endothelial cells under static conditions. It 
is important to note that endothelial cells tend to adapt themselves 
to different microenvironments [6, 7]. The expression of certain genes 
may drift significantly in endothelial cells after being isolated from 
their organ microenvironment and cultured under static conditions 
for a few days [8]. This drift indicates that environmental factors such 
as hemodynamic forces play crucial roles in controlling endothelial 
functions in vivo. Even though over the past two decades in vitro studies 
on the influence of shear stress on vascular endothelial cell function 
have provided considerable insights [9], it is still urgently needed to 
engineer a more physiological environment for cell cultures to achieve 
in vitro results that better predict in vivo behavior. 
Laminar shear stress exposure for a prolonged period of time will 
render endothelial cells in a more physiological state, facilitating the 
translation of in vitro study to in vivo conditions. Vascular endothelium 
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responds to alterations in the level of blood flow, which may contribute 
to the pathophysiology of diseases associated with an increase or 
decrease in tissue perfusion. A period of laminar shear stress adaptation 
is necessary to elicit a response of endothelial cells to changes in shear 
stress level [10], therefore flow adapted endothelial cells have been 
used in our studies to determine the consequences and molecular 
mechanisms of flow disturbances as occur in, e.g., sepsis and hemorrhagic 
shock. Our in vitro work provided evidence that removal of flow and 
subsequent application of acute reflow are capable of activating flow-
preconditioned endothelial cells [4], indicating a contributing effect of 
blood flow alterations to shock associated pathogenesis. Abrupt flow 
cessation simulated ischemia in vitro was demonstrated to induce the 
generation of reactive oxygen species (ROS) in flow adapted pulmonary 
endothelial cells [11, 12], which recapitulated the events as occurred in 
an ex vivo lung model due to stopped perfusion [13, 14]. Collectively, 
these findings have helped us to understand loss of flow associated 
endothelial responses. What should be kept in mind is that vascular 
endothelial cells are highly heterogeneous in response to extracellular 
stimuli [15], thus it is possible that endothelial cells from different 
vascular segments adapt in a different way to local blood flow and will 
differently respond to mechanical stress depending on their position 
in the vascular system. Further studies are required to elucidate these 
differences to gain a full understanding of the role of this cellular milieu 
in determining endothelial function, and the potential of mimicking 
parts of it in an in vitro context. 
To improve the in vitro context, co-culture of aortic endothelial 
cells with smooth muscle cells under shear stress has been used 
to be representative of arteries in the study of the pathogenesis of 
atherosclerosis [16]. Laminar shear stress induced increase of anti-
inflammatory microRNA-146a expression in aortic endothelial cells 
co-cultured with smooth muscle cells declined due to flow stagnation, 
which was next validated in vivo in neointima formation in injured 
arteries [17]. In addition, it has been reported that the presence of 
pericytes surrounding perfused microvasculature has a dramatic effect 
on vessel functions such as vasoconstriction and permeability, and 
that human lung microvasculature can be mimicked by the co-culture 
of primary human lung microvascular endothelial cells and pericytes 
under perfusion [18]. This novel co-culture based vascular models 





allows building tissue and disease specific microvasculature which are 
more suitable for tissue- or disease-specific drug testing in vitro.
Besides flow, a variety of other important factors such as the 
diffusion of cell secretions as well as the concentration gradients of 
supplied nutrient and oxygen cannot be controlled under standard 
static conditions in vitro, which will lead to non-physiological cell 
environment and limit cellular development [19]. Recently developed 
options to mimic in vivo controlled microenvironment during in vitro 
culture include a multi-organ chip (MOC) microfluidic platform. It allows 
co-culture of multi-tissues, including primary cells, tissue equivalent, 
and tissue biopsies, under dynamic flow conditions over prolonged 
periods [20]. This MOC system enables prediction of interactions 
between co-cultured cells and tissues and better evaluation of drugs 
under development for their preclinical performance in vitro. 
Microcirculation as a therapeutic target in the treatment of shock
Homeostasis of the microcirculation becomes severely altered 
during critical illness. Microcirculatory dysfunction has been considered 
to initiate a sequence of events that leads to MODS and represent a 
key factor for poor outcome [21]. We have investigated flow alterations-
associated endothelial pro-inflammatory activation [4] and the 
involvement of histone deacetylation and NF-κB activation in these 
processes in our in vitro studies. Although not the scope of this thesis, 
the microcirculation as a therapeutic target in the treatment of shock 
needs further attention. 
Observations of microcirculatory alterations in animals and patients 
have helped us to better understand the pathophysiology of shock-
associated multiple organ failure [22]. Moreover, clinical research has 
identified various therapeutic approaches that have effectively modified 
the microcirculation. The administration of low-dose hydrocortisone has 
been reported to slightly improve sublingual microvascular perfusion in 
septic shock [23], although it did not improve survival or reverse shock 
at these doses [24]. Furthermore, the use of vasodilators in shock may 
increase the local blood flow in specific microvascular regions, thereby 
(re)perfusing hypoxic regions and improve organ functions [25]. In 
addition, besides effectively increasing arterial pressure, vasopressors 
such as norepinephrine could improve perfused capillary density in 
patients with baseline sublingual perfusion [26]. However, the effects 
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of vasodilators and vasopressors on different microvascular beds in 
organs are largely unknown. It is of note that the clinical effectiveness 
of these approaches may be affected by the considerable variation in 
the response of patients. It needs to be determined whether enhancing 
the microcirculation will contribute to improving the outcome of 
individual critically ill patients and include the amelioration of systemic 
inflammatory response, vascular permeability, and organ function.
In the clinic, a patient’s response to resuscitation following circulatory 
shock can be monitored by means of careful clinical evaluation and 
blood lactate measurements [5]. Bedside techniques are still required 
to allow the evaluation of the microcirculation, including determination 
of tissue perfusion and oxygenation [5]. Recently, the so called 
sidestream dark-field imaging technique has been applied to visualize 
and assess perioperative perfusion in the sublingual microcirculation 
during cardiopulmonary bypass [27], septic shock [28], and traumatic 
hemorrhagic shock [29]. The therapeutic end points of microcirculation 
for resuscitation have not been defined yet so that monitoring of the 
microcirculation is still not ready for routine clinical practice. Further 
preclinical studies with microcirculation improvement-controlled 
resuscitation strategies will provide more insight in the consequences 
of improved microcirculation on shock-associated responses such as the 
systemic and local production of pro-inflammatory cytokines, oxygen 
delivery, and tissue damage.
Improving preclinical animal models for sepsis study
Due to the limited availability of effective therapeutic strategies 
for sepsis, it is critically needed to improve our understanding of the 
pathophysiology of sepsis and to disclose novel targets for therapeutic 
interventions of critically ill patients. Despite substantial efforts, 
numerous therapeutic strategies that have had promising effects in 
animal models of sepsis have failed to demonstrate clinical efficacy in 
clinical trials [30], which may be attributed to the complexity of the 
causes and processes of sepsis in the patient and the limited clinical 
relevance of present animal models [30, 31]. 
Animal models are crucial in translational research. A clinical 
relevant animal model of sepsis should be capable of reproducing the 
complexity of human sepsis, including the pace and severity, and hyper-
inflammatory to immunosuppressive stages [32]. An LPS “double hit” 





mouse model was applied in our study to simulate the host response 
to more episodes of infection and to extend the severity and duration 
of the response as often occurs in sepsis patients. We found that the 
consecutive injection of LPS did not improve the model compared to 
traditional single injection of LPS. This may be explained by the doses 
of LPS used, time interval between the two injections, or LPS injection 
induced endotoxin tolerance of immune cells which is characterized by 
reduced sensitivity to endotoxin re-challenge [33]. Although endotoxin 
tolerance was initially thought to be a beneficial adaptive response of 
the host, it may be associated with immune dysregulation and the risk 
of secondary infections, which complicates the management of patients 
with severe sepsis and organ dysfunction [33]. For example, the initial 
endotoxin priming in the Shwartzman phenomenon is essential to 
induce lethality [34]. Low dose endotoxin priming (5 µg LPS, intradermal 
injection) induced endotoxin tolerance 24h prior to an LPS challenge 
(300 µg, intravenous injection) is accountable for the development of 
microvascular thrombosis in lung and liver via the Shwartzman reaction 
and for subsequent organ failure following sepsis [35]. The dose of the 
priming endotoxin and the timing interval until the secondary endotoxin 
challenge are critical determinants for the host responsiveness [33], and 
should be further studied to establish a more clinically relevant sepsis 
model.
Furthermore, sepsis is often encountered in the presence of other 
comorbidities such as other initial injuries including burn and traumatic 
hemorrhage [36], and other pre-existing diseases, e.g., chronic kidney 
disease [37], which will influence the host response to sepsis and 
should be taken into account in therapy. Therefore, complex animal 
models of human sepsis would be more suitable for testing therapeutics 
compared to simple animal models as they may more accurately predict 
drug responsiveness in humans. To this end, a two-stage mouse model 
consisting of pre-existing injuries or disease and subsequent sepsis may 
be more helpful to understand the pathophysiological mechanisms of 
sepsis patients and to better characterize the potential of therapeutic 
strategies. In the study by Gierer et al [38], pre-existing traumatic injury 
exaggerated the inflammatory response to subsequent LPS challenge. 
In addition, the incidence of sepsis increases with age, and elderly 
patients are more prone to sepsis [39, 40]. Moreover, from a clinical 
perspective, treatments comparable to the standard supportive therapy 
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for ICU patients should be included in animal studies to mimic the 
clinical conditions more optimally and to test the underlying benefit of 
new therapeutic interventions. By incorporating these variables in one 
animal model, we can distinguish the amplifying factors in sepsis and 
discover suitable therapeutic targets for different subpopulations of 
sepsis patients based on their distinct pathophysiological mechanisms. 
Analysis of (post-mortem) human biopsy samples is also an important 
tool to verify and extrapolate animal studies to human trials, 
complementing human plasma analysis to provide relevant human data 
of sepsis [41].
Endothelial directed therapeutic strategies for the treatment of shock
For the treatment of shock either induced by hemorrhage or sepsis, 
resuscitation is the first-line therapy, but it might not improve the 
outcome of shock patients although restoring systemic perfusion [42]. 
Therefore, to move forward, investigations have focused on potent 
pharmacological agents to add to resuscitation regimens to minimize 
cell and tissue injury and maintain or recreate physiological homeostasis 
[43]. The vascular endothelium is widely recognized as a critical 
component in maintaining physiological homeostasis and regulating 
pathological responses to injury. Thus, endothelial cells are important 
targets for therapeutic interventions in the treatment of shock. 
In our study, the administration of histone deacetylase (HDAC) 
inhibitor valproic acid (VPA) respectively IKK inhibitor BAY11-7082 
as an adjunct to resuscitation after hemorrhagic shock showed anti-
inflammatory effects in the microvasculature, suggesting a possible 
role for these drugs in the treatment of shock associated multiple 
organ failure. However, systemic intervention of HDAC activity and 
IKK/NF-κB signaling likely will have side effects as both enzymes are of 
importance for maintaining cellular functions. First, the broad effects 
of VPA as a pan HDAC inhibitor on different cell types may be related 
to its reported side effects including coagulopathies, aplastic anemia, 
and hepatotoxicity [44]. The water-soluble property of the drug allows 
for formulation of VPA into immunoliposomes that can be modified 
to achieve endothelial specific delivery, thereby counteracting the 
underlying toxicity of systemic administration. However, we found that 
VPA leaked out rapidly after being formulated into liposomes (data not 
shown). This may be due to the amphiphilic structure of VPA with the 





hydrophobic part buried in the phospholipid bilayer, which destabilizes 
the liposomal membrane. To address this problem, chemical strategies 
can be used to modify the hydrophobic part into a more hydrophilic 
part, thereby increasing the retention time of incorporated drug in 
the liposomal core and the stability of drug loaded liposomes. It is of 
interest in future studies to evaluate the efficacy of chemically modified 
VPA loaded endothelial targeted immunoliposomes in animal models of 
sepsis and hemorrhagic shock, to create a better understanding of the 
consequences of endothelial specific delivery of VPA for microvascular 
performance in these diseases. 
Furthermore, general blockade of NF-κB signaling is capable of 
ameliorating the pathological profiles of several inflammatory diseases 
such as rheumatoid arthritis [45], hemorrhagic shock [46], and sepsis 
[47]. However, NF-κB activation is also involved in the resolution of 
inflammation and thus may differently affect inflammatory processes 
depending on the cell type in which it is active and the development stage 
of the disease [48]. Moreover, NF-κB is of importance in maintaining 
cell survival and various organ functions, and general blockade of NF-
κB signaling by small molecule inhibitors is associated with serious side 
effects [49]. Therapeutic strategies targeting NF-κB signaling specifically 
in endothelial cells help to determine the effects of endothelial specific 
inhibition of NF-κB signaling on tissue damage in these inflammatory 
diseases. Using a recombinant “sneaking ligand construct” (SLC)-1 
which contains an E-selectin targeting domain, a Pseudomonas exotoxin 
A translocation domain, and a NF-κB essential modifier-binding effector 
domain, specific inhibition of NF-κB activation in activated endothelial 
cells in arthritis was achieved [50]. This strategy revealed that the 
inflammatory processes were critically dependent on endothelial NF-
κB activation, thereby providing a proof of concept for the therapeutic 
application of endothelial cell specific NF-κB blockade in this immune 
disease [50]. 
In addition, new molecular drugs such as small interfering RNAs 
(siRNAs) offer high molecular specificity and potent silencing of disease 
associated genes [51]. Due to the physicochemical properties, siRNAs 
need to be formulated into a delivery system in order to modify their 
pharmacokinetic profiles, reduce off-target toxicity, and to improve their 
therapeutic efficacy [52]. The cellular and molecular concepts of targeted 
delivery of siRNAs to activated endothelial cells have been reviewed by 
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Kowalski et al [53]. NF-κB subunit RelA siRNA loaded SAINT-O-Somes 
conjugated with antibodies against VCAM-1 expressed on activated 
endothelial cells have been demonstrated to be capable of attenuating 
endothelial inflammatory response in the renal microvasculature 
towards LPS induced endotoxemia through silencing the expression of 
RelA in endothelial cells [54]. 
Although potential benefits of endothelial targeted therapeutics 
have been demonstrated, it cannot be ignored that multiple cell types 
are participants and/or regulators in the complex processes of systemic 
inflammation and tissue injury [55]. In our in vivo study of hemorrhagic 
shock, we observed that hemorrhagic shock and subsequent 
resuscitation resulted in the activation of neutrophils and monocytes 
in the circulation (Figure 1), which corroborated other previous studies 
[56, 57]. Furthermore, the recruitment and transmigration of leukocytes 
Figure 1. Activation status of neutrophils and monocytes in systemic circulation of 
mice after hemorrhagic shock and resuscitation.
Neutrophils (A) and monocytes (B) from fresh whole blood were stained for Ly6G, 
CD11b, CD62L, and CD80. The percentage of CD11b positive and CD62L negative 
neutrophils relative to the total number of Ly6G stained neutrophils as well as the 
percentage of CD80 positive monocytes relative to total number of monocytes was 
quantified. Data represent mean ± SD of 4 mice per group. *, P<0.05, 1h respectively 
4h after resuscitation vs. control. R, resuscitation.





into underlying tissues plays a pivotal role in tissue injury [58]. Therefore, 
effects of pharmacological interventions on leukocytes may significantly 
influence the outcomes of shock associated inflammation. It thus needs 
to be established what the real extent of effects on disease outcome is 
of endothelial cell targeted therapeutic interventions. 
In summary, shock is often a fatal disease in the intensive care unit 
that involves complex pathophysiological processes. Early recognition 
and monitoring of risk factors as well as effective therapeutic modulation 
of the inflammatory immune response should be the aim of future 
therapy of shock. Preclinical in vitro and in vivo translational models are 
required to better understand the vascular consequences of MODS in 
critically ill patients based on which novel therapeutic options can be 
developed in future investigations. 
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Shock is een levensbedreigende situatie die kan ontstaan door 
bijvoorbeeld grote bloedingen (hemorrhagische shock) of door een 
bacteriële infectie (septische shock). Shock wordt gekenmerkt door een 
sterke bloeddrukdaling als gevolg waarvan het hartritme omhoog gaat 
en tegelijkertijd een verminderde doorbloeding van organen optreedt. 
Tevens worden er ontstekingsmoleculen (cytokines) gemaakt en hopen 
cellen van het afweersysteem zich op in de organen en beschadigen 
deze. Voor patienten in shock die worden behandeld op de eerste hulp, 
en in de operatie kamers en de intensive care units van ziekenhuizen, 
is op dit moment geen andere behandeling mogelijk dan het opheffen 
van de oorzaak van de bloeding of de infectie, het op peil brengen 
(resuscitatie) en daarna in stand houden van de doorbloeding, het 
mechanisch ondersteunen van organen die functieverlies vertonen en, 
zo nodig, het toedienen van antibiotica. 
Het onderzoek in dit proefschrift beschrijft de effecten van acute 
bloeddrukverlaging gevolgd door resuscitatie op de cellen die de 
binnenkant van de kleinste bloedvaatjes in de organen bekleden, de 
endotheelcellen. In shock voelen deze cellen direct dat de bloeddruk 
daalt als gevolg van de verminderde bloeddoorstroming. Ook ervaren 
zij als eerste wanneer de dokter met vloeistof de bloeddruk weer op 
peilt brengt. 
De belangrijkste vraagstelling in dit onderzoek was wat de effecten 
van bloedstroom-veranderingen zijn op endotheelcellen op moleculair 
niveau, en of deze effecten farmacologisch kunnen worden geremd, 
met als doel afweercelinflux en orgaanschade te voorkomen of 
verminderen. De nadruk hierbij lag op twee moleculaire systemen die 
in diverse ziekten verantwoordelijk worden geacht voor het controleren 
van ontstekingsstatus van (endotheel)cellen, te weten de NFkB (nuclear 
factor kappaB) en HDAC (histone deacetylase) signaaltransductie/
genexpressieroutes. Voor beide routes bestaan farmacologische 
mogelijkheden om ze te blokkeren, zowel met gerichte remmers als 
met de weinig specifiek werkende ontstekingsremmer dexamethason, 
een in de kliniek veel gebruikt geneesmiddel uit de klasse van de 
corticosteroiden. Er is in endotheelcelkweken en in muizenmodellen van 
shock gekeken naar de effecten van deze remmers op endotheelactivatie, 
orgaanfunctie en afweercelinflux in de organen. 





De opvallendste uitkomsten van het uitgevoerde onderzoek zijn 
dat acute (bloed)stroomveranderingen op zichzelf de endotheelcellen 
activeren tot een toestand waarin ze afweercellen kunnen aantrekken, en 
dat de aanwezigheid van bij shock aangemaakte ontstekingsinducerende 
cytokines deze activatie versterkt. In endotheelcelkweken leidt remming 
van de intracellulaire NFκB en HDAC routes als boven beschreven tot 
effectieve blokkade van celactivatie. In het muizenmodel van bloeding 
gerelateerde shock hangt de mate van effectiviteit van remming af van 
het orgaan in het lichaam waar de bloedvaatjes zich bevinden, en net 
als in de celkweken reageren niet alle ontstekingsgerelateerde genen 
even sterk op de geneesmiddelinterventie. Het met immunoliposomen 
gericht afleveren van het corticosteroid dexamethasone in de 
endotheelcellen van muizen met sepsis liet eenzelfde effect zien: de 
effectiviteit van het geneesmiddel hangt af van het type bloedvat en 
niet alle ontstekings-geassocieerde genen reageerden even sterk op de 
therapeutische interventie. Verder onderzoek zal moeten uitwijzen of 
deze geneesmiddelen een toegevoegde waarde voor de behandeling 
van shock in patienten kunnen hebben.
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